enhancedcohort,startdate,linenumber,linesetting,linename,patientid,ismaintenancetherapy,enddate
NSCLC,3/13/2024,2,ADVANCED,Amivantamab-Vmjw,G2FB35E4B8C3C,FALSE,8/29/2024
NSCLC,2/22/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G24G:14D89BD9,FALSE,12/30/2019
NSCLC,12/19/2024,-1,ADJUVANT,Pembrolizumab,G26FC954B79DD,FALSE,4/15/2025
NSCLC,12/12/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G496F9G6DFG23,FALSE,12/18/2022
NSCLC,3/1/2018,1,ADVANCED,Osimertinib,G257459B7FF:E,FALSE,11/12/2019
NSCLC,3/18/2021,-1,ADJUVANT,Durvalumab,G4::3E61CFBB9,FALSE,5/15/2022
NSCLC,9/23/2016,2,ADVANCED,Pembrolizumab,G46E218G4252C,FALSE,12/16/2016
NSCLC,9/23/2022,1,ADVANCED,Pembrolizumab,G2D168F99BCD4,TRUE,2/21/2023
NSCLC,8/28/2020,-1,ADJUVANT,Off Systemic Therapy,G346FFEC8FE4C,FALSE,5/9/2023
NSCLC,4/11/2013,-1,ADJUVANT,"Carboplatin,Paclitaxel",G24C:63G27686,FALSE,6/30/2013
NSCLC,1/28/2019,2,ADVANCED,Pemetrexed,G221C:3FD2EGB,FALSE,3/31/2019
NSCLC,8/5/2017,5,ADVANCED,"Cisplatin,Gemcitabine,Necitumumab",G5762B778F:95,FALSE,6/22/2017
NSCLC,2/21/2015,2,ADVANCED,Paclitaxel Protein-Bound,G14FD45889171,FALSE,10/17/2015
NSCLC,4/15/2024,1,ADVANCED,Alectinib,G26F5C48G8168,FALSE,4/21/2025
NSCLC,11/8/2024,1,ADVANCED,Osimertinib,G4::3E61CFBB9,FALSE,2/17/2025
NSCLC,11/1/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G174FDF7E16C9,FALSE,2/2/2016
NSCLC,3/22/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G126:384BC665,FALSE,4/18/2015
NSCLC,6/21/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2F327FD5:2:3,FALSE,4/15/2025
NSCLC,9/11/2015,2,ADVANCED,Pembrolizumab,G4DE3DE99E:13,FALSE,11/18/2015
NSCLC,5/2/2022,-1,ADJUVANT,Durvalumab,G53C52948773G,FALSE,4/30/2023
NSCLC,4/27/2016,-1,ADJUVANT,Off Systemic Therapy,G4C2EB36BG3:G,FALSE,4/28/2018
NSCLC,8/19/2020,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,11/25/2020
NSCLC,9/22/2016,2,ADVANCED,"Bevacizumab,Cisplatin,Pemetrexed",G39G:1GDD6BB5,FALSE,5/8/2017
NSCLC,7/9/2018,2,ADVANCED,"Carboplatin,Gemcitabine",G26EFGF738125,FALSE,8/12/2018
NSCLC,12/4/2015,2,ADVANCED,Pemetrexed,G167G71733G69,FALSE,4/27/2016
NSCLC,2/25/2022,1,ADVANCED,Pembrolizumab,G557E997E81G5,TRUE,9/13/2022
NSCLC,2/23/2018,1,ADVANCED,Nivolumab,G25C4B:8:3FF2,FALSE,3/29/2018
NSCLC,9/4/2014,-1,ADJUVANT,"Carboplatin,Paclitaxel",G19E:848FD3G5,FALSE,11/29/2014
NSCLC,8/21/2021,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G3:F3B2CEG21C,FALSE,9/8/2021
NSCLC,5/15/2017,1,ADVANCED,Nivolumab,G1G618861EGD9,FALSE,4/3/2019
NSCLC,5/31/2024,-1,ADJUVANT,Off Systemic Therapy,G2518G1D763FB,FALSE,8/7/2024
NSCLC,4/28/2015,-1,ADJUVANT,Off Systemic Therapy,G3EC5EB18C676,FALSE,5/23/2016
NSCLC,5/14/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G15F6:966BBB3,FALSE,7/22/2016
NSCLC,10/13/2022,-1,NEOADJUVANT,"Carboplatin,Nivolumab,Pemetrexed",G138G5E13CC3:,FALSE,11/12/2022
NSCLC,1/31/2019,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G1B982CB17239,FALSE,4/20/2019
NSCLC,6/4/2016,-1,ADJUVANT,Off Systemic Therapy,G358EF4457D52,FALSE,4/30/2024
NSCLC,4/3/2014,1,ADVANCED,Docetaxel,G3C826F5CD726,FALSE,4/2/2014
NSCLC,4/22/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G5:919981B622,FALSE,6/25/2023
NSCLC,7/1/2013,1,ADVANCED,Vinorelbine,G19BD1725:45F,FALSE,11/11/2013
NSCLC,12/18/2014,1,ADVANCED,Pemetrexed,G1E35BD845958,TRUE,4/10/2015
NSCLC,5/28/2022,-1,ADJUVANT,Hydroxyurea,G41DE1E3BE99:,FALSE,4/15/2022
NSCLC,3/28/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1D4BED:EE889,FALSE,7/3/2023
NSCLC,11/8/2016,4,ADVANCED,Clinical Study Drug,G5762B778F:95,FALSE,6/19/2017
NSCLC,6/24/2016,3,ADVANCED,"Afatinib,Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,FALSE,11/1/2016
NSCLC,11/23/2021,-1,CONCURRENT,Off Systemic Therapy,G23ED3EB7B1B2,FALSE,5/9/2022
NSCLC,2/21/2019,1,ADVANCED,Pembrolizumab,G21953622CB66,FALSE,8/7/2019
NSCLC,11/14/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G45C13CFDDB84,FALSE,2/26/2015
NSCLC,10/26/2018,4,ADVANCED,Osimertinib,G26EFGF738125,FALSE,11/28/2018
NSCLC,5/15/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G1B913698546B,FALSE,6/30/2017
NSCLC,2/13/2020,-1,ADJUVANT,Off Systemic Therapy,G4992B5EB431G,FALSE,8/9/2020
NSCLC,6/22/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G1ED5EF238G3C,FALSE,7/31/2024
NSCLC,3/17/2016,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G1D:B49GGG719,FALSE,7/9/2016
NSCLC,5/19/2024,1,ADVANCED,Pembrolizumab,G2F5C96E2545B,FALSE,6/17/2024
NSCLC,4/28/2020,2,ADVANCED,"Afatinib,Osimertinib",G1542E4F46G4B,FALSE,8/5/2021
NSCLC,12/20/2019,1,ADVANCED,Pembrolizumab,G172GFE717:24,FALSE,3/26/2020
NSCLC,10/15/2024,-1,ADJUVANT,Off Systemic Therapy,G2GDF48F:5EGB,FALSE,4/8/2025
NSCLC,9/11/2020,-1,ADVANCED,Off Systemic Therapy,G29D9FB:D1D6B,FALSE,10/24/2020
NSCLC,2/27/2023,1,LOCOREGIONAL,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16DE246787:5,FALSE,5/24/2023
NSCLC,7/1/2023,1,ADVANCED,"Cisplatin,Pembrolizumab,Pemetrexed",G15DCCD:D9154,FALSE,7/31/2023
NSCLC,7/23/2022,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,1/8/2023
NSCLC,12/7/2019,1,LOCOREGIONAL,"Carboplatin,Pemetrexed",G3:67CF8FF:28,FALSE,4/16/2020
NSCLC,9/3/2024,1,ADVANCED,Osimertinib,G13C2:FDBFBC2,FALSE,5/10/2025
NSCLC,8/12/2021,1,ADVANCED,Clinical Study Drug,G3F2D34C5366D,FALSE,5/7/2022
NSCLC,1/28/2023,1,LOCOREGIONAL,Pembrolizumab,G199:3GD5C8:8,TRUE,3/2/2023
NSCLC,7/7/2024,1,ADVANCED,Durvalumab,G157317FG3387,TRUE,9/25/2024
NSCLC,7/2/2024,1,ADVANCED,Pembrolizumab,G1FD696E::692,FALSE,10/29/2024
NSCLC,5/18/2023,2,ADVANCED,Pembrolizumab,G1D3:96CE9334,FALSE,8/1/2023
NSCLC,10/1/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3E76E32E795:,FALSE,12/27/2019
NSCLC,8/12/2011,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G3:G31857DB4:,FALSE,12/13/2011
NSCLC,10/11/2024,4,ADVANCED,"Ipilimumab,Nivolumab",G3E76E32E795:,FALSE,3/30/2025
NSCLC,7/12/2024,-1,NEOADJUVANT,Off Systemic Therapy,G2::G3B8CFF4C,FALSE,3/8/2025
NSCLC,9/21/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G564F8B8:FB1E,FALSE,12/18/2022
NSCLC,2/4/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3B1F6B561ED5,FALSE,5/12/2019
NSCLC,11/8/2023,-1,ADJUVANT,"Carboplatin,Paclitaxel",G1EFD1E1::C6E,FALSE,1/18/2024
NSCLC,7/30/2020,3,ADVANCED,"Ipilimumab,Nivolumab",G3E76E32E795:,FALSE,8/29/2024
NSCLC,7/8/2020,1,ADVANCED,Pembrolizumab,G1983:3F:98B7,FALSE,7/22/2020
NSCLC,5/11/2024,1,ADVANCED,Durvalumab,G3B76E8182:B:,TRUE,2/4/2025
NSCLC,12/23/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:EBC916F5,FALSE,3/20/2022
NSCLC,10/25/2024,1,ADVANCED,Adagrasib,G16952:711:93,FALSE,12/18/2024
NSCLC,2/3/2014,1,ADVANCED,"Carboplatin,Docetaxel",G264:CC4B7D1:,FALSE,9/10/2018
NSCLC,8/23/2021,-1,ADJUVANT,Off Systemic Therapy,G1B4BCEG8F6B7,FALSE,11/22/2022
NSCLC,12/21/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2777F3E771D8,FALSE,2/21/2019
NSCLC,11/4/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G1B2469295BGE,FALSE,2/27/2014
NSCLC,12/5/2020,1,ADVANCED,Selpercatinib,G145E1G:C6189,FALSE,7/6/2021
NSCLC,5/31/2016,2,ADVANCED,"Carboplatin,Paclitaxel",G212CFB5F9B91,FALSE,1/18/2017
NSCLC,10/27/2017,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,5/24/2018
NSCLC,7/30/2014,-1,ADJUVANT,"Bevacizumab,Carboplatin,Paclitaxel",G1D21B52C3732,FALSE,10/6/2015
NSCLC,7/4/2018,2,ADVANCED,Nivolumab,G555D3D316568,FALSE,9/27/2018
NSCLC,1/12/2013,1,ADVANCED,Paclitaxel Protein-Bound,G2C2DDG:4G:32,FALSE,8/22/2013
NSCLC,10/15/2011,-1,ADJUVANT,Off Systemic Therapy,G579E53D92:75,FALSE,8/7/2014
NSCLC,6/16/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1B4BCEG8F6B7,FALSE,7/24/2021
NSCLC,1/28/2018,1,ADVANCED,Nivolumab,G5:3DFC66422C,FALSE,3/13/2019
NSCLC,9/2/2024,5,ADVANCED,Temsirolimus,G22GF5E64E49D,FALSE,1/2/2025
NSCLC,3/18/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1:CFD526E3::,FALSE,4/28/2025
NSCLC,8/9/2020,-1,ADJUVANT,Off Systemic Therapy,G52B74F86723D,FALSE,6/10/2023
NSCLC,11/5/2023,1,ADVANCED,Pembrolizumab,G554292GGE7B7,FALSE,4/27/2025
NSCLC,10/23/2023,-1,ADJUVANT,Ivosidenib,G13F761779185,FALSE,4/16/2024
NSCLC,11/16/2020,1,ADVANCED,"Carboplatin,Paclitaxel",G17177B5C7D7F,FALSE,2/13/2021
NSCLC,5/24/2024,2,ADVANCED,"Docetaxel,Ramucirumab",G3CG5712E:B54,FALSE,7/11/2024
NSCLC,8/21/2024,3,ADVANCED,"Carboplatin,Pemetrexed",G2FB35E4B8C3C,FALSE,8/27/2024
NSCLC,3/7/2017,-1,NEOADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,4/20/2017
NSCLC,10/10/2022,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G37374D4F9C65,FALSE,2/15/2023
NSCLC,2/16/2023,2,ADVANCED,Docetaxel,G38C61:99G266,FALSE,3/12/2023
NSCLC,6/20/2020,2,ADVANCED,"Dabrafenib,Osimertinib,Trametinib",G1B:1G86333FB,FALSE,10/3/2020
NSCLC,5/23/2016,-1,ADJUVANT,"Carboplatin,Paclitaxel",G15C9CDFE7236,FALSE,7/18/2016
NSCLC,3/6/2012,1,ADVANCED,"Carboplatin,Docetaxel",G2745:9D5G3DG,FALSE,3/5/2012
NSCLC,4/30/2014,1,ADVANCED,"Carboplatin,Docetaxel",G4ECBF26D2579,FALSE,8/8/2014
NSCLC,5/9/2020,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,10/20/2020
NSCLC,7/27/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G11E:D3E21E6:,FALSE,10/30/2024
NSCLC,3/1/2024,-1,ADJUVANT,Osimertinib,G2:737C75FGBF,FALSE,2/23/2025
NSCLC,12/13/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G28BE11563666,FALSE,2/7/2014
NSCLC,10/29/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G23ED3EB7B1B2,FALSE,11/23/2021
NSCLC,11/24/2021,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G557E997E81G5,FALSE,2/18/2022
NSCLC,2/4/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G54B14B192B6B,FALSE,1/28/2019
NSCLC,3/11/2025,1,ADVANCED,Durvalumab,G33:335715B9G,TRUE,4/24/2025
NSCLC,9/10/2016,-1,ADJUVANT,Palbociclib,G286G2E848134,FALSE,9/12/2016
NSCLC,4/17/2022,1,ADVANCED,"Anastrozole,Carboplatin,Paclitaxel",G1885B3G8447B,FALSE,8/1/2022
NSCLC,9/21/2016,1,ADVANCED,Rituximab,G27471:8B6217,FALSE,7/20/2018
NSCLC,4/1/2024,2,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G17G71B51EFE2,FALSE,5/17/2024
NSCLC,12/4/2023,5,ADVANCED,"Dabrafenib,Trametinib",G2D168F99BCD4,FALSE,12/1/2024
NSCLC,5/14/2023,1,ADVANCED,"Carboplatin,Durvalumab,Pemetrexed,Tremelimumab-Actl",G5722GECG4G16,FALSE,10/7/2023
NSCLC,1/3/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,TRUE,8/1/2021
NSCLC,1/5/2023,-1,ADJUVANT,Atezolizumab,G1445DG1:E6:D,FALSE,9/29/2023
NSCLC,7/26/2018,1,ADVANCED,Osimertinib,G1D:61B997689,FALSE,9/14/2018
NSCLC,10/9/2013,1,ADVANCED,Pemetrexed,G2E8B56477B83,FALSE,3/8/2014
NSCLC,11/5/2013,3,ADVANCED,Pemetrexed,G56CF8BF38D:7,FALSE,10/16/2014
NSCLC,8/26/2019,2,ADVANCED,Durvalumab,G58E33F7EG254,FALSE,12/7/2019
NSCLC,12/3/2017,3,ADVANCED,Nivolumab,G56B4BCB27428,FALSE,6/21/2023
NSCLC,7/1/2024,-1,ADJUVANT,Durvalumab,G1F23G9736:B3,FALSE,4/26/2025
NSCLC,11/10/2019,1,ADVANCED,"Cisplatin,Paclitaxel",G147ED4GE76EE,FALSE,11/20/2019
NSCLC,6/26/2019,-1,NEOADJUVANT,Off Systemic Therapy,G122G2D35B8CE,FALSE,12/11/2019
NSCLC,5/25/2023,-1,ADJUVANT,Durvalumab,G5:919981B622,FALSE,8/4/2023
NSCLC,7/10/2015,1,ADVANCED,Pemetrexed,G2628C28G7613,TRUE,10/17/2015
NSCLC,3/23/2018,1,ADVANCED,Afatinib,G1542E4F46G4B,FALSE,4/1/2020
NSCLC,5/4/2017,1,ADVANCED,Pemetrexed,G253:45FB2F1:,TRUE,12/30/2018
NSCLC,1/21/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G3C98:B743F7B,FALSE,6/15/2013
NSCLC,12/13/2019,1,ADVANCED,Pembrolizumab,G1C22CGB1F5C2,TRUE,9/12/2020
NSCLC,2/16/2025,1,ADVANCED,Durvalumab,G332:25G93F26,TRUE,5/1/2025
NSCLC,8/12/2024,2,ADVANCED,"Carboplatin,Paclitaxel",G437:CB1EF9DB,FALSE,3/26/2025
NSCLC,2/18/2016,1,ADVANCED,Clinical Study Drug,G4G3G:984BG53,FALSE,12/24/2016
NSCLC,10/6/2014,-1,ADJUVANT,Off Systemic Therapy,G16GE86G42194,FALSE,1/26/2015
NSCLC,8/6/2012,1,ADVANCED,"Carboplatin,Pemetrexed",G2263646BG1E5,FALSE,9/8/2012
NSCLC,11/11/2017,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G5:1C6DEC2:1:,FALSE,12/14/2017
NSCLC,10/22/2016,1,ADVANCED,"Cisplatin,Pemetrexed",G4C65C839C5CC,FALSE,11/30/2016
NSCLC,7/30/2016,2,ADVANCED,Temozolomide,G4B63:1C9D452,FALSE,11/4/2016
NSCLC,1/29/2024,-1,ADJUVANT,Durvalumab,G1GEF44EBD419,FALSE,8/5/2024
NSCLC,11/5/2015,-1,ADVANCED,Off Systemic Therapy,G134249173C:9,FALSE,10/26/2015
NSCLC,7/23/2024,-1,ADJUVANT,Anastrozole,G1F482136BDE5,FALSE,9/4/2024
NSCLC,10/28/2017,2,ADVANCED,Paclitaxel Protein-Bound,G545:2F182DD:,FALSE,9/30/2017
NSCLC,12/10/2014,1,ADVANCED,"Carboplatin,Gemcitabine",G1G:1C482FFGC,FALSE,1/6/2017
NSCLC,7/18/2023,4,ADVANCED,Gemcitabine,G1FFE6DDFB4DE,FALSE,8/25/2023
NSCLC,8/5/2023,3,ADVANCED,"Gemcitabine,Paclitaxel Protein-Bound,Pembrolizumab",G22GF5E64E49D,FALSE,5/2/2024
NSCLC,2/20/2019,4,ADVANCED,"Docetaxel,Gemcitabine,Vinorelbine",G1G78CEE:7E:3,FALSE,4/18/2019
NSCLC,7/9/2016,1,ADVANCED,"Carboplatin,Pemetrexed",G3GF73E51BG1F,FALSE,11/24/2016
NSCLC,10/3/2023,1,ADVANCED,Pembrolizumab,G36G688G4EBD6,TRUE,10/31/2023
NSCLC,9/28/2017,-1,ADJUVANT,Erlotinib,G2E99628474:8,FALSE,10/11/2018
NSCLC,4/1/2013,-1,NEOADJUVANT,Off Systemic Therapy,G259:1C2D4D19,FALSE,1/11/2015
NSCLC,2/1/2025,-1,ADJUVANT,Letrozole,G31G19E54FC:B,FALSE,5/16/2025
NSCLC,5/23/2022,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,12/14/2022
NSCLC,3/14/2016,-1,CONCURRENT,"Cisplatin,Etoposide",G5817G:99GE51,FALSE,6/6/2016
NSCLC,2/7/2019,2,ADVANCED,Afatinib,G21BD9C1D75:6,FALSE,6/13/2019
NSCLC,10/9/2021,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,4/10/2022
NSCLC,1/29/2024,-1,ADJUVANT,Off Systemic Therapy,G224DD757657B,FALSE,7/22/2024
NSCLC,3/9/2020,2,ADVANCED,"Docetaxel,Ramucirumab",G3E76E32E795:,FALSE,6/23/2020
NSCLC,7/1/2023,-1,ADJUVANT,Osimertinib,G1:F21E8E2D45,FALSE,3/15/2024
NSCLC,3/29/2017,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G19D32D1B89D8,FALSE,5/29/2017
NSCLC,8/17/2019,-1,ADJUVANT,Off Systemic Therapy,G1D41F368EE:G,FALSE,11/16/2019
NSCLC,7/18/2018,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1C8BC23336FC,TRUE,11/19/2018
NSCLC,1/10/2022,1,ADVANCED,"Carboplatin,Paclitaxel",G48FCG1D:D6C5,FALSE,5/5/2022
NSCLC,2/4/2015,4,ADVANCED,Etoposide,G3:D1D2EG5C21,FALSE,5/31/2015
NSCLC,3/12/2025,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G559EGF3BF82E,FALSE,5/4/2025
NSCLC,7/6/2023,-1,ADJUVANT,Nivolumab,G2DC29B:962F1,FALSE,12/14/2023
NSCLC,12/7/2012,2,ADVANCED,"Bevacizumab,Pemetrexed",G166B735:96D2,FALSE,7/24/2013
NSCLC,2/19/2019,1,ADVANCED,"Carboplatin,Pemetrexed",G4D2G1D2:G:5D,FALSE,5/10/2019
NSCLC,6/30/2016,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4ED3922EEE48,FALSE,10/4/2016
NSCLC,5/2/2016,3,ADVANCED,Alectinib,G53C61B2GG71F,FALSE,5/30/2016
NSCLC,2/10/2017,2,ADVANCED,Nivolumab,G1C49C5CC7:F7,FALSE,5/5/2017
NSCLC,4/28/2020,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1934B71378C6,TRUE,1/15/2023
NSCLC,2/11/2012,2,ADVANCED,Docetaxel,G283EB4BF8E72,FALSE,1/3/2012
NSCLC,7/23/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G3B8B956G8339,FALSE,9/20/2024
NSCLC,12/16/2023,-1,ADJUVANT,Off Systemic Therapy,G3316B72:E:48,FALSE,4/16/2025
NSCLC,8/27/2015,-1,ADJUVANT,Off Systemic Therapy,G1D21B52C3732,FALSE,4/24/2017
NSCLC,8/27/2019,-1,ADJUVANT,Off Systemic Therapy,G34BG69F45EE4,FALSE,10/31/2024
NSCLC,11/12/2022,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G4CF4FFFDGB63,FALSE,11/30/2022
NSCLC,10/23/2024,2,ADVANCED,Fam-Trastuzumab Deruxtecan-Nxki,G1G4D4C5D65E7,FALSE,4/19/2025
NSCLC,6/2/2024,4,ADVANCED,Vinorelbine,G22GF5E64E49D,FALSE,8/30/2024
NSCLC,11/11/2022,1,LOCOREGIONAL,Durvalumab,G2141CBEF3GD3,TRUE,11/25/2022
NSCLC,11/22/2021,1,ADVANCED,Pembrolizumab,G1653:4:85F6:,TRUE,4/23/2025
NSCLC,3/27/2016,-1,ADJUVANT,"Carboplatin,Pemetrexed",G55D6D2EG3F64,FALSE,4/10/2016
NSCLC,9/25/2021,1,ADVANCED,Pembrolizumab,G1C3CCC:C44GD,TRUE,7/23/2022
NSCLC,6/26/2014,-1,ADJUVANT,Off Systemic Therapy,G358EF4457D52,FALSE,5/15/2015
NSCLC,8/1/2016,3,ADVANCED,"Carboplatin,Pemetrexed",G137D67:GFD9F,FALSE,9/27/2016
NSCLC,1/14/2021,4,ADVANCED,Clinical Study Drug,G3:C9BECD3F55,FALSE,1/28/2021
NSCLC,1/2/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel,Pemetrexed",G283EB4BF8E72,FALSE,1/7/2012
NSCLC,4/14/2024,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G2216DG74F41B,FALSE,5/10/2024
NSCLC,6/5/2021,1,ADVANCED,"Atezolizumab,Carboplatin,Etoposide",G475BB:CGC731,FALSE,7/10/2021
NSCLC,4/28/2022,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,4/19/2022
NSCLC,2/16/2023,2,ADVANCED,Durvalumab,G4G84CDE8:3F:,FALSE,8/11/2023
NSCLC,7/17/2016,1,ADVANCED,"Carboplatin,Paclitaxel,Trastuzumab",G478G1D7C64C4,FALSE,12/10/2016
NSCLC,12/16/2018,2,ADVANCED,"Carboplatin,Paclitaxel",G462G467E1BF1,FALSE,2/18/2019
NSCLC,8/5/2021,1,ADVANCED,Atezolizumab,G475BB:CGC731,TRUE,4/3/2025
NSCLC,2/2/2014,1,ADVANCED,Erlotinib,G3:D1D2EG5C21,FALSE,9/3/2014
NSCLC,9/13/2014,2,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G1978F5FFE:43,FALSE,11/18/2014
NSCLC,4/21/2021,2,ADVANCED,Osimertinib,G4CG4:632GG8E,FALSE,9/19/2021
NSCLC,7/9/2023,1,ADVANCED,Osimertinib,G2GB:GBC6G568,FALSE,5/1/2025
NSCLC,12/4/2022,2,ADVANCED,"Gemcitabine,Pembrolizumab",G1934B71378C6,FALSE,10/3/2024
NSCLC,7/3/2023,1,ADVANCED,"Pembrolizumab,Pemetrexed",G44DDC8341D18,TRUE,3/3/2025
NSCLC,6/13/2015,1,ADVANCED,Nivolumab,G3G57E5:BG72C,FALSE,9/18/2015
NSCLC,5/19/2019,2,ADVANCED,Osimertinib,G4ED3922EEE48,FALSE,9/20/2022
NSCLC,5/10/2020,2,ADVANCED,Osimertinib,G2FF5BBF:G7GF,FALSE,10/25/2023
NSCLC,2/1/2020,-1,ADJUVANT,Off Systemic Therapy,G21C1861C3393,FALSE,9/20/2022
NSCLC,3/16/2020,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3GB7EGGB7:9D,FALSE,3/3/2020
NSCLC,2/14/2019,-1,ADJUVANT,Bortezomib,G37C2D6679F35,FALSE,7/24/2020
NSCLC,3/7/2017,1,ADVANCED,Pembrolizumab,G131892E39563,FALSE,12/24/2018
NSCLC,10/17/2019,-1,ADJUVANT,Durvalumab,G1CG8EF93777D,FALSE,5/3/2020
NSCLC,5/21/2019,1,ADVANCED,"Cisplatin,Pemetrexed",G5:D955C88D97,FALSE,9/25/2022
NSCLC,12/25/2019,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,6/29/2020
NSCLC,8/2/2013,3,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G2G7B3CB6D5C4,FALSE,9/17/2013
NSCLC,6/19/2024,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed,Sotorasib",G1D2821G451G:,FALSE,3/19/2025
NSCLC,2/21/2020,2,ADVANCED,Pembrolizumab,G4936::B67G17,FALSE,1/24/2021
NSCLC,4/2/2019,-1,ADJUVANT,Off Systemic Therapy,G2CCC3642E:67,FALSE,12/24/2019
NSCLC,1/9/2024,-1,ADVANCED,Off Systemic Therapy,G3G18F3E9E3C8,FALSE,2/5/2024
NSCLC,9/11/2017,1,ADVANCED,"Carboplatin,Paclitaxel",G4464DBGC:5B4,FALSE,3/3/2018
NSCLC,6/13/2015,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G1GC444DCD149,FALSE,8/13/2015
NSCLC,10/20/2012,1,ADVANCED,"Carboplatin,Gemcitabine,Paclitaxel",G15F86:BG28CB,FALSE,1/20/2014
NSCLC,8/2/2019,1,ADVANCED,"Carboplatin,Pemetrexed",G49E3CE9E292G,FALSE,10/24/2019
NSCLC,9/23/2023,-1,ADJUVANT,Off Systemic Therapy,G1445DG1:E6:D,FALSE,11/30/2024
NSCLC,6/30/2019,-1,ADJUVANT,Anastrozole,G1:9FCE6E6G6C,FALSE,8/17/2019
NSCLC,3/13/2013,1,ADVANCED,Carboplatin,G1E1C181843G1,FALSE,8/28/2014
NSCLC,10/13/2019,1,ADVANCED,Pembrolizumab,G275592:9ED79,FALSE,9/30/2021
NSCLC,9/10/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G529G2C3FCBC7,FALSE,11/23/2015
NSCLC,4/8/2024,-1,ADJUVANT,Off Systemic Therapy,G2GD72:FBC5FG,FALSE,2/6/2025
NSCLC,1/21/2025,1,ADVANCED,Pembrolizumab,G1:2GG784D6FD,TRUE,5/5/2025
NSCLC,11/5/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Docetaxel",G193F989CDC3D,FALSE,2/2/2016
NSCLC,3/15/2022,2,ADVANCED,"Carboplatin,Paclitaxel",G1GC97BGC25B3,FALSE,1/31/2023
NSCLC,2/9/2021,2,ADVANCED,"Docetaxel,Ramucirumab",G17177B5C7D7F,FALSE,6/7/2022
NSCLC,9/9/2016,2,ADVANCED,Pemetrexed,G163D9B593927,FALSE,5/14/2017
NSCLC,9/1/2014,2,ADVANCED,Erlotinib,G1E1C181843G1,FALSE,4/23/2015
NSCLC,2/25/2025,1,ADVANCED,Gemcitabine,G4G4D:D9D8152,FALSE,4/7/2025
NSCLC,8/20/2020,-1,ADJUVANT,Off Systemic Therapy,G1:F129FBCE3F,FALSE,2/10/2021
NSCLC,7/4/2017,-1,ADJUVANT,Off Systemic Therapy,G1F9CDC2FCB:5,FALSE,5/4/2021
NSCLC,12/12/2018,-1,ADJUVANT,Off Systemic Therapy,G432E:9E:21DC,FALSE,9/17/2019
NSCLC,10/3/2019,-1,ADJUVANT,Off Systemic Therapy,G432E:9E:21DC,FALSE,2/4/2021
NSCLC,2/14/2015,-1,ADJUVANT,"Carboplatin,Pemetrexed",G3EC5EB18C676,FALSE,4/13/2015
NSCLC,5/24/2014,1,ADVANCED,Erlotinib,G3::1:B4F:3D4,TRUE,8/14/2015
NSCLC,6/19/2017,1,ADVANCED,"Carboplatin,Paclitaxel",G4FG9D112D:6F,FALSE,6/21/2017
NSCLC,11/5/2021,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G22FG21G231E9,FALSE,10/22/2021
NSCLC,11/30/2022,1,LOCOREGIONAL,"Carboplatin,Pembrolizumab,Pemetrexed",G199:3GD5C8:8,FALSE,3/12/2023
NSCLC,4/8/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G157317FG3387,FALSE,6/20/2024
NSCLC,9/7/2024,-1,ADJUVANT,Off Systemic Therapy,G2518G1D763FB,FALSE,5/27/2025
NSCLC,12/21/2014,3,ADVANCED,Pembrolizumab,G3C:F1C:2BF6C,FALSE,3/15/2015
NSCLC,4/5/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1BBCG87E12DG,FALSE,9/11/2015
NSCLC,5/6/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G459D:92E2344,FALSE,10/8/2018
NSCLC,5/7/2022,1,ADVANCED,Pembrolizumab,G1G:EECBFBEGD,FALSE,7/2/2022
NSCLC,2/3/2024,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1:46DC16B5B8,FALSE,4/4/2024
NSCLC,1/22/2020,1,ADVANCED,Durvalumab,G1G194ECBE647,TRUE,3/5/2020
NSCLC,4/29/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G2628C28G7613,FALSE,6/10/2015
NSCLC,11/14/2023,2,ADVANCED,"Anastrozole,Ramucirumab",G1GFD92F489E7,FALSE,10/22/2023
NSCLC,10/16/2017,-1,ADJUVANT,"Anastrozole,Trastuzumab",G1:9FCE6E6G6C,FALSE,4/9/2018
NSCLC,4/9/2014,-1,NEOADJUVANT,Ado-Trastuzumab Emtansine,G16GE86G42194,FALSE,5/4/2014
NSCLC,12/27/2014,4,ADVANCED,"Bevacizumab,Paclitaxel,Vinorelbine",G4:72GGEFB4B:,FALSE,1/31/2015
NSCLC,11/30/2022,-1,NEOADJUVANT,Off Systemic Therapy,G138G5E13CC3:,FALSE,1/21/2025
NSCLC,6/2/2021,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1B11153DEF52,FALSE,6/6/2021
NSCLC,4/20/2018,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G459D:92E2344,FALSE,4/21/2018
NSCLC,6/14/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1441B4DG:6FF,FALSE,8/2/2024
NSCLC,5/18/2024,3,ADVANCED,"Carboplatin,Leuprolide,Paclitaxel,Pembrolizumab",G17G71B51EFE2,FALSE,1/4/2025
NSCLC,2/21/2023,4,ADVANCED,"Alectinib,Bevacizumab-Awwb,Capmatinib,Pemetrexed",G217694659D6F,FALSE,7/12/2023
NSCLC,6/30/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G119DBG986C45,FALSE,10/12/2022
NSCLC,4/3/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2763DEB9848B,FALSE,5/15/2020
NSCLC,4/10/2013,2,ADVANCED,Erlotinib,G2G7B3CB6D5C4,FALSE,7/6/2013
NSCLC,9/25/2024,2,ADVANCED,Sotorasib,G47DG9518GG1E,FALSE,1/14/2025
NSCLC,9/24/2019,1,LOCOREGIONAL,Pembrolizumab,G1D3:96CE9334,TRUE,4/14/2023
NSCLC,9/24/2024,-1,ADJUVANT,"Cisplatin,Pemetrexed",G25B:66F61266,FALSE,1/28/2025
NSCLC,6/22/2015,-1,NEOADJUVANT,Crizotinib,G2F:C3344EG8G,FALSE,8/28/2015
NSCLC,6/9/2023,4,ADVANCED,Vinorelbine,G557E997E81G5,FALSE,9/10/2023
NSCLC,10/31/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G2339E2EC4B:E,TRUE,4/4/2025
NSCLC,10/21/2013,1,LOCOREGIONAL,Gemcitabine,G21C61GC:BF54,FALSE,3/25/2014
NSCLC,11/19/2021,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,7/25/2022
NSCLC,1/4/2020,3,ADVANCED,Erlotinib,G147ED4GE76EE,FALSE,3/18/2020
NSCLC,11/14/2014,-1,ADJUVANT,Off Systemic Therapy,G58E8F29:9:45,FALSE,5/23/2015
NSCLC,6/24/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G193F52G:DDG7,FALSE,6/23/2024
NSCLC,7/21/2021,-1,CONCURRENT,Cisplatin,G434GE998725C,FALSE,9/27/2021
NSCLC,3/24/2019,1,ADVANCED,Osimertinib,G1B:1G86333FB,FALSE,7/20/2020
NSCLC,4/7/2020,1,ADVANCED,Durvalumab,G327B2G171G96,TRUE,5/28/2022
NSCLC,4/6/2024,-1,ADJUVANT,Leuprolide,G369D5G3B91:2,FALSE,4/26/2024
NSCLC,10/25/2023,-1,ADJUVANT,Abiraterone,G2G419135CEEC,FALSE,11/27/2023
NSCLC,4/10/2023,3,ADVANCED,"Docetaxel,Ramucirumab",G557E997E81G5,FALSE,7/7/2023
NSCLC,2/16/2024,1,ADVANCED,"Carboplatin,Clinical Study Drug,Pemetrexed",G4F52FDF7GFG5,FALSE,5/12/2025
NSCLC,11/23/2019,2,ADVANCED,Afatinib,G147ED4GE76EE,FALSE,12/26/2019
NSCLC,10/27/2023,1,LOCOREGIONAL,Docetaxel,G24F:E99C2926,FALSE,12/12/2023
NSCLC,7/27/2020,3,ADVANCED,Niraparib,G38D11EG5F826,FALSE,5/9/2021
NSCLC,12/15/2020,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,11/28/2020
NSCLC,12/16/2023,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G5395BFB17GD:,FALSE,5/2/2024
NSCLC,11/16/2016,-1,CONCURRENT,"Carboplatin,Docetaxel",G14G5B9C531F6,FALSE,2/7/2017
NSCLC,8/29/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G5177EGEDDF9F,FALSE,2/4/2015
NSCLC,12/20/2013,3,ADVANCED,"Eribulin,Exemestane",G19937F58E541,FALSE,4/30/2014
NSCLC,1/21/2022,2,ADVANCED,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G3698C8B:5EE7,FALSE,4/28/2022
NSCLC,4/12/2021,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,6/2/2021
NSCLC,8/10/2024,-1,CONCURRENT,Off Systemic Therapy,G46:6C69:D9:C,FALSE,3/29/2025
NSCLC,10/2/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G4C53C5GC48E:,FALSE,3/7/2015
NSCLC,5/4/2023,1,ADVANCED,Nivolumab,G1E2B6::D8477,TRUE,4/22/2024
NSCLC,12/29/2018,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G153G5833D6D1,FALSE,1/12/2019
NSCLC,11/25/2018,1,ADVANCED,Afatinib,G431ECG92273D,FALSE,11/18/2018
NSCLC,9/7/2013,1,ADVANCED,Erlotinib,G1968F::311C2,FALSE,5/23/2018
NSCLC,6/1/2016,2,ADVANCED,Nivolumab,G11B743:8G337,FALSE,1/24/2017
NSCLC,3/2/2023,-1,ADJUVANT,Off Systemic Therapy,G253322FB7:C9,FALSE,12/14/2024
NSCLC,4/5/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G1B8EF2645E7F,FALSE,4/30/2015
NSCLC,9/28/2014,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2::9G57327G:,FALSE,10/14/2014
NSCLC,1/30/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1GC7BGB8G544,FALSE,4/15/2020
NSCLC,11/2/2021,1,ADVANCED,Pembrolizumab,G3698C8B:5EE7,TRUE,2/21/2022
NSCLC,1/31/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3F1C8BD8324B,FALSE,3/27/2025
NSCLC,12/16/2022,-1,NEOADJUVANT,Abiraterone,G53D3D6874EB3,FALSE,1/19/2023
NSCLC,11/7/2019,1,LOCOREGIONAL,"Carboplatin,Docetaxel",G225477:C1158,FALSE,12/11/2019
NSCLC,12/5/2020,1,ADVANCED,Alectinib,G2CG3EF9E5:2B,FALSE,6/20/2021
NSCLC,3/6/2021,-1,ADJUVANT,"Cisplatin,Pemetrexed",G319D776C24D5,FALSE,6/18/2021
NSCLC,6/23/2023,-1,ADJUVANT,Pembrolizumab,G1:3BC3:FEF23,FALSE,5/17/2024
NSCLC,11/27/2019,1,ADVANCED,Durvalumab,G49E3CE9E292G,TRUE,5/2/2020
NSCLC,8/16/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G26B488B88188,FALSE,10/22/2022
NSCLC,4/30/2020,-1,ADJUVANT,"Cisplatin,Pemetrexed",G52B74F86723D,FALSE,6/19/2020
NSCLC,5/10/2013,1,ADVANCED,"Carboplatin,Pemetrexed",G168G1C789D7C,FALSE,6/20/2013
NSCLC,2/16/2013,1,ADVANCED,"Bevacizumab,Paclitaxel Protein-Bound",G393CEF118B21,FALSE,9/18/2013
NSCLC,5/26/2018,1,ADVANCED,"Carboplatin,Gemcitabine",G3E567F5B3:95,FALSE,8/19/2018
NSCLC,6/27/2024,-1,ADJUVANT,Off Systemic Therapy,G1:3BC3:FEF23,FALSE,3/29/2025
NSCLC,4/12/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G3GE686D11C25,FALSE,5/4/2015
NSCLC,5/18/2024,5,ADVANCED,"Carboplatin,Etoposide,Ipilimumab,Nivolumab",G54F545489E59,FALSE,7/26/2024
NSCLC,4/7/2020,-1,ADJUVANT,"Fluorouracil,Irinotecan,Leucovorin,Oxaliplatin",G15875498G:F4,FALSE,3/27/2020
NSCLC,8/29/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G445B:B:15B5F,FALSE,11/3/2014
NSCLC,2/2/2022,3,ADVANCED,"Osimertinib,Paclitaxel",G1594:E29D2D9,FALSE,4/11/2022
NSCLC,9/28/2018,1,ADVANCED,Pembrolizumab,G55CDGC1298EB,FALSE,4/27/2021
NSCLC,5/22/2017,2,ADVANCED,Afatinib,G16:GC1C87FG:,FALSE,7/14/2017
NSCLC,11/7/2013,-1,ADJUVANT,Off Systemic Therapy,G58E8F29:9:45,FALSE,10/2/2014
NSCLC,3/5/2018,1,LOCOREGIONAL,Durvalumab,G3D1FC341FBF7,TRUE,10/10/2021
NSCLC,8/16/2024,4,ADVANCED,Nivolumab,G2C38B34G8794,FALSE,12/6/2024
NSCLC,2/17/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G25F6:5:2:C36,FALSE,5/7/2019
NSCLC,6/17/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G35DB7G1CE73D,FALSE,8/20/2015
NSCLC,8/24/2011,-1,CONCURRENT,"Cisplatin,Etoposide",G3BCC2GG732G:,FALSE,1/9/2012
NSCLC,5/21/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G161:GEG632G8,FALSE,7/25/2019
NSCLC,5/10/2025,-1,ADJUVANT,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G148327249BD9,FALSE,4/2/2025
NSCLC,8/28/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G1E35BD845958,FALSE,12/2/2014
NSCLC,6/13/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,FALSE,10/3/2022
NSCLC,12/7/2019,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G3D:24E398DDF,FALSE,3/21/2020
NSCLC,3/23/2021,4,ADVANCED,Pazopanib,G51:G:C712CC6,FALSE,7/9/2021
NSCLC,8/23/2011,1,ADVANCED,"Carboplatin,Pemetrexed",G2177D1::DG1E,FALSE,12/10/2011
NSCLC,7/9/2016,-1,ADJUVANT,Letrozole,G29D9FB:D1D6B,FALSE,9/3/2016
NSCLC,7/28/2014,1,ADVANCED,Clinical Study Drug,G261CF698E543,FALSE,2/3/2015
NSCLC,12/17/2022,1,ADVANCED,Nivolumab,G1D75:47CG6C7,FALSE,8/31/2024
NSCLC,4/18/2022,1,ADVANCED,"Carboplatin,Pemetrexed",G4G84CDE8:3F:,FALSE,2/12/2023
NSCLC,8/6/2020,2,ADVANCED,Docetaxel,G3:C9BECD3F55,FALSE,9/8/2020
NSCLC,11/18/2015,1,ADVANCED,"Carboplatin,Gemcitabine",G242B854DCE96,FALSE,1/22/2016
NSCLC,10/28/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G3B942496:87:,FALSE,12/17/2012
NSCLC,10/17/2021,1,ADVANCED,Durvalumab,G439D41E1E1FB,TRUE,10/9/2022
NSCLC,9/3/2014,-1,ADJUVANT,Off Systemic Therapy,G26EF86FE2766,FALSE,8/11/2015
NSCLC,2/18/2025,3,ADVANCED,Pemetrexed,G3G18F3E9E3C8,FALSE,3/17/2025
NSCLC,2/9/2023,-1,ADJUVANT,Durvalumab,G4CF4FFFDGB63,FALSE,2/4/2024
NSCLC,10/14/2013,1,ADVANCED,Crizotinib,G2FF1862EC655,FALSE,12/5/2013
NSCLC,5/8/2013,-1,CONCURRENT,Off Systemic Therapy,G289C6438E26:,FALSE,7/31/2013
NSCLC,4/1/2019,1,ADVANCED,Atezolizumab,G26D38EC278C1,FALSE,6/28/2019
NSCLC,8/30/2020,1,ADVANCED,Capecitabine,G23G4C57:DEB5,FALSE,11/4/2020
NSCLC,1/30/2013,-1,ADJUVANT,Off Systemic Therapy,G5545136B977G,FALSE,10/14/2019
NSCLC,9/27/2024,-1,ADJUVANT,Off Systemic Therapy,G535G:C261F1E,FALSE,12/14/2024
NSCLC,7/30/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1CCE24EED8F8,FALSE,8/26/2022
NSCLC,2/14/2022,3,ADVANCED,"Dabrafenib,Trametinib",G1G54G4GB8B24,FALSE,8/24/2022
NSCLC,3/14/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G56ED712FC18F,FALSE,6/10/2019
NSCLC,12/31/2021,4,ADVANCED,"Bevacizumab-Bvzr,Erlotinib,Osimertinib",G4CG4:632GG8E,FALSE,3/7/2022
NSCLC,3/16/2024,-1,ADJUVANT,"Carboplatin,Gemcitabine",G2G6E1E144F8E,FALSE,6/2/2024
NSCLC,4/21/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2CBC84D5ED1E,FALSE,6/10/2021
NSCLC,5/13/2014,1,ADVANCED,Pemetrexed,G43D:C17:25FG,FALSE,2/17/2015
NSCLC,1/13/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G4FC5:16DD742,FALSE,4/1/2021
NSCLC,6/28/2014,-1,ADJUVANT,Off Systemic Therapy,G23BB82DB453D,FALSE,5/13/2025
NSCLC,11/22/2022,2,ADVANCED,Paclitaxel Protein-Bound,G564F8B8:FB1E,FALSE,2/26/2023
NSCLC,10/13/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G2GC:751BF4B8,FALSE,11/9/2018
NSCLC,2/20/2020,2,ADVANCED,Clinical Study Drug,G3B1F6B561ED5,FALSE,3/27/2021
NSCLC,5/27/2024,1,ADVANCED,Durvalumab,G211B9B8E3:3E,FALSE,2/10/2025
NSCLC,2/16/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G34:7B13D9C5F,FALSE,10/20/2015
NSCLC,7/20/2023,2,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G13FC564CF8GF,FALSE,6/16/2024
NSCLC,4/11/2016,2,ADVANCED,Erlotinib,G193F989CDC3D,FALSE,11/8/2017
NSCLC,1/20/2022,-1,ADJUVANT,Clinical Study Drug,G485C85BECGC4,FALSE,4/12/2022
NSCLC,7/26/2013,2,ADVANCED,Erlotinib,G29C71B44G:B6,FALSE,10/7/2013
NSCLC,3/14/2013,-1,ADJUVANT,Off Systemic Therapy,G33E77:6CF7F3,FALSE,9/22/2016
NSCLC,5/30/2020,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G3BE152FFEBG3,FALSE,1/16/2021
NSCLC,7/4/2024,1,LOCOREGIONAL,"Carboplatin,Nivolumab,Pembrolizumab,Pemetrexed",G47DG9518GG1E,FALSE,10/5/2024
NSCLC,10/23/2017,2,ADVANCED,Pembrolizumab,G4GE2BD8C57D9,FALSE,12/22/2018
NSCLC,7/20/2012,1,ADVANCED,"Carboplatin,Gemcitabine",G2CE6D3C3EFDC,FALSE,5/25/2013
NSCLC,3/17/2022,-1,ADJUVANT,"Carboplatin,Pemetrexed",G22FG21G231E9,FALSE,3/25/2022
NSCLC,8/22/2024,3,ADVANCED,Pembrolizumab,G1:46DC16B5B8,FALSE,4/3/2025
NSCLC,3/28/2020,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G1:59G2916:FE,FALSE,7/11/2020
NSCLC,3/21/2023,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,6/10/2023
NSCLC,12/10/2021,2,ADVANCED,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G147B:8F3B:52,FALSE,11/10/2021
NSCLC,6/16/2014,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1F7B4C2F:FF2,FALSE,7/14/2014
NSCLC,4/21/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G42:C947GB97B,FALSE,5/20/2014
NSCLC,3/23/2021,1,LOCOREGIONAL,"Carboplatin,Pemetrexed",G19B:27:ECB43,FALSE,8/5/2021
NSCLC,11/14/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,FALSE,4/11/2015
NSCLC,1/28/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4B1G4D17C4F8,FALSE,4/26/2022
NSCLC,5/15/2025,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1FE4F243:1FG,FALSE,4/11/2025
NSCLC,3/14/2021,3,ADVANCED,"Capecitabine,Pembrolizumab",G2G1D1B:745EG,FALSE,8/31/2021
NSCLC,1/7/2024,-1,ADJUVANT,Pembrolizumab,G12184C2C1CC4,FALSE,2/8/2025
NSCLC,9/9/2016,6,ADVANCED,"Gemcitabine,Pembrolizumab,Vemurafenib",G4C53C5GC48E:,FALSE,10/15/2016
NSCLC,3/26/2021,2,ADVANCED,"Atezolizumab,Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,FALSE,2/13/2022
NSCLC,8/22/2019,1,ADVANCED,Pembrolizumab,G4C915B9CFD61,TRUE,10/2/2020
NSCLC,5/26/2022,1,ADVANCED,Pembrolizumab,G13GE1E25174F,TRUE,9/21/2022
NSCLC,6/30/2013,2,ADVANCED,Erlotinib,G133G3GCBGE3D,FALSE,3/18/2014
NSCLC,11/18/2014,1,ADVANCED,Pemetrexed,G12D5DB79FEED,FALSE,4/28/2015
NSCLC,10/15/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1953CC93B6FB,FALSE,12/9/2023
NSCLC,7/24/2024,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1ED5EF238G3C,FALSE,12/25/2024
NSCLC,11/15/2015,1,ADVANCED,Paclitaxel Protein-Bound,G2F23BB58DF:9,FALSE,3/13/2016
NSCLC,7/28/2024,3,ADVANCED,"Bevacizumab-Bvzr,Carboplatin,Paclitaxel",G15517:BF5DE4,FALSE,5/5/2025
NSCLC,4/27/2021,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,4/28/2021
NSCLC,10/22/2017,-1,ADJUVANT,"Carboplatin,Paclitaxel",G1FD6C9677C56,FALSE,12/3/2017
NSCLC,4/1/2020,1,ADVANCED,"Carboplatin,Paclitaxel",G11DC:E9G171F,FALSE,3/31/2020
NSCLC,6/20/2011,1,ADVANCED,"Carboplatin,Etoposide",G1468E9F5C9CG,FALSE,10/30/2011
NSCLC,12/17/2019,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,12/22/2019
NSCLC,1/26/2018,1,ADVANCED,"Carboplatin,Pemetrexed",G4G:96542E2BG,FALSE,7/15/2018
NSCLC,11/7/2023,2,ADVANCED,"Docetaxel,Ramucirumab",G1ECEG1B31B5C,FALSE,2/3/2024
NSCLC,5/23/2016,3,ADVANCED,"Nivolumab,Paclitaxel",G242B854DCE96,FALSE,10/7/2016
NSCLC,10/3/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G36CD19:738D6,FALSE,12/22/2021
NSCLC,5/2/2024,-1,ADJUVANT,Off Systemic Therapy,G445F26762F72,FALSE,1/19/2025
NSCLC,7/21/2023,-1,ADJUVANT,Paclitaxel,G2G22BF9DCG81,FALSE,9/13/2023
NSCLC,4/10/2023,-1,ADJUVANT,"Enzalutamide,Leuprolide",G53D3D6874EB3,FALSE,8/11/2023
NSCLC,7/16/2015,2,ADVANCED,Nivolumab,G11D1:8:62429,FALSE,9/29/2015
NSCLC,11/8/2017,-1,ADJUVANT,Off Systemic Therapy,G2514B78G7G83,FALSE,6/3/2018
NSCLC,12/30/2017,3,ADVANCED,Pemetrexed,G4C:6:784E1GF,FALSE,1/24/2018
NSCLC,10/10/2017,1,ADVANCED,Atezolizumab,G221C:3FD2EGB,FALSE,2/11/2019
NSCLC,8/15/2023,-1,ADJUVANT,"Docetaxel,Leuprolide",G53D3D6874EB3,FALSE,10/4/2023
NSCLC,7/26/2018,2,ADVANCED,Alectinib,G19GDC129D136,FALSE,1/18/2021
NSCLC,3/21/2023,3,ADVANCED,"Docetaxel,Ramucirumab",G54F545489E59,FALSE,11/24/2023
NSCLC,11/9/2018,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,TRUE,2/8/2020
NSCLC,8/18/2022,1,ADVANCED,Pembrolizumab,G4CCEFF5GB86F,TRUE,4/29/2024
NSCLC,7/18/2014,2,ADVANCED,Pemetrexed,G1:78734BCEDB,FALSE,2/10/2015
NSCLC,12/25/2020,-1,ADJUVANT,Durvalumab,G459D:92E2344,FALSE,12/18/2020
NSCLC,3/1/2018,3,ADVANCED,Clinical Study Drug,G3EC5EB18C676,FALSE,6/21/2018
NSCLC,7/29/2021,-1,ADVANCED,Off Systemic Therapy,G11F85:F1CG29,FALSE,8/21/2021
NSCLC,9/20/2020,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G358C8DCE9BD5,FALSE,11/21/2020
NSCLC,12/2/2022,1,ADVANCED,"Carboplatin,Pemetrexed",G58C6E1DD1D13,FALSE,12/2/2022
NSCLC,5/23/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G17EC67:48631,TRUE,3/19/2025
NSCLC,11/1/2024,1,ADVANCED,"Carboplatin,Etoposide",G33:335715B9G,FALSE,2/27/2025
NSCLC,8/3/2015,2,ADVANCED,Clinical Study Drug,G46:87GF7FGC9,FALSE,12/17/2015
NSCLC,5/17/2023,1,ADVANCED,"Afatinib,Osimertinib",G4GF74CE8E4:6,FALSE,6/30/2023
NSCLC,5/14/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G212D32:BD3B6,FALSE,8/25/2021
NSCLC,3/10/2023,-1,ADJUVANT,"Cisplatin,Gemcitabine",G4C4:64E35941,FALSE,4/16/2023
NSCLC,7/19/2018,1,ADVANCED,Pembrolizumab,G28EFBDGDC712,FALSE,2/24/2019
NSCLC,7/19/2018,1,ADVANCED,Alectinib,G51:CGD7GD6C4,FALSE,1/11/2025
NSCLC,9/19/2020,-1,ADJUVANT,"Cisplatin,Pemetrexed",G574795::16B2,FALSE,11/21/2020
NSCLC,5/2/2022,-1,ADJUVANT,Durvalumab,G4B1G4D17C4F8,FALSE,2/20/2023
NSCLC,5/23/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G42D:4D9G6157,FALSE,8/29/2023
NSCLC,4/6/2018,1,ADVANCED,Erlotinib,G2D2EC6C91F3C,FALSE,8/12/2018
NSCLC,10/9/2024,1,ADVANCED,Durvalumab,G116C37BB:EB1,TRUE,4/6/2025
NSCLC,3/11/2025,4,ADVANCED,Clinical Study Drug,G177G4:B9E394,FALSE,4/4/2025
NSCLC,7/4/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G1:B8CFFD1931,FALSE,8/30/2014
NSCLC,6/18/2019,3,ADVANCED,"Fluorouracil,Irinotecan,Leucovorin,Trastuzumab",G56ED712FC18F,FALSE,8/19/2019
NSCLC,1/24/2024,-1,ADJUVANT,Off Systemic Therapy,G2DC29B:962F1,FALSE,12/8/2024
NSCLC,11/18/2022,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G43E:81EC19B6,FALSE,6/29/2023
NSCLC,10/25/2014,2,ADVANCED,"Carboplatin,Gemcitabine",G3C:F1C:2BF6C,FALSE,12/18/2014
NSCLC,5/30/2024,1,LOCOREGIONAL,"Carboplatin,Nivolumab,Paclitaxel Protein-Bound",G1D25F1::ED5E,FALSE,8/16/2024
NSCLC,11/6/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G327B2G171G96,FALSE,3/2/2020
NSCLC,7/12/2024,2,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1:46DC16B5B8,FALSE,9/30/2024
NSCLC,8/31/2019,2,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G121:2D8:4E94,FALSE,9/28/2020
NSCLC,8/12/2022,1,ADVANCED,"Carboplatin,Paclitaxel",G43E:81EC19B6,FALSE,10/19/2022
NSCLC,8/25/2020,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G42B4F:55::6F,FALSE,7/10/2020
NSCLC,12/31/2015,2,ADVANCED,Nivolumab,G242B854DCE96,FALSE,3/29/2016
NSCLC,8/3/2022,3,ADVANCED,Bosutinib,G14E7662::61C,FALSE,11/11/2022
NSCLC,7/2/2018,2,ADVANCED,Durvalumab,G17171D313CCE,FALSE,2/25/2020
NSCLC,9/12/2021,1,ADVANCED,Alectinib,G3BBG95F1669C,FALSE,12/4/2021
NSCLC,4/4/2025,1,ADVANCED,Durvalumab,G127F7CE9C111,TRUE,3/30/2025
NSCLC,8/29/2018,2,ADVANCED,Pemetrexed,G1G78CEE:7E:3,FALSE,11/3/2018
NSCLC,11/3/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G24167D1DD5FG,FALSE,1/30/2025
NSCLC,2/11/2014,3,ADVANCED,Irinotecan,G393CEF118B21,FALSE,1/23/2014
NSCLC,11/6/2018,2,ADVANCED,"Carboplatin,Pemetrexed",G4ED25F4G24F2,FALSE,11/19/2018
NSCLC,12/24/2018,1,ADVANCED,Afatinib,G4CG4:632GG8E,FALSE,5/4/2021
NSCLC,11/9/2016,2,LOCOREGIONAL,Nivolumab,G1:63D151:BB3,FALSE,10/6/2016
NSCLC,2/6/2014,1,ADVANCED,"Cisplatin,Pemetrexed",G253D7G:9C8CE,FALSE,6/17/2014
NSCLC,10/12/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G4DE3DE99E:13,FALSE,2/27/2015
NSCLC,3/19/2014,-1,ADJUVANT,Off Systemic Therapy,G11D1:8:62429,FALSE,1/18/2015
NSCLC,4/20/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G14361:3FBBE:,FALSE,8/2/2018
NSCLC,7/10/2023,1,ADVANCED,"Carboplatin,Paclitaxel",G2262335C:D62,FALSE,10/1/2023
NSCLC,3/6/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3E12EBD52F4D,FALSE,4/5/2018
NSCLC,2/7/2020,1,ADVANCED,Nivolumab,G1GC97BGC25B3,FALSE,4/14/2022
NSCLC,6/29/2021,-1,CONCURRENT,Pembrolizumab,G38C61:99G266,FALSE,12/13/2022
NSCLC,3/12/2019,-1,ADJUVANT,Durvalumab,G153G5833D6D1,FALSE,6/4/2020
NSCLC,1/3/2014,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1185:32426FB,FALSE,3/15/2014
NSCLC,7/15/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G4F354B:F341F,FALSE,10/18/2014
NSCLC,6/8/2018,1,ADVANCED,Osimertinib,G33159ECF97CC,FALSE,6/30/2019
NSCLC,5/23/2012,-1,ADJUVANT,Off Systemic Therapy,G5995:57EB51E,FALSE,11/13/2012
NSCLC,12/17/2013,-1,ADJUVANT,Vinorelbine,G13F669ED2119,FALSE,2/8/2014
NSCLC,6/25/2013,1,ADVANCED,Erlotinib,G1CGCC1C6CF35,FALSE,8/12/2013
NSCLC,9/9/2020,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,11/5/2020
NSCLC,6/2/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G116C37BB:EB1,FALSE,9/26/2024
NSCLC,4/4/2021,1,ADVANCED,Pembrolizumab,G114FBBG316GG,TRUE,12/2/2022
NSCLC,8/10/2018,4,ADVANCED,Docetaxel,G3EC5EB18C676,FALSE,8/17/2019
NSCLC,2/21/2025,2,ADVANCED,Clinical Study Drug,G3867F7D51E3D,FALSE,3/22/2025
NSCLC,1/6/2023,-1,ADJUVANT,Off Systemic Therapy,G41DE1E3BE99:,FALSE,7/20/2024
NSCLC,10/31/2015,2,ADVANCED,Nivolumab,G14DC7EEE99BF,FALSE,12/1/2015
NSCLC,1/23/2025,-1,ADJUVANT,Pembrolizumab,G22CF9C794236,FALSE,4/17/2025
NSCLC,10/29/2014,-1,ADJUVANT,Anastrozole,G58E8F29:9:45,FALSE,10/16/2014
NSCLC,11/11/2023,1,ADVANCED,Sotorasib,G1D2821G451G:,FALSE,6/19/2024
NSCLC,7/20/2013,2,ADVANCED,"Bevacizumab,Docetaxel",G168G1C789D7C,FALSE,3/15/2014
NSCLC,7/20/2011,-1,NEOADJUVANT,"Cisplatin,Docetaxel",G4G98:8D426E2,FALSE,8/25/2011
NSCLC,12/19/2012,1,ADVANCED,Gemcitabine,G3CE666498C:9,FALSE,2/21/2013
NSCLC,8/14/2024,-1,ADJUVANT,Off Systemic Therapy,G1GEF44EBD419,FALSE,11/29/2024
NSCLC,7/9/2017,-1,CONCURRENT,"Carboplatin,Docetaxel",G58FCD4G:G6DF,FALSE,9/14/2017
NSCLC,2/16/2019,2,ADVANCED,"Nivolumab,Pemetrexed",G5:3DFC66422C,FALSE,9/2/2019
NSCLC,2/5/2025,-1,ADJUVANT,Pembrolizumab,G25B:66F61266,FALSE,3/19/2025
NSCLC,1/27/2014,2,ADVANCED,"Carboplatin,Gemcitabine",G1B2469295BGE,FALSE,2/1/2014
NSCLC,11/26/2013,-1,CONCURRENT,Cisplatin,G13D3F29D3FFF,FALSE,3/26/2014
NSCLC,11/17/2023,-1,ADJUVANT,Off Systemic Therapy,G1953CC93B6FB,FALSE,11/20/2024
NSCLC,8/1/2019,3,ADVANCED,Erlotinib,G21BD9C1D75:6,FALSE,5/11/2020
NSCLC,7/25/2019,-1,ADJUVANT,Leuprolide,G1D41F368EE:G,FALSE,7/10/2019
NSCLC,3/7/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G45311117177E,TRUE,4/20/2025
NSCLC,2/4/2024,-1,ADJUVANT,Pembrolizumab,G1EFD1E1::C6E,FALSE,5/7/2025
NSCLC,2/3/2013,4,ADVANCED,Gemcitabine,G1468E9F5C9CG,FALSE,5/18/2013
NSCLC,4/12/2015,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2F23BB58DF:9,FALSE,3/30/2015
NSCLC,12/6/2014,2,ADVANCED,"Carboplatin,Etoposide",G1B7793:6:9E1,FALSE,12/2/2014
NSCLC,6/27/2015,-1,ADJUVANT,Off Systemic Therapy,G24:75F1:6CB3,FALSE,9/14/2022
NSCLC,6/7/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2G251E378FE8,FALSE,9/30/2019
NSCLC,11/3/2023,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G3CG5712E:B54,FALSE,3/25/2024
NSCLC,3/31/2018,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,2/14/2019
NSCLC,3/5/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G1:C59D3F54:2,FALSE,8/2/2021
NSCLC,12/23/2014,3,ADVANCED,Vinorelbine,G3:D1D2EG5C21,FALSE,2/4/2015
NSCLC,7/16/2020,-1,ADJUVANT,Off Systemic Therapy,G2F1E5F6F6:E1,FALSE,6/22/2024
NSCLC,6/21/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3D741EB4:B76,FALSE,9/25/2022
NSCLC,5/9/2017,-1,ADJUVANT,Off Systemic Therapy,G2F:C3344EG8G,FALSE,4/27/2024
NSCLC,11/28/2018,2,ADVANCED,Pemetrexed,G131892E39563,FALSE,2/28/2020
NSCLC,9/24/2023,5,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G1G54G4GB8B24,FALSE,3/1/2024
NSCLC,10/19/2014,-1,ADJUVANT,"Carboplatin,Paclitaxel",G1B6F2D98G4BD,FALSE,12/22/2014
NSCLC,10/17/2015,-1,ADJUVANT,Off Systemic Therapy,G3GB6D5C:448G,FALSE,5/11/2017
NSCLC,12/31/2023,1,ADVANCED,"Carboplatin,Cemiplimab,Paclitaxel",G4484725BB423,FALSE,4/6/2024
NSCLC,11/13/2014,1,ADVANCED,"Bevacizumab,Pemetrexed",G48EG9E748G84,FALSE,1/15/2015
NSCLC,1/26/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G45311117177E,FALSE,3/7/2024
NSCLC,3/3/2014,1,ADVANCED,Clinical Study Drug,G1:78734BCEDB,FALSE,8/5/2014
NSCLC,8/28/2013,2,ADVANCED,"Carboplatin,Paclitaxel",G56CF8BF38D:7,FALSE,11/25/2013
NSCLC,9/29/2015,3,ADVANCED,Nivolumab,G18:439734B::,FALSE,12/16/2015
NSCLC,11/10/2012,-1,ADJUVANT,Tamoxifen,G1B:584419G11,FALSE,10/14/2012
NSCLC,3/15/2024,1,ADVANCED,Pembrolizumab,G126FD37CD5C9,FALSE,7/14/2024
NSCLC,5/24/2017,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G356E75GB3883,FALSE,9/24/2017
NSCLC,11/28/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G3FGEBG3CG127,FALSE,3/27/2025
NSCLC,9/9/2013,1,ADVANCED,Erlotinib,G2E1F163ECG9B,FALSE,9/26/2013
NSCLC,2/1/2022,2,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G4C4C3G28CF33,FALSE,7/20/2022
NSCLC,4/4/2025,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1G7:7E:2641G,FALSE,5/19/2025
NSCLC,10/10/2014,2,ADVANCED,Clinical Study Drug,G2EBF3CF86FF9,FALSE,10/20/2014
NSCLC,7/28/2013,3,ADVANCED,Erlotinib,G166B735:96D2,FALSE,9/24/2013
NSCLC,10/28/2018,-1,ADJUVANT,Rituximab,G1EG8767G6BG4,FALSE,12/6/2018
NSCLC,2/14/2014,3,ADVANCED,"Bevacizumab,Erlotinib",G168G1C789D7C,FALSE,4/3/2014
NSCLC,7/1/2019,3,ADVANCED,Nivolumab,G14F3GC2D5E43,FALSE,9/29/2019
NSCLC,12/15/2017,2,ADVANCED,"Carboplatin,Pemetrexed",G484BED:E686:,FALSE,11/25/2017
NSCLC,10/23/2013,2,ADVANCED,Vinorelbine,G5::D4E74F959,FALSE,10/26/2013
NSCLC,9/28/2021,3,ADVANCED,"Carboplatin,Osimertinib,Paclitaxel,Pembrolizumab",G4CG4:632GG8E,FALSE,1/22/2022
NSCLC,2/10/2015,-1,ADJUVANT,Off Systemic Therapy,G4G78ED3FGCF8,FALSE,1/20/2023
NSCLC,1/30/2024,-1,ADJUVANT,Pembrolizumab,G1:3B43D3B55G,FALSE,3/7/2025
NSCLC,7/22/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G35CFEB37C9D3,FALSE,9/14/2012
NSCLC,1/21/2017,2,ADVANCED,"Carboplatin,Paclitaxel",G4C65C839C5CC,FALSE,7/23/2021
NSCLC,8/9/2022,4,ADVANCED,"Docetaxel,Ramucirumab",G1G54G4GB8B24,FALSE,9/25/2023
NSCLC,4/4/2019,3,ADVANCED,Pemetrexed,G35DE4B3:BCB8,FALSE,4/27/2019
NSCLC,1/31/2025,2,ADVANCED,Tepotinib,G211B9B8E3:3E,FALSE,4/5/2025
NSCLC,9/14/2024,-1,NEOADJUVANT,Anastrozole,G2B4648:BGD83,FALSE,9/21/2024
NSCLC,2/10/2022,2,ADVANCED,Atezolizumab,G337BE1E83:B7,FALSE,5/16/2025
NSCLC,5/22/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G49422G5E1G86,FALSE,7/2/2015
NSCLC,6/27/2023,2,ADVANCED,"Docetaxel,Ramucirumab",G1532797B869C,FALSE,9/11/2023
NSCLC,7/3/2019,2,ADVANCED,"Docetaxel,Ramucirumab",G21953622CB66,FALSE,4/18/2020
NSCLC,3/21/2024,1,LOCOREGIONAL,"Cisplatin,Pembrolizumab,Pemetrexed",G25BG745::8GE,FALSE,7/19/2024
NSCLC,4/13/2024,-1,ADJUVANT,Off Systemic Therapy,G156F22D:3335,FALSE,1/10/2025
NSCLC,6/17/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G419BEEC19D2C,FALSE,8/29/2021
NSCLC,3/5/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G1C19:B29DB3F,FALSE,5/11/2021
NSCLC,10/9/2024,2,ADVANCED,"Osimertinib,Pembrolizumab",G12DD1599F4EF,FALSE,4/24/2025
NSCLC,4/24/2022,1,ADVANCED,Durvalumab,G48FCG1D:D6C5,TRUE,8/26/2024
NSCLC,7/11/2015,-1,CONCURRENT,Crizotinib,G2F:C3344EG8G,FALSE,4/22/2017
NSCLC,2/27/2015,1,ADVANCED,Pemetrexed,G4DE3DE99E:13,TRUE,9/12/2015
NSCLC,12/27/2014,-1,CONCURRENT,"Carboplatin,Paclitaxel",G16B34C4BF7EB,FALSE,3/16/2015
NSCLC,11/19/2021,1,ADVANCED,"Carboplatin,Pemetrexed",G51D:5CB4GC6B,FALSE,5/23/2022
NSCLC,7/15/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G18:DBEFC6231,FALSE,10/5/2019
NSCLC,11/4/2024,-1,ADJUVANT,Durvalumab,G11E:D3E21E6:,FALSE,3/4/2025
NSCLC,3/31/2016,-1,ADJUVANT,"Cisplatin,Pemetrexed",G257459B7FF:E,FALSE,6/9/2016
NSCLC,7/7/2022,1,ADVANCED,"Bevacizumab-Awwb,Pemetrexed",G129:BF885666,TRUE,9/25/2022
NSCLC,11/25/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel,Pembrolizumab",G1C633337DF67,FALSE,4/5/2025
NSCLC,1/30/2023,-1,CONCURRENT,Acalabrutinib,G3124B666:88D,FALSE,4/27/2023
NSCLC,3/24/2022,2,ADVANCED,Osimertinib,G4725296E3CE4,FALSE,11/4/2022
NSCLC,12/23/2014,-1,CONCURRENT,Off Systemic Therapy,G163D9B593927,FALSE,6/10/2016
NSCLC,5/12/2023,-1,ADJUVANT,"Azacitidine,Venetoclax",G13F761779185,FALSE,10/1/2023
NSCLC,7/9/2016,-1,ADJUVANT,Off Systemic Therapy,G257459B7FF:E,FALSE,3/5/2018
NSCLC,6/16/2016,-1,ADJUVANT,Off Systemic Therapy,G15C9CDFE7236,FALSE,1/25/2017
NSCLC,12/22/2023,4,ADVANCED,"Carboplatin,Paclitaxel",G1:64BD9C5919,FALSE,10/21/2024
NSCLC,12/9/2011,-1,NEOADJUVANT,"Carboplatin,Paclitaxel Protein-Bound",G454DBCD9D942,FALSE,2/16/2012
NSCLC,4/7/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1G:548DD7228,FALSE,6/6/2015
NSCLC,1/22/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G4G1G16FE1GF8,FALSE,6/18/2014
NSCLC,6/1/2017,-1,ADJUVANT,Anastrozole,G1B8G131F6FC6,FALSE,5/13/2017
NSCLC,10/28/2014,1,ADVANCED,"Carboplatin,Docetaxel",G3C:F1C:2BF6C,FALSE,12/7/2014
NSCLC,9/26/2021,1,ADVANCED,Erlotinib,G4725296E3CE4,TRUE,3/8/2022
NSCLC,1/19/2018,1,LOCOREGIONAL,Anastrozole,G22F:D77B6329,FALSE,3/4/2018
NSCLC,7/9/2024,2,ADVANCED,Gemcitabine,G3G18F3E9E3C8,FALSE,2/27/2025
NSCLC,12/10/2023,1,ADVANCED,"Cisplatin,Pemetrexed",G56D5:EDD9C68,FALSE,3/5/2024
NSCLC,12/2/2017,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,12/13/2017
NSCLC,7/8/2014,-1,ADJUVANT,"Carboplatin,Pemetrexed",G26EF86FE2766,FALSE,8/20/2014
NSCLC,12/21/2018,1,ADVANCED,Pembrolizumab,G2E14C6F:EG9B,FALSE,8/4/2020
NSCLC,12/15/2019,1,LOCOREGIONAL,"Carboplatin,Pemetrexed",G1G88D5G998GE,FALSE,12/18/2019
NSCLC,12/25/2018,-1,ADJUVANT,Off Systemic Therapy,G4992B5EB431G,FALSE,6/13/2019
NSCLC,3/16/2015,1,ADVANCED,Erlotinib,G4C7:4GCD96C:,FALSE,6/23/2017
NSCLC,8/16/2023,1,ADVANCED,Ramucirumab,G1GFD92F489E7,FALSE,10/14/2023
NSCLC,9/5/2017,1,ADVANCED,Clinical Study Drug,G2C4G1G76816F,FALSE,3/24/2025
NSCLC,3/1/2014,-1,CONCURRENT,"Cisplatin,Pemetrexed",G24365CF6:6G7,FALSE,4/14/2014
NSCLC,9/14/2016,1,ADVANCED,Nivolumab,G33E77:6CF7F3,FALSE,10/19/2017
NSCLC,10/22/2023,-1,ADJUVANT,Durvalumab,G35DGE621BE1E,FALSE,10/25/2024
NSCLC,2/27/2022,4,ADVANCED,Pembrolizumab,G4936::B67G17,FALSE,5/7/2022
NSCLC,5/15/2023,-1,CONCURRENT,Off Systemic Therapy,G2B71GB3997CF,FALSE,9/6/2023
NSCLC,11/24/2014,-1,NEOADJUVANT,Carboplatin,G21:3143F86E6,FALSE,12/26/2014
NSCLC,12/23/2017,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G33E77:6CF7F3,FALSE,7/18/2018
NSCLC,4/6/2016,2,ADVANCED,Nivolumab,G56B4BCB27428,FALSE,10/18/2017
NSCLC,3/17/2018,1,ADVANCED,"Carboplatin,Docetaxel",G17171D313CCE,FALSE,8/12/2018
NSCLC,10/20/2023,-1,ADJUVANT,Nintedanib,G2848BE3831EF,FALSE,11/3/2023
NSCLC,7/5/2024,1,ADVANCED,Pembrolizumab,G27868:751BDF,FALSE,1/2/2025
NSCLC,11/5/2024,-1,ADJUVANT,"Carboplatin,Paclitaxel",G1E3BGE6C42B6,FALSE,10/19/2024
NSCLC,10/2/2019,-1,ADJUVANT,Durvalumab,G358C8DCE9BD5,FALSE,9/13/2020
NSCLC,8/26/2015,-1,NEOADJUVANT,Off Systemic Therapy,G1GC444DCD149,FALSE,3/24/2022
NSCLC,11/30/2018,-1,ADJUVANT,Off Systemic Therapy,G1EG8767G6BG4,FALSE,2/20/2023
NSCLC,5/12/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G56B4BCB27428,FALSE,3/22/2016
NSCLC,12/26/2023,-1,ADJUVANT,Letrozole,G31G19E54FC:B,FALSE,2/3/2024
NSCLC,12/3/2011,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G21B7762691EE,FALSE,1/3/2012
NSCLC,12/12/2016,-1,ADJUVANT,Carboplatin,G3GB8B495B6:3,FALSE,12/27/2016
NSCLC,10/22/2022,2,ADVANCED,Lorlatinib,G26C728549E7G,FALSE,1/26/2023
NSCLC,3/5/2018,2,ADVANCED,Crizotinib,G3E12EBD52F4D,FALSE,6/10/2018
NSCLC,12/5/2013,-1,ADJUVANT,Off Systemic Therapy,G2BE13CEFB231,FALSE,10/29/2015
NSCLC,3/12/2020,-1,ADJUVANT,Off Systemic Therapy,G15875498G:F4,FALSE,11/13/2020
NSCLC,2/9/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G253:45FB2F1:,FALSE,4/4/2017
NSCLC,7/31/2017,-1,ADJUVANT,"Carboplatin,Paclitaxel",G2514B78G7G83,FALSE,11/15/2017
NSCLC,10/19/2019,3,ADVANCED,"Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,FALSE,2/11/2020
NSCLC,7/27/2022,-1,ADJUVANT,Off Systemic Therapy,G432E:9E:21DC,FALSE,8/28/2023
NSCLC,7/14/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G27456:36F5D8,FALSE,6/9/2019
NSCLC,8/15/2013,4,ADVANCED,Docetaxel,G166B735:96D2,FALSE,9/27/2013
NSCLC,9/5/2022,1,ADVANCED,"Pembrolizumab,Pemetrexed",G18D6GFCCC88F,TRUE,10/17/2023
NSCLC,12/10/2020,1,ADVANCED,Osimertinib,G1GC7B8314B6D,FALSE,5/29/2023
NSCLC,3/27/2014,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G1117E45EE891,FALSE,7/24/2014
NSCLC,2/24/2022,-1,CONCURRENT,Afatinib,G1B56G7791723,FALSE,3/3/2022
NSCLC,2/7/2013,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1G:1C482FFGC,FALSE,4/29/2013
NSCLC,10/11/2022,-1,ADJUVANT,Off Systemic Therapy,G5344:8G5698G,FALSE,9/29/2024
NSCLC,10/24/2016,-1,ADJUVANT,Gemcitabine,G4:9C89B3B891,FALSE,2/19/2017
NSCLC,3/9/2020,1,ADVANCED,Pembrolizumab,G17BG4264193F,FALSE,4/2/2025
NSCLC,6/18/2018,-1,ADJUVANT,Osimertinib,G59G454E1B6B3,FALSE,9/21/2024
NSCLC,11/18/2013,1,ADVANCED,Docetaxel,G1153B156D:49,FALSE,12/22/2013
NSCLC,2/1/2024,1,ADVANCED,Osimertinib,G1G9455D2D9G7,FALSE,4/6/2025
NSCLC,3/22/2012,1,ADVANCED,"Carboplatin,Clinical Study Drug,Pemetrexed",G571:F2184:45,FALSE,8/31/2012
NSCLC,1/1/2017,-1,ADJUVANT,Off Systemic Therapy,G1658GGG424E:,FALSE,6/28/2020
NSCLC,4/25/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G4FC5:16DD742,TRUE,9/16/2021
NSCLC,8/26/2021,2,ADVANCED,"Carboplatin,Paclitaxel",G1:64BD9C5919,FALSE,12/13/2021
NSCLC,1/19/2024,1,ADVANCED,Pembrolizumab,G177G4:B9E394,TRUE,3/7/2024
NSCLC,8/25/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G23GGE54BGGDF,FALSE,9/30/2020
NSCLC,2/3/2019,-1,ADJUVANT,Anastrozole,G1:9FCE6E6G6C,FALSE,1/18/2019
NSCLC,6/10/2015,3,ADVANCED,"Docetaxel,Ramucirumab",G1:B8CFFD1931,FALSE,11/26/2015
NSCLC,2/16/2023,3,ADVANCED,Nivolumab,G19:83254DDF6,FALSE,10/3/2024
NSCLC,9/1/2021,5,ADVANCED,Gemcitabine,G1BB2C23:5573,FALSE,6/26/2022
NSCLC,12/30/2018,3,ADVANCED,Rituximab,G27471:8B6217,FALSE,9/20/2020
NSCLC,2/28/2024,-1,ADJUVANT,Off Systemic Therapy,G3:G1:CC15DG9,FALSE,4/11/2025
NSCLC,7/28/2015,2,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G3::1:B4F:3D4,FALSE,10/21/2015
NSCLC,11/18/2011,1,ADVANCED,Pemetrexed,G2177D1::DG1E,TRUE,4/3/2012
NSCLC,7/1/2011,1,ADVANCED,Clinical Study Drug,G1969F536B2DD,FALSE,10/27/2011
NSCLC,2/5/2015,2,ADVANCED,Vinorelbine,G1:B8CFFD1931,FALSE,6/9/2015
NSCLC,8/2/2019,-1,ADJUVANT,Off Systemic Therapy,G29D9FB:D1D6B,FALSE,9/12/2020
NSCLC,2/28/2020,1,ADVANCED,Pembrolizumab,G19D38B88F559,FALSE,4/26/2020
NSCLC,5/29/2018,2,ADVANCED,"Carboplatin,Etoposide",G1968F::311C2,FALSE,11/9/2018
NSCLC,2/3/2020,1,ADVANCED,Pembrolizumab,G3419F1B75FG6,FALSE,4/22/2020
NSCLC,8/22/2022,1,ADVANCED,Pembrolizumab,G3E1::7EC84D4,FALSE,8/25/2023
NSCLC,1/13/2023,1,ADVANCED,Durvalumab,G15517:BF5DE4,TRUE,8/26/2023
NSCLC,9/2/2018,1,ADVANCED,Afatinib,G325BD94D:C:4,FALSE,1/7/2019
NSCLC,12/20/2011,-1,CONCURRENT,"Carboplatin,Paclitaxel",G21B7762691EE,FALSE,3/23/2012
NSCLC,4/5/2013,-1,NEOADJUVANT,Pemetrexed,G19DB44:G31G8,FALSE,10/2/2013
NSCLC,5/28/2023,2,ADVANCED,Capmatinib,G278ED563CF9F,FALSE,10/30/2023
NSCLC,6/22/2017,-1,ADJUVANT,Off Systemic Therapy,G225D72BD2FD7,FALSE,4/10/2025
NSCLC,11/14/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G3FFB5516FEDF,FALSE,3/3/2014
NSCLC,8/31/2015,-1,ADJUVANT,"Carboplatin,Paclitaxel",G3GB6D5C:448G,FALSE,10/20/2015
NSCLC,2/5/2019,2,ADVANCED,Osimertinib,G325BD94D:C:4,FALSE,4/6/2019
NSCLC,10/8/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG8DEC7576,FALSE,2/16/2019
NSCLC,1/29/2019,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G1BBDD:8BDED9,FALSE,5/26/2019
NSCLC,9/21/2017,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,6/21/2019
NSCLC,10/30/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G35B956BB:BG8,FALSE,1/11/2022
NSCLC,8/15/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G35DGE621BE1E,FALSE,10/12/2023
NSCLC,3/24/2018,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G1366655F1B29,FALSE,1/21/2019
NSCLC,12/14/2021,2,ADVANCED,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G12998681218G,FALSE,5/15/2022
NSCLC,3/6/2021,4,ADVANCED,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,FALSE,4/6/2021
NSCLC,11/20/2024,-1,ADJUVANT,"Carboplatin,Gemcitabine",G1E3BGE6C42B6,FALSE,1/18/2025
NSCLC,4/5/2024,0,,Line Zero,G13C2:FDBFBC2,FALSE,9/7/2024
NSCLC,7/17/2018,1,ADVANCED,Nivolumab,G21BD9C1D75:6,FALSE,1/16/2019
NSCLC,2/3/2012,1,ADVANCED,"Carboplatin,Docetaxel",G4G98:8D426E2,FALSE,4/3/2012
NSCLC,1/15/2014,-1,ADJUVANT,"Carboplatin,Paclitaxel",G11D1:8:62429,FALSE,4/19/2014
NSCLC,11/7/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G1GG86B599E79,FALSE,4/2/2015
NSCLC,8/30/2014,1,ADVANCED,Pemetrexed,G1:B8CFFD1931,TRUE,2/28/2015
NSCLC,11/25/2014,-1,CONCURRENT,Carboplatin,G21:3143F86E6,FALSE,1/21/2015
NSCLC,9/16/2020,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4::3E61CFBB9,FALSE,2/19/2021
NSCLC,10/14/2017,-1,ADJUVANT,Off Systemic Therapy,G3E567F5B3:95,FALSE,4/9/2018
NSCLC,12/14/2024,-1,ADJUVANT,Pembrolizumab,G2E42F615FFFC,FALSE,12/29/2024
NSCLC,7/15/2017,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G175D38G17E84,FALSE,8/18/2018
NSCLC,3/14/2017,-1,ADJUVANT,Off Systemic Therapy,G14G5B9C531F6,FALSE,7/19/2017
NSCLC,6/2/2016,3,ADVANCED,Gemcitabine,G1GDCB:FF9G:1,FALSE,7/11/2016
NSCLC,8/24/2022,1,ADVANCED,Sotorasib,G28:58D343FCF,FALSE,12/31/2022
NSCLC,10/26/2011,1,ADVANCED,Clinical Study Drug,G344BC2:6BGE1,FALSE,4/10/2012
NSCLC,5/27/2018,1,ADVANCED,Osimertinib,G4ED25F4G24F2,FALSE,11/18/2018
NSCLC,2/9/2016,2,ADVANCED,Nivolumab,G174FDF7E16C9,FALSE,1/4/2016
NSCLC,9/27/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1EG52BB38B29,FALSE,11/16/2019
NSCLC,11/24/2024,2,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G1FD696E::692,FALSE,5/16/2025
NSCLC,3/29/2023,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G164G31958638,FALSE,6/4/2023
NSCLC,1/29/2015,2,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G2G76D1E7GG61,FALSE,1/12/2015
NSCLC,6/15/2024,-1,ADJUVANT,Leuprolide,G369D5G3B91:2,FALSE,11/21/2024
NSCLC,1/31/2018,1,ADVANCED,Pembrolizumab,G45B53B:15E3F,FALSE,9/16/2018
NSCLC,1/6/2024,3,ADVANCED,Cemiplimab,G252328CFG4E1,FALSE,4/8/2024
NSCLC,8/7/2024,1,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G11E67B3F9DC7,FALSE,10/13/2024
NSCLC,5/10/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G44785496DGE9,FALSE,9/6/2024
NSCLC,3/10/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2CCC3642E:67,FALSE,5/8/2019
NSCLC,5/4/2020,2,ADVANCED,Pemetrexed,G49E3CE9E292G,FALSE,4/14/2023
NSCLC,6/6/2023,1,ADVANCED,Pembrolizumab,G535BE993E221,FALSE,8/18/2023
NSCLC,8/3/2021,3,ADVANCED,Pembrolizumab,G1G7:9D7EC1EC,FALSE,8/7/2022
NSCLC,6/2/2024,-1,ADJUVANT,Off Systemic Therapy,G242GD729:FB:,FALSE,4/2/2025
NSCLC,1/21/2022,1,ADVANCED,Osimertinib,G24F68:FC41G2,FALSE,3/31/2023
NSCLC,3/23/2014,2,ADVANCED,Erlotinib,G2E8B56477B83,FALSE,6/13/2014
NSCLC,11/19/2016,2,ADVANCED,Clinical Study Drug,G1CD225858D1:,FALSE,8/5/2017
NSCLC,1/4/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2985DF45658D,FALSE,6/21/2019
NSCLC,6/23/2023,1,ADVANCED,"Ipilimumab,Nivolumab",G1411E9::FGC8,FALSE,5/24/2023
NSCLC,9/20/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G57EFDC229G9E,FALSE,11/21/2013
NSCLC,8/12/2012,2,ADVANCED,Gemcitabine,G38GE:9D51587,FALSE,11/15/2012
NSCLC,2/8/2020,2,ADVANCED,"Carboplatin,Pemetrexed",G324DD277533C,FALSE,2/28/2020
NSCLC,11/18/2013,-1,ADJUVANT,"Cisplatin,Clinical Study Drug,Pemetrexed",G358963178E45,FALSE,1/2/2014
NSCLC,10/9/2018,-1,ADJUVANT,Letrozole,G29D9FB:D1D6B,FALSE,8/14/2018
NSCLC,1/15/2013,-1,ADJUVANT,"Carboplatin,Gemcitabine",G3DG:2D1DGE8B,FALSE,3/15/2013
NSCLC,2/28/2019,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,10/24/2019
NSCLC,6/29/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1GDCB:FF9G:1,FALSE,2/4/2016
NSCLC,3/14/2018,1,ADVANCED,"Bevacizumab,Pemetrexed",G266E6248F531,TRUE,7/8/2018
NSCLC,11/18/2022,-1,ADJUVANT,Pembrolizumab,G437:CB1EF9DB,FALSE,7/1/2023
NSCLC,8/1/2024,2,ADVANCED,Osimertinib,G44785496DGE9,FALSE,5/5/2025
NSCLC,10/25/2011,-1,NEOADJUVANT,Pemetrexed,G3G18D5D62822,FALSE,11/12/2011
NSCLC,12/26/2024,3,ADVANCED,"Docetaxel,Ramucirumab",G47DG9518GG1E,FALSE,1/24/2025
NSCLC,7/30/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G1CFE2442E26G,FALSE,10/18/2013
NSCLC,2/26/2020,3,ADVANCED,"Carboplatin,Pemetrexed",G131892E39563,FALSE,1/6/2021
NSCLC,9/6/2024,-1,ADJUVANT,Rituximab-Arrx,G2GDF48F:5EGB,FALSE,10/14/2024
NSCLC,4/14/2015,1,ADVANCED,"Carboplatin,Gemcitabine",G1:C9B9B392:C,FALSE,5/16/2015
NSCLC,6/14/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G346FFEC8FE4C,FALSE,9/8/2019
NSCLC,1/28/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G158118CE1E2C,FALSE,1/15/2018
NSCLC,7/13/2014,1,ADVANCED,"Cisplatin,Pemetrexed",G2D3FB2DD2C:1,FALSE,8/24/2014
NSCLC,11/23/2024,-1,ADJUVANT,Off Systemic Therapy,G26FC954B79DD,FALSE,12/24/2024
NSCLC,10/11/2021,1,ADVANCED,Pembrolizumab,G4C4C3G28CF33,FALSE,1/24/2022
NSCLC,2/7/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G15B:95:E93C7,FALSE,4/1/2015
NSCLC,10/26/2020,2,ADVANCED,Gemcitabine,G23G4C57:DEB5,FALSE,5/23/2021
NSCLC,11/13/2016,2,ADVANCED,Nivolumab,G1D:B49GGG719,FALSE,5/29/2017
NSCLC,5/11/2014,1,ADVANCED,Gemcitabine,G5:7591G6FGGG,FALSE,7/22/2014
NSCLC,8/8/2019,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3D59288727DB,FALSE,11/6/2019
NSCLC,7/20/2013,-1,CONCURRENT,"Carboplatin,Gemcitabine",G289C6438E26:,FALSE,7/9/2013
NSCLC,5/26/2013,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G1G911BEC5817,FALSE,9/12/2013
NSCLC,10/30/2022,-1,ADJUVANT,Durvalumab,G119DBG986C45,FALSE,12/5/2023
NSCLC,7/12/2020,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,7/24/2020
NSCLC,5/9/2020,1,ADVANCED,"Carboplatin,Paclitaxel",G3D:2:59GC48E,FALSE,4/1/2021
NSCLC,10/18/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G52FEFD8:E24C,FALSE,1/21/2022
NSCLC,4/16/2020,-1,ADJUVANT,Off Systemic Therapy,G2342EB991FC8,FALSE,9/25/2020
NSCLC,12/21/2023,1,ADVANCED,Durvalumab,G1EC14EC2:22:,TRUE,3/30/2024
NSCLC,6/7/2012,-1,ADJUVANT,Off Systemic Therapy,G1B:584419G11,FALSE,11/30/2012
NSCLC,12/13/2011,3,ADVANCED,"Carboplatin,Etoposide",G1468E9F5C9CG,FALSE,12/31/2012
NSCLC,12/21/2022,2,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G287777772FGE,FALSE,12/27/2022
NSCLC,10/8/2011,-1,ADJUVANT,Off Systemic Therapy,G3G18D5D62822,FALSE,1/5/2012
NSCLC,4/6/2024,-1,ADJUVANT,Off Systemic Therapy,G369D5G3B91:2,FALSE,6/25/2024
NSCLC,2/20/2013,2,ADVANCED,Pemetrexed,G493:D:293BE2,FALSE,2/4/2013
NSCLC,1/17/2015,1,ADVANCED,"Cisplatin,Etoposide",G1D26B928965F,FALSE,3/2/2015
NSCLC,4/11/2024,-1,ADJUVANT,"Cisplatin,Pemetrexed",G52:6C556E791,FALSE,6/27/2024
NSCLC,1/9/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1E1BE62:E61G,FALSE,12/18/2019
NSCLC,1/25/2020,-1,ADJUVANT,Carboplatin,G2342EB991FC8,FALSE,2/28/2020
NSCLC,9/1/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G298FGDFDG8E7,FALSE,11/22/2019
NSCLC,9/18/2019,-1,ADJUVANT,Anastrozole,G432E:9E:21DC,FALSE,11/5/2019
NSCLC,5/8/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G5::D4E74F959,FALSE,11/16/2013
NSCLC,5/29/2024,1,ADVANCED,"Decitabine,Venetoclax",G41DE1E3BE99:,FALSE,7/4/2024
NSCLC,6/10/2020,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G3EC2153F:341,FALSE,6/22/2020
NSCLC,2/4/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G4E68514B7GFD,FALSE,4/15/2015
NSCLC,2/26/2019,2,ADVANCED,Letrozole,G44DBB13D9C9:,FALSE,4/5/2019
NSCLC,5/31/2018,-1,ADJUVANT,"Carboplatin,Pembrolizumab,Pemetrexed",G5995:57EB51E,FALSE,10/22/2019
NSCLC,7/24/2023,2,ADVANCED,Nivolumab,G15517:BF5DE4,FALSE,8/19/2024
NSCLC,12/29/2015,-1,ADJUVANT,Off Systemic Therapy,G2G776C59C653,FALSE,4/23/2020
NSCLC,2/17/2023,1,ADVANCED,"Carboplatin,Clinical Study Drug,Pemetrexed",G191DF9724793,FALSE,5/9/2025
NSCLC,12/23/2013,1,ADVANCED,Clinical Study Drug,G24C:63G27686,FALSE,2/4/2014
NSCLC,12/7/2012,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G289C6438E26:,FALSE,12/19/2012
NSCLC,3/3/2018,-1,ADJUVANT,"Carboplatin,Pemetrexed",G3142D1E86841,FALSE,5/22/2018
NSCLC,10/12/2024,1,ADVANCED,"Crizotinib,Lorlatinib",G24G49:3G:B1G,FALSE,2/25/2025
NSCLC,2/27/2015,1,ADVANCED,Pemetrexed,G4B1F584CB682,TRUE,10/25/2015
NSCLC,9/12/2022,1,ADVANCED,"Carboplatin,Pemetrexed",G15517:BF5DE4,FALSE,1/2/2023
NSCLC,5/5/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G18DFE96F9:2G,FALSE,6/15/2024
NSCLC,7/24/2022,-1,CONCURRENT,Off Systemic Therapy,G1CCE24EED8F8,FALSE,12/18/2024
NSCLC,3/24/2023,-1,NEOADJUVANT,Enzalutamide,G53D3D6874EB3,FALSE,5/9/2023
NSCLC,8/2/2024,2,LOCOREGIONAL,Osimertinib,G25BG745::8GE,FALSE,3/25/2025
NSCLC,4/3/2020,1,LOCOREGIONAL,Afatinib,G26C72D6F6G:5,FALSE,7/25/2020
NSCLC,9/28/2020,-1,ADJUVANT,Bicalutamide,G4992B5EB431G,FALSE,2/6/2021
NSCLC,5/18/2018,3,ADVANCED,"Clinical Study Drug,Docetaxel",G3B26D:2G114C,FALSE,2/19/2019
NSCLC,1/2/2025,-1,ADJUVANT,Off Systemic Therapy,G2E42F615FFFC,FALSE,3/3/2025
NSCLC,6/27/2024,2,ADVANCED,"Carboplatin,Gemcitabine",G2:5874817G9C,FALSE,10/4/2024
NSCLC,7/21/2017,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G184:C43CDE:B,FALSE,7/13/2017
NSCLC,11/24/2018,-1,ADJUVANT,Anastrozole,G432E:9E:21DC,FALSE,12/14/2018
NSCLC,7/18/2016,1,ADVANCED,"Carboplatin,Pemetrexed",G3B26D:2G114C,FALSE,1/19/2018
NSCLC,8/30/2021,-1,NEOADJUVANT,Afatinib,G1B56G7791723,FALSE,2/14/2022
NSCLC,12/23/2020,-1,ADJUVANT,Hydroxyurea,G1:F129FBCE3F,FALSE,1/26/2021
NSCLC,1/23/2023,-1,ADJUVANT,Off Systemic Therapy,G1B6GF976DEG:,FALSE,5/6/2025
NSCLC,10/17/2013,-1,ADJUVANT,"Carboplatin,Etoposide",G2BE13CEFB231,FALSE,11/30/2013
NSCLC,10/1/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2CC42E:::G72,FALSE,10/16/2018
NSCLC,8/24/2023,-1,NEOADJUVANT,Osimertinib,G1G9455D2D9G7,FALSE,2/7/2024
NSCLC,10/16/2022,1,LOCOREGIONAL,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G1G5G15146B3D,FALSE,10/15/2022
NSCLC,2/16/2020,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,2/2/2020
NSCLC,1/4/2020,1,ADVANCED,Crizotinib,G1B59D86EEB5E,FALSE,5/17/2020
NSCLC,11/22/2013,-1,ADJUVANT,"Carboplatin,Paclitaxel",G2D3FB2DD2C:1,FALSE,2/8/2014
NSCLC,10/20/2023,-1,ADJUVANT,Off Systemic Therapy,G437:CB1EF9DB,FALSE,5/27/2024
NSCLC,3/17/2023,-1,ADJUVANT,Off Systemic Therapy,G4B1G4D17C4F8,FALSE,4/2/2025
NSCLC,5/5/2023,1,ADVANCED,Clinical Study Drug,G3GF88F:7::4:,FALSE,3/20/2024
NSCLC,7/8/2019,-1,ADJUVANT,Enzalutamide,G1D41F368EE:G,FALSE,8/11/2019
NSCLC,5/4/2021,2,ADVANCED,Pemetrexed,G3642135:5B4C,FALSE,10/2/2021
NSCLC,6/30/2021,-1,ADJUVANT,Temozolomide,G3DB42DD29B5G,FALSE,8/29/2021
NSCLC,5/17/2019,-1,NEOADJUVANT,"Cisplatin,Etoposide",G122G2D35B8CE,FALSE,6/9/2019
NSCLC,3/13/2014,2,ADVANCED,"Carboplatin,Cyclophosphamide,Doxorubicin,Gemcitabine,Rituximab,Vincristine",G1C9B158617B6,FALSE,10/28/2020
NSCLC,12/28/2018,-1,NEOADJUVANT,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,FALSE,4/18/2019
NSCLC,8/13/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1B278956E5G4,FALSE,11/15/2024
NSCLC,3/30/2024,1,ADVANCED,Durvalumab,G56D5:EDD9C68,TRUE,4/13/2025
NSCLC,9/29/2024,2,ADVANCED,"Carboplatin,Lorlatinib,Pemetrexed",G59243DC543:8,FALSE,12/24/2024
NSCLC,8/6/2024,-1,NEOADJUVANT,"Carboplatin,Paclitaxel,Pembrolizumab",G22CF9C794236,FALSE,9/17/2024
NSCLC,1/31/2017,3,ADVANCED,Pembrolizumab,G212CFB5F9B91,FALSE,4/20/2025
NSCLC,11/5/2021,3,ADVANCED,"Osimertinib,Pembrolizumab",G4826CB54C27:,FALSE,6/8/2024
NSCLC,6/16/2019,2,ADVANCED,Atezolizumab,G17BB6EDG:98F,FALSE,7/30/2019
NSCLC,3/27/2022,0,,Line Zero,G4FCB886B34DC,FALSE,12/8/2022
NSCLC,10/18/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G381867BDG3G2,FALSE,12/23/2014
NSCLC,10/29/2016,1,ADVANCED,Erlotinib,G4C:6:784E1GF,FALSE,9/14/2017
NSCLC,9/26/2014,3,ADVANCED,"Bevacizumab,Paclitaxel",G4:72GGEFB4B:,FALSE,12/26/2014
NSCLC,3/24/2024,1,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel",G3G18F3E9E3C8,FALSE,3/24/2024
NSCLC,2/20/2015,-1,CONCURRENT,"Carboplatin,Docetaxel,Paclitaxel",G2:B72E3:5CD9,FALSE,5/7/2015
NSCLC,3/13/2013,-1,ADJUVANT,"Carboplatin,Vinorelbine",G12F2F77BF3BF,FALSE,5/19/2013
NSCLC,11/14/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G4253CG56F6FC,FALSE,3/14/2023
NSCLC,3/24/2018,1,ADVANCED,Alectinib,G38G2BBE55G71,FALSE,2/17/2025
NSCLC,7/2/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G39183B93EFDG,FALSE,2/10/2020
NSCLC,8/25/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G21C1861C3393,FALSE,1/13/2019
NSCLC,12/31/2024,-1,ADJUVANT,Enzalutamide,G214C6EC1517:,FALSE,4/13/2025
NSCLC,7/15/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G218159B8:4F6,FALSE,11/3/2019
NSCLC,10/25/2023,3,ADVANCED,"Carboplatin,Osimertinib,Pemetrexed",G31C:9::5EG5D,FALSE,5/9/2024
NSCLC,11/13/2015,3,ADVANCED,Nivolumab,G46:87GF7FGC9,FALSE,9/21/2016
NSCLC,10/6/2018,1,ADVANCED,Carboplatin,G44DBB13D9C9:,FALSE,2/15/2019
NSCLC,11/22/2022,-1,ADJUVANT,Nintedanib,G2848BE3831EF,FALSE,12/2/2022
NSCLC,4/30/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G53BC434E6BF:,FALSE,7/22/2024
NSCLC,9/2/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1D894G21GC1E,TRUE,12/24/2024
NSCLC,9/15/2023,-1,ADJUVANT,Durvalumab,G42D:4D9G6157,FALSE,11/29/2023
NSCLC,6/5/2021,2,ADVANCED,"Bevacizumab-Bvzr,Carboplatin,Pemetrexed",G1:EE91B54:7C,FALSE,8/10/2022
NSCLC,1/18/2024,1,LOCOREGIONAL,"Carboplatin,Crizotinib,Pemetrexed",G1D4DE:C3C41C,FALSE,4/4/2025
NSCLC,9/28/2020,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G26C72D6F6G:5,FALSE,1/19/2021
NSCLC,6/25/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G16D13269DE9G,FALSE,11/27/2022
NSCLC,11/24/2014,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4G78ED3FGCF8,FALSE,3/14/2015
NSCLC,11/21/2013,2,ADVANCED,Eribulin,G19937F58E541,FALSE,12/7/2013
NSCLC,11/23/2021,1,LOCOREGIONAL,Durvalumab,G1G4BC1:B::63,TRUE,3/10/2022
NSCLC,9/1/2018,-1,ADJUVANT,Decitabine,G1F5415D1B672,FALSE,12/25/2018
NSCLC,5/27/2022,-1,ADJUVANT,Atezolizumab,G32B1E29263BG,FALSE,2/17/2023
NSCLC,8/16/2024,-1,ADJUVANT,Durvalumab,G147D:E6:68B1,FALSE,10/8/2024
NSCLC,7/24/2022,-1,ADJUVANT,Anastrozole,G432E:9E:21DC,FALSE,7/15/2022
NSCLC,12/20/2020,4,ADVANCED,Vinorelbine,G1BB2C23:5573,FALSE,8/16/2021
NSCLC,10/30/2023,-1,CONCURRENT,"Carboplatin,Pemetrexed",G3:G1:CC15DG9,FALSE,1/27/2024
NSCLC,8/8/2020,2,ADVANCED,Nivolumab,G26C72D6F6G:5,FALSE,9/20/2020
NSCLC,11/25/2024,1,ADVANCED,Osimertinib,G434D7BE:6E1:,FALSE,11/24/2024
NSCLC,4/15/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G13CCC275:E7G,FALSE,6/25/2012
NSCLC,12/3/2018,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G22D6BD662E16,FALSE,2/11/2019
NSCLC,12/26/2024,3,ADVANCED,"Docetaxel,Lorlatinib,Tepotinib",G59243DC543:8,FALSE,4/9/2025
NSCLC,5/26/2016,-1,CONCURRENT,"Carboplatin,Paclitaxel",G119F2D14F4C3,FALSE,10/3/2016
NSCLC,7/4/2016,4,ADVANCED,Docetaxel,G1GDCB:FF9G:1,FALSE,7/8/2016
NSCLC,5/10/2016,4,ADVANCED,"Pemetrexed,Vemurafenib",G4C53C5GC48E:,FALSE,8/27/2016
NSCLC,5/23/2023,-1,ADJUVANT,"Cisplatin,Pemetrexed",G17169D3:3667,FALSE,7/8/2023
NSCLC,11/6/2021,-1,ADJUVANT,Off Systemic Therapy,G1E16D::267DF,FALSE,3/31/2025
NSCLC,9/14/2024,-1,NEOADJUVANT,"Carboplatin,Paclitaxel,Pembrolizumab",G26FC954B79DD,FALSE,10/23/2024
NSCLC,8/15/2018,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G34BG69F45EE4,FALSE,7/19/2018
NSCLC,2/14/2021,-1,ADJUVANT,Durvalumab,G4D62843::5E1,FALSE,2/22/2022
NSCLC,7/1/2021,1,ADVANCED,Pembrolizumab,G1CB3B346155D,TRUE,9/17/2021
NSCLC,8/27/2014,1,ADVANCED,"Cisplatin,Etoposide",G3BCC2GG732G:,FALSE,5/30/2015
NSCLC,2/5/2024,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G26B488B88188,FALSE,2/29/2024
NSCLC,1/7/2022,2,ADVANCED,"Alectinib,Osimertinib",G3BBG95F1669C,FALSE,11/6/2022
NSCLC,9/6/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G58G2E7D9G4E7,FALSE,5/11/2018
NSCLC,3/31/2013,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2B:D6686421C,FALSE,9/8/2013
NSCLC,12/10/2021,2,ADVANCED,Pembrolizumab,G16227785C51C,FALSE,12/12/2021
NSCLC,11/9/2011,-1,NEOADJUVANT,Off Systemic Therapy,G3:G31857DB4:,FALSE,6/26/2019
NSCLC,1/10/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G1B7793:6:9E1,FALSE,11/10/2014
NSCLC,2/24/2014,-1,ADJUVANT,Off Systemic Therapy,G2D3FB2DD2C:1,FALSE,7/3/2014
NSCLC,10/31/2013,1,ADVANCED,"Bevacizumab,Pemetrexed",G1CFE2442E26G,TRUE,1/1/2014
NSCLC,12/7/2016,1,ADVANCED,Nivolumab,G1F:9CFGFGFC1,FALSE,5/19/2020
NSCLC,11/28/2020,1,ADVANCED,Pembrolizumab,G385EEC4EF993,FALSE,12/14/2020
NSCLC,12/23/2024,1,LOCOREGIONAL,Clinical Study Drug,G2C233C2:5B1:,FALSE,5/19/2025
NSCLC,2/28/2023,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,FALSE,6/4/2023
NSCLC,10/13/2022,4,ADVANCED,"Hydroxyurea,Imatinib",G14E7662::61C,FALSE,12/27/2022
NSCLC,8/12/2024,1,ADVANCED,"Alectinib,Lorlatinib",G59243DC543:8,FALSE,10/31/2024
NSCLC,9/14/2023,1,ADVANCED,"Carboplatin,Gemcitabine",G2B71GB3997CF,FALSE,10/1/2023
NSCLC,12/20/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G2G76D1E7GG61,FALSE,1/6/2015
NSCLC,2/11/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G17EC67:48631,FALSE,4/7/2024
NSCLC,5/11/2025,1,ADVANCED,"Carboplatin,Paclitaxel",G4FG6E1D:B1B7,FALSE,4/16/2025
NSCLC,8/24/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G53BC434E6BF:,TRUE,4/23/2025
NSCLC,1/29/2024,1,ADVANCED,Cemiplimab,G14E999899EFC,FALSE,5/8/2024
NSCLC,11/29/2022,1,ADVANCED,"Cisplatin,Osimertinib,Pemetrexed",G52B6FD5G4D5:,FALSE,3/30/2025
NSCLC,4/6/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2518G1D763FB,FALSE,4/11/2024
NSCLC,6/14/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G1E589EBD8F93,FALSE,11/28/2012
NSCLC,4/17/2017,3,ADVANCED,Gemcitabine,G163D9B593927,FALSE,11/9/2017
NSCLC,8/15/2018,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G11:1G4CE9G7B,FALSE,1/22/2019
NSCLC,2/10/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G4D:183G813CB,FALSE,9/26/2018
NSCLC,11/25/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G3G18F3E9E3C8,FALSE,1/9/2024
NSCLC,7/26/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G2G38:E36D42B,FALSE,9/3/2024
NSCLC,11/28/2012,-1,CONCURRENT,"Carboplatin,Paclitaxel",G289C6438E26:,FALSE,2/26/2013
NSCLC,4/27/2018,1,ADVANCED,Pembrolizumab,G11D8D2G1D8CD,FALSE,4/2/2025
NSCLC,6/24/2015,-1,ADJUVANT,"Bevacizumab,Carboplatin,Pemetrexed",G3DB42DD29B5G,FALSE,1/4/2016
NSCLC,2/20/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G1BGE419C:CE7,FALSE,4/23/2024
NSCLC,6/4/2014,1,ADVANCED,Vinorelbine,G1D84CDE8:C5E,FALSE,12/14/2014
NSCLC,5/18/2019,1,ADVANCED,"Carboplatin,Nivolumab,Paclitaxel",G3:G31857DB4:,FALSE,12/29/2021
NSCLC,3/17/2013,2,ADVANCED,Gemcitabine,G49E8CFG53::D,FALSE,7/29/2013
NSCLC,9/20/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1B278956E5G4,TRUE,5/2/2025
NSCLC,6/2/2013,1,ADVANCED,Pemetrexed,G2EF5C6677DE:,FALSE,7/15/2013
NSCLC,12/17/2013,1,ADVANCED,"Carboplatin,Pemetrexed",G14ECFDEBG33C,FALSE,5/25/2014
NSCLC,4/19/2023,-1,ADJUVANT,"Cisplatin,Pemetrexed",G419EE8F1F59D,FALSE,7/24/2023
NSCLC,9/30/2023,4,ADVANCED,Pembrolizumab,G2D168F99BCD4,FALSE,12/8/2023
NSCLC,1/22/2019,2,ADVANCED,"Carboplatin,Pemetrexed",G28EFBDGDC712,FALSE,2/16/2025
NSCLC,11/2/2018,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,10/19/2018
NSCLC,1/23/2020,2,LOCOREGIONAL,"Carboplatin,Pembrolizumab,Pemetrexed",G548B2:G6G6D:,FALSE,2/24/2023
NSCLC,3/13/2023,-1,ADJUVANT,Atezolizumab,G53EDE5926292,FALSE,1/31/2024
NSCLC,2/27/2024,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G2:5874817G9C,FALSE,6/12/2024
NSCLC,3/15/2016,3,ADVANCED,Nivolumab,G2D5B71G65F2G,FALSE,4/25/2016
NSCLC,9/29/2015,-1,ADJUVANT,"Carboplatin,Paclitaxel",G2G776C59C653,FALSE,1/8/2016
NSCLC,10/11/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G3D7ED2233C43,TRUE,2/18/2022
NSCLC,11/4/2020,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,5/20/2021
NSCLC,12/17/2021,1,ADVANCED,Nivolumab,G4G88:D789F74,TRUE,12/2/2024
NSCLC,9/29/2014,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G163D9B593927,FALSE,11/30/2014
NSCLC,11/20/2016,2,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,FALSE,3/29/2017
NSCLC,5/3/2021,-1,ADJUVANT,Anastrozole,G1:9FCE6E6G6C,FALSE,5/24/2021
NSCLC,11/24/2023,3,ADVANCED,"Anastrozole,Atezolizumab",G1GFD92F489E7,FALSE,12/28/2023
NSCLC,5/13/2020,-1,ADJUVANT,Cisplatin,G2G88EE8653C2,FALSE,7/20/2020
NSCLC,10/3/2014,2,ADVANCED,Clinical Study Drug,G3:D1D2EG5C21,FALSE,11/5/2014
NSCLC,12/16/2022,-1,NEOADJUVANT,Anastrozole,G1GFD92F489E7,FALSE,2/7/2023
NSCLC,1/3/2021,3,ADVANCED,"Cisplatin,Gemcitabine",G332GBGFG7416,FALSE,6/29/2021
NSCLC,6/18/2015,1,ADVANCED,"Gemcitabine,Paclitaxel Protein-Bound",G167G71733G69,FALSE,11/9/2015
NSCLC,11/8/2017,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G266E6248F531,FALSE,4/19/2018
NSCLC,10/21/2022,2,ADVANCED,"Capmatinib,Erlotinib",G12E5EG31:6:5,FALSE,11/30/2022
NSCLC,2/2/2022,-1,ADJUVANT,Osimertinib,G253322FB7:C9,FALSE,3/3/2023
NSCLC,6/27/2016,-1,NEOADJUVANT,Off Systemic Therapy,G27471:8B6217,FALSE,9/26/2016
NSCLC,10/21/2022,3,ADVANCED,"Clinical Study Drug,Osimertinib",G3BBG95F1669C,FALSE,1/26/2023
NSCLC,11/5/2019,-1,ADJUVANT,Off Systemic Therapy,G14EB8:1:D44G,FALSE,2/28/2020
NSCLC,9/8/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G445F26762F72,FALSE,1/18/2024
NSCLC,12/8/2017,2,ADVANCED,Clinical Study Drug,G57G45B:D1F17,FALSE,1/22/2025
NSCLC,10/6/2021,2,ADVANCED,"Dabrafenib,Trametinib",G4FC5:16DD742,FALSE,9/14/2023
NSCLC,5/31/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1C3CCC:C44GD,FALSE,9/26/2021
NSCLC,8/9/2024,1,ADVANCED,Pembrolizumab,G1E69F659F391,TRUE,3/29/2025
NSCLC,12/23/2018,-1,NEOADJUVANT,Bortezomib,G37C2D6679F35,FALSE,12/23/2018
NSCLC,12/15/2013,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G2398:2936:C9,FALSE,1/9/2014
NSCLC,10/28/2016,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G264B2D11BG13,FALSE,10/21/2016
NSCLC,6/25/2018,2,ADVANCED,Nivolumab,G135BB2F5GCDF,FALSE,12/25/2018
NSCLC,1/1/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G56BF:5789F3D,FALSE,4/16/2015
NSCLC,7/12/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G48796B29723B,FALSE,6/14/2013
NSCLC,11/26/2015,2,ADVANCED,Nivolumab,G45C13CFDDB84,FALSE,5/17/2017
NSCLC,10/10/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G23:3:B689E33,FALSE,11/17/2015
NSCLC,11/16/2017,1,ADVANCED,Afatinib,G26EFGF738125,FALSE,6/5/2018
NSCLC,4/27/2021,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,10/30/2021
NSCLC,7/9/2017,1,ADVANCED,Nivolumab,G14G5B9C531F6,FALSE,1/30/2018
NSCLC,11/10/2014,2,ADVANCED,"Carboplatin,Pemetrexed",G161297FC6EC1,FALSE,1/18/2015
NSCLC,6/17/2020,-1,ADJUVANT,Rituximab,G5545136B977G,FALSE,7/13/2020
NSCLC,4/17/2014,1,ADVANCED,"Carboplatin,Erlotinib,Paclitaxel",G3::1:B4F:3D4,FALSE,6/8/2014
NSCLC,12/6/2023,-1,ADJUVANT,"Abiraterone,Cisplatin,Leuprolide,Pemetrexed",G2G419135CEEC,FALSE,3/10/2024
NSCLC,9/4/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G12DD1599F4EF,FALSE,10/10/2024
NSCLC,9/26/2020,-1,ADJUVANT,Letrozole,G29D9FB:D1D6B,FALSE,10/19/2020
NSCLC,3/2/2023,3,ADVANCED,"Carboplatin,Paclitaxel",G1GC97BGC25B3,FALSE,2/27/2023
NSCLC,5/11/2020,2,LOCOREGIONAL,Osimertinib,G3:67CF8FF:28,FALSE,11/6/2021
NSCLC,4/23/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G4B9:3796F753,FALSE,12/7/2014
NSCLC,10/12/2020,-1,ADJUVANT,Durvalumab,G11F85:F1CG29,FALSE,6/17/2021
NSCLC,11/3/2012,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G19DB44:G31G8,FALSE,4/4/2013
NSCLC,4/17/2025,1,ADVANCED,Durvalumab,G3FGEBG3CG127,TRUE,5/9/2025
NSCLC,3/6/2023,-1,CONCURRENT,Off Systemic Therapy,G1B11FE17FE99,FALSE,6/18/2023
NSCLC,2/5/2025,1,ADVANCED,Pralsetinib,G4C89FC6D8388,FALSE,5/7/2025
NSCLC,2/25/2018,1,ADVANCED,Alectinib,G1:3G:24D:34B,FALSE,4/27/2025
NSCLC,8/28/2024,1,ADVANCED,Atezolizumab,G48::2:98C2EE,TRUE,5/9/2025
NSCLC,10/30/2023,-1,ADJUVANT,Off Systemic Therapy,G2848BE3831EF,FALSE,3/10/2025
NSCLC,11/2/2023,2,ADVANCED,"Docetaxel,Leuprolide",G24F:E99C2926,FALSE,12/24/2023
NSCLC,1/22/2025,1,ADVANCED,"Cisplatin,Pemetrexed",G127F7CE9C111,FALSE,3/26/2025
NSCLC,6/20/2015,2,ADVANCED,Clinical Study Drug,G5:CE:F92EE8D,FALSE,2/20/2016
NSCLC,5/25/2019,2,ADVANCED,"Docetaxel,Ramucirumab",G1BBDD:8BDED9,FALSE,7/15/2019
NSCLC,9/18/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G55D67392F8:9,FALSE,12/3/2023
NSCLC,3/25/2022,-1,ADJUVANT,"Carboplatin,Paclitaxel",G53C52948773G,FALSE,5/22/2022
NSCLC,6/15/2024,1,ADVANCED,Pembrolizumab,G1195EGCD:B45,TRUE,7/2/2024
NSCLC,4/22/2023,1,ADVANCED,Pembrolizumab,G14955945B53:,TRUE,6/14/2023
NSCLC,5/25/2024,4,ADVANCED,"Carboplatin,Pemetrexed",G252328CFG4E1,FALSE,7/24/2024
NSCLC,4/25/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G3B2G711:7F8:,FALSE,5/19/2015
NSCLC,3/16/2015,1,ADVANCED,"Bevacizumab,Pemetrexed",G44B44661:316,FALSE,3/13/2016
NSCLC,10/12/2018,1,ADVANCED,Pembrolizumab,G15GFGE5:BDC9,TRUE,4/16/2019
NSCLC,7/2/2016,-1,CONCURRENT,Cisplatin,G1G618861EGD9,FALSE,9/13/2016
NSCLC,1/12/2016,-1,CONCURRENT,"Carboplatin,Hydroxyurea,Paclitaxel",G4C2EB36BG3:G,FALSE,4/6/2016
NSCLC,6/12/2018,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1B59D86EEB5E,FALSE,6/28/2018
NSCLC,11/7/2019,1,ADVANCED,"Docetaxel,Gemcitabine",G51:G:C712CC6,FALSE,1/1/2020
NSCLC,8/10/2024,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G3867F7D51E3D,FALSE,11/6/2024
NSCLC,10/24/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G166B735:96D2,FALSE,1/26/2013
NSCLC,10/14/2024,-1,NEOADJUVANT,Off Systemic Therapy,G22CF9C794236,FALSE,12/14/2024
NSCLC,12/14/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G184:2G6G88:G,FALSE,1/2/2013
NSCLC,8/3/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G38D11EG5F826,FALSE,2/9/2016
NSCLC,12/4/2023,-1,ADJUVANT,Off Systemic Therapy,G16D13269DE9G,FALSE,5/8/2025
NSCLC,1/1/2025,3,ADVANCED,"Carboplatin,Pemetrexed",G14E999899EFC,FALSE,5/6/2025
NSCLC,10/29/2014,1,ADVANCED,"Bevacizumab,Pemetrexed",G4F354B:F341F,TRUE,9/6/2016
NSCLC,1/16/2019,1,ADVANCED,"Gemcitabine,Osimertinib,Oxaliplatin",G287BD28548B:,FALSE,4/13/2019
NSCLC,7/1/2012,1,ADVANCED,"Carboplatin,Docetaxel",G133G3GCBGE3D,FALSE,6/10/2013
NSCLC,5/8/2023,1,ADVANCED,"Carboplatin,Pemetrexed",G1CF4D5D1:BF3,FALSE,10/22/2023
NSCLC,10/28/2013,-1,NEOADJUVANT,Off Systemic Therapy,G227FDC93E654,FALSE,6/27/2014
NSCLC,8/1/2020,2,ADVANCED,"Docetaxel,Ramucirumab",G11:F93GC6851,FALSE,12/30/2020
NSCLC,7/10/2013,1,ADVANCED,"Carboplatin,Pemetrexed",G29C71B44G:B6,FALSE,8/8/2013
NSCLC,12/14/2021,-1,CONCURRENT,"Carboplatin,Pemetrexed",G2GD72:FBC5FG,FALSE,3/12/2022
NSCLC,9/10/2016,5,ADVANCED,"Pembrolizumab,Vemurafenib",G4C53C5GC48E:,FALSE,10/4/2016
NSCLC,5/12/2024,1,ADVANCED,Pembrolizumab,G437:CB1EF9DB,FALSE,8/25/2024
NSCLC,9/28/2021,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G38F772G48B9C,FALSE,3/21/2022
NSCLC,7/17/2017,3,ADVANCED,"Docetaxel,Ramucirumab",G4F354B:F341F,FALSE,9/15/2017
NSCLC,9/28/2017,1,ADVANCED,Atezolizumab,G21B7762691EE,FALSE,8/14/2018
NSCLC,5/17/2024,-1,NEOADJUVANT,Clinical Study Drug,G1DCDG73E53FF,FALSE,7/22/2024
NSCLC,11/25/2023,1,ADVANCED,Durvalumab,G5722GECG4G16,TRUE,3/8/2024
NSCLC,2/27/2012,-1,ADJUVANT,Off Systemic Therapy,G131CBG478:94,FALSE,5/1/2014
NSCLC,4/5/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G26G426GG3C8F,FALSE,7/20/2017
NSCLC,5/2/2021,-1,NEOADJUVANT,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G54F545489E59,FALSE,11/5/2021
NSCLC,9/13/2014,4,ADVANCED,Clinical Study Drug,G56CF8BF38D:7,FALSE,12/26/2014
NSCLC,9/2/2013,2,ADVANCED,"Gemcitabine,Vinorelbine",G131EFCB91:B2,FALSE,10/6/2013
NSCLC,12/26/2011,-1,ADJUVANT,"Cisplatin,Etoposide",G131CBG478:94,FALSE,4/11/2012
NSCLC,2/9/2019,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G35F74FGBE8CE,FALSE,2/6/2019
NSCLC,8/23/2022,1,ADVANCED,Pembrolizumab,G3D741EB4:B76,TRUE,5/21/2025
NSCLC,7/12/2014,2,ADVANCED,Pemetrexed,G4ECBF26D2579,FALSE,8/17/2014
NSCLC,6/3/2024,1,ADVANCED,"Carboplatin,Cemiplimab,Pemetrexed",G25:D5732783D,FALSE,9/16/2024
NSCLC,2/26/2019,1,ADVANCED,"Carboplatin,Pemetrexed",G4ED3922EEE48,FALSE,6/14/2019
NSCLC,6/15/2020,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,5/26/2020
NSCLC,3/15/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G166FBC749F7D,FALSE,4/6/2013
NSCLC,2/26/2023,1,ADVANCED,"Cyclophosphamide,Doxorubicin,Rituximab-Arrx,Vincristine",G252328CFG4E1,FALSE,11/27/2023
NSCLC,3/31/2012,-1,ADJUVANT,"Carboplatin,Pemetrexed",G5995:57EB51E,FALSE,5/15/2012
NSCLC,11/6/2024,-1,ADJUVANT,Off Systemic Therapy,G147D:E6:68B1,FALSE,1/15/2025
NSCLC,1/20/2021,-1,ADJUVANT,Off Systemic Therapy,G4992B5EB431G,FALSE,3/20/2025
NSCLC,2/8/2024,1,ADVANCED,Leuprolide,G17G71B51EFE2,FALSE,4/14/2024
NSCLC,3/5/2019,-1,ADJUVANT,Off Systemic Therapy,G3642135:5B4C,FALSE,10/12/2020
NSCLC,9/17/2023,5,ADVANCED,Sotorasib,G56B4BCB27428,FALSE,9/26/2023
NSCLC,9/23/2022,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G2141CBEF3GD3,FALSE,11/28/2022
NSCLC,7/15/2013,2,ADVANCED,Paclitaxel,G3ED9686E8628,FALSE,2/22/2014
NSCLC,2/4/2019,1,ADVANCED,"Carboplatin,Pemetrexed",G19:83254DDF6,FALSE,9/3/2022
NSCLC,4/11/2019,-1,ADJUVANT,Durvalumab,G2E14:97G:FFD,FALSE,4/20/2019
NSCLC,3/17/2022,2,ADVANCED,Osimertinib,G1F9BCG13:EFD,FALSE,10/19/2023
NSCLC,2/20/2013,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G259:1C2D4D19,FALSE,3/16/2013
NSCLC,1/11/2022,-1,ADJUVANT,"Carboplatin,Pemetrexed",G32B1E29263BG,FALSE,4/9/2022
NSCLC,9/23/2015,1,ADVANCED,Nivolumab,G26EF86FE2766,FALSE,7/13/2018
NSCLC,10/17/2023,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1554C84G3CD2,FALSE,6/6/2024
NSCLC,1/22/2019,-1,ADJUVANT,Off Systemic Therapy,G57FE598G618G,FALSE,1/29/2021
NSCLC,2/11/2020,2,ADVANCED,Pemetrexed,G26G426GG3C8F,FALSE,6/15/2020
NSCLC,4/5/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G2471D2GFG2E4,FALSE,8/8/2016
NSCLC,6/2/2024,1,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Paclitaxel,Pemetrexed",G47DB481E783:,FALSE,10/11/2024
NSCLC,2/9/2016,1,ADVANCED,Anastrozole,G175D38G17E84,FALSE,7/16/2017
NSCLC,10/24/2018,3,ADVANCED,"Gemcitabine,Vinorelbine",G1G78CEE:7E:3,FALSE,2/18/2019
NSCLC,12/14/2014,1,ADVANCED,"Afatinib,Crizotinib,Erlotinib",G3C99CBDB5D54,FALSE,2/3/2015
NSCLC,9/24/2014,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1G:DDC4EED88,FALSE,7/12/2015
NSCLC,7/5/2019,-1,ADJUVANT,"Carboplatin,Paclitaxel Protein-Bound",G27B37646G3C2,FALSE,11/2/2019
NSCLC,2/6/2012,1,ADVANCED,"Bevacizumab,Pemetrexed",G38GE:9D51587,FALSE,9/3/2012
NSCLC,2/26/2018,1,ADVANCED,Paclitaxel,G1G5771EC2C8F,FALSE,3/10/2018
NSCLC,7/12/2018,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1E7D2D8C57F8,FALSE,11/7/2018
NSCLC,8/12/2021,-1,ADJUVANT,Durvalumab,G376E97C95:G:,FALSE,7/31/2022
NSCLC,2/11/2025,2,ADVANCED,Pemetrexed,G28F814933C3F,FALSE,3/28/2025
NSCLC,9/8/2017,-1,ADJUVANT,Off Systemic Therapy,G58FCD4G:G6DF,FALSE,3/6/2018
NSCLC,6/3/2024,-1,ADJUVANT,Off Systemic Therapy,G419EE8F1F59D,FALSE,9/25/2024
NSCLC,12/26/2015,2,ADVANCED,Capecitabine,G16GE86G42194,FALSE,4/3/2016
NSCLC,3/6/2023,1,ADVANCED,Pemetrexed,G22GF5E64E49D,FALSE,4/6/2023
NSCLC,5/27/2022,2,ADVANCED,Nivolumab,G28E1765:691E,FALSE,4/16/2023
NSCLC,5/31/2021,2,ADVANCED,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,FALSE,11/13/2022
NSCLC,8/28/2016,1,ADVANCED,Erlotinib,G484BED:E686:,FALSE,11/22/2017
NSCLC,4/13/2017,-1,ADJUVANT,"Paclitaxel,Trastuzumab",G1:9FCE6E6G6C,FALSE,11/30/2017
NSCLC,9/4/2018,2,ADVANCED,Nivolumab,G499EB:16:7F3,FALSE,9/2/2019
NSCLC,11/26/2022,1,ADVANCED,"Cisplatin,Pemetrexed",G2DCF3C5B462B,FALSE,12/20/2022
NSCLC,9/26/2020,-1,ADJUVANT,Off Systemic Therapy,G27B37646G3C2,FALSE,10/15/2023
NSCLC,1/22/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G1185:32426FB,FALSE,5/24/2016
NSCLC,8/11/2021,2,ADVANCED,Osimertinib,G17:EF9E52451,FALSE,9/25/2024
NSCLC,12/11/2020,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G114FBBG316GG,FALSE,3/15/2021
NSCLC,6/14/2024,2,ADVANCED,"Carboplatin,Paclitaxel",G3FG621769317,FALSE,9/27/2024
NSCLC,12/23/2014,-1,ADJUVANT,Off Systemic Therapy,G325B2E578F89,FALSE,9/26/2015
NSCLC,11/3/2016,7,ADVANCED,"Gemcitabine,Vinorelbine",G4C53C5GC48E:,FALSE,11/26/2016
NSCLC,12/4/2019,-1,ADJUVANT,Off Systemic Therapy,G5545136B977G,FALSE,5/10/2020
NSCLC,4/18/2025,1,ADVANCED,"Carboplatin,Paclitaxel",G4F:7C5268:G1,FALSE,5/12/2025
NSCLC,5/13/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G45388C4DCEFB,FALSE,7/11/2012
NSCLC,4/5/2019,-1,NEOADJUVANT,Off Systemic Therapy,G1B982CB17239,FALSE,10/6/2024
NSCLC,12/14/2024,-1,ADJUVANT,Osimertinib,G2D284G82G31F,FALSE,4/18/2025
NSCLC,8/27/2017,1,ADVANCED,Clinical Study Drug,G545:2F182DD:,FALSE,9/24/2017
NSCLC,12/19/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G11B743:8G337,FALSE,4/5/2015
NSCLC,7/10/2023,3,ADVANCED,Adagrasib,G43E:81EC19B6,FALSE,5/7/2025
NSCLC,6/19/2023,-1,ADJUVANT,Off Systemic Therapy,G33G487624E32,FALSE,1/20/2025
NSCLC,3/30/2019,-1,ADJUVANT,Off Systemic Therapy,G1D41F368EE:G,FALSE,5/12/2019
NSCLC,10/9/2016,3,ADVANCED,Nivolumab,G226G4F43C6FE,FALSE,3/29/2017
NSCLC,10/31/2019,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,3/16/2020
NSCLC,8/20/2017,-1,ADJUVANT,"Carboplatin,Paclitaxel",G171879EG:3B:,FALSE,11/23/2017
NSCLC,11/19/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G213:1B:7D2CF,FALSE,2/7/2024
NSCLC,5/16/2024,-1,CONCURRENT,Osimertinib,G15F23FC1G645,FALSE,12/7/2024
NSCLC,8/13/2017,-1,ADJUVANT,"Cisplatin,Docetaxel",G3E567F5B3:95,FALSE,8/28/2017
NSCLC,1/24/2017,3,ADVANCED,Paclitaxel,G11B743:8G337,FALSE,3/15/2017
NSCLC,9/7/2017,2,ADVANCED,Osimertinib,G4C:6:784E1GF,FALSE,1/31/2018
NSCLC,5/31/2023,1,ADVANCED,Pembrolizumab,G149B7C41:236,FALSE,6/8/2023
NSCLC,11/29/2019,1,ADVANCED,"Carboplatin,Clinical Study Drug,Pemetrexed",G3:C9BECD3F55,FALSE,8/12/2020
NSCLC,7/12/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,FALSE,10/13/2024
NSCLC,4/1/2016,2,ADVANCED,"Cisplatin,Irinotecan",G325B2E578F89,FALSE,4/8/2016
NSCLC,8/19/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G21G114D2C:9D,FALSE,9/4/2014
NSCLC,3/23/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G1EEBCF2E91G2,FALSE,6/24/2012
NSCLC,8/12/2014,1,ADVANCED,"Cisplatin,Etoposide",G212CFB5F9B91,FALSE,5/17/2016
NSCLC,3/14/2024,-1,ADJUVANT,"Hydroxyurea,Ivosidenib,Olutasidenib",G13F761779185,FALSE,5/5/2024
NSCLC,5/13/2022,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1B2DF1F46EDF,FALSE,5/22/2022
NSCLC,10/17/2015,2,ADVANCED,"Docetaxel,Ramucirumab",G2628C28G7613,FALSE,4/5/2016
NSCLC,10/15/2017,1,ADVANCED,"Carboplatin,Paclitaxel",G3842BD:23EG:,FALSE,11/4/2017
NSCLC,6/3/2015,-1,ADJUVANT,"Cisplatin,Etoposide",G42734BB63:32,FALSE,8/18/2015
NSCLC,12/12/2016,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1G3399F19C56,FALSE,1/20/2017
NSCLC,1/20/2021,3,ADVANCED,Gemcitabine,G11:F93GC6851,FALSE,4/18/2021
NSCLC,4/7/2022,-1,ADJUVANT,Off Systemic Therapy,G197EF388:C98,FALSE,2/22/2025
NSCLC,7/29/2013,-1,ADJUVANT,"Cisplatin,Etoposide",G24FFF679CFG7,FALSE,8/18/2013
NSCLC,5/10/2024,-1,ADJUVANT,Off Systemic Therapy,G1D14:53C99:F,FALSE,3/5/2025
NSCLC,8/28/2015,2,ADVANCED,Nivolumab,G25E1C41F29EC,FALSE,2/22/2021
NSCLC,2/2/2021,1,ADVANCED,"Bevacizumab-Awwb,Carboplatin,Paclitaxel",G1G54G4GB8B24,FALSE,2/11/2021
NSCLC,7/18/2019,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1897773:BE4G,FALSE,11/1/2019
NSCLC,7/10/2023,-1,ADJUVANT,Osimertinib,G1G:2:8D7GC6F,FALSE,10/25/2024
NSCLC,9/7/2024,1,ADVANCED,"Dabrafenib,Trametinib",G547F143D3DEG,FALSE,2/9/2025
NSCLC,7/29/2018,2,ADVANCED,Nivolumab,G266E6248F531,FALSE,4/1/2019
NSCLC,7/18/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G4G53233CD43C,FALSE,11/20/2024
NSCLC,12/10/2016,2,ADVANCED,Nivolumab,G1G:1C482FFGC,FALSE,2/23/2025
NSCLC,12/7/2017,-1,ADJUVANT,Nivolumab,G264B2D11BG13,FALSE,6/30/2018
NSCLC,4/6/2020,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G28CE5:9D6585,FALSE,11/14/2020
NSCLC,6/8/2024,4,ADVANCED,"Osimertinib,Trametinib",G31C:9::5EG5D,FALSE,8/7/2024
NSCLC,7/13/2013,3,ADVANCED,Paclitaxel,G247F67418GGD,FALSE,7/25/2013
NSCLC,2/5/2013,-1,CONCURRENT,"Carboplatin,Etoposide,Ifosfamide,Mesna",G48842BBE3634,FALSE,2/5/2013
NSCLC,8/23/2024,-1,NEOADJUVANT,Daratumumab/Hyaluronidase-Fihj,G17DB15D8C7CG,FALSE,8/27/2024
NSCLC,1/26/2019,1,ADVANCED,Afatinib,G4936::B67G17,FALSE,2/6/2020
NSCLC,1/1/2014,1,ADVANCED,"Cisplatin,Paclitaxel",G3848B49CFD:G,FALSE,1/17/2015
NSCLC,6/27/2021,2,LOCOREGIONAL,Osimertinib,G19B:27:ECB43,FALSE,1/15/2025
NSCLC,8/2/2014,-1,CONCURRENT,Off Systemic Therapy,G1F7B4C2F:FF2,FALSE,2/24/2015
NSCLC,2/18/2015,-1,ADJUVANT,"Carboplatin,Paclitaxel Protein-Bound",G21:3143F86E6,FALSE,3/13/2015
NSCLC,12/29/2014,-1,ADJUVANT,Off Systemic Therapy,G1B6F2D98G4BD,FALSE,11/20/2024
NSCLC,8/11/2012,4,ADVANCED,Erlotinib,G18E7528ED97:,FALSE,6/29/2013
NSCLC,10/12/2018,2,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,FALSE,7/10/2019
NSCLC,2/8/2014,3,ADVANCED,Vinorelbine,G3ED9686E8628,FALSE,6/11/2014
NSCLC,8/18/2012,-1,ADJUVANT,Off Systemic Therapy,G58E8F29:9:45,FALSE,10/29/2013
NSCLC,12/20/2017,-1,ADJUVANT,Off Systemic Therapy,G171879EG:3B:,FALSE,5/14/2022
NSCLC,8/27/2023,-1,NEOADJUVANT,"Abiraterone,Leuprolide",G2G419135CEEC,FALSE,11/1/2023
NSCLC,10/17/2021,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G32F58D86GG8D,FALSE,12/8/2021
NSCLC,12/1/2011,1,ADVANCED,Pemetrexed,G3G18D5D62822,FALSE,5/29/2012
NSCLC,12/16/2024,5,ADVANCED,"Osimertinib,Pembrolizumab",G4826CB54C27:,FALSE,3/7/2025
NSCLC,6/30/2020,1,ADVANCED,Osimertinib,G1BG11DG4E257,FALSE,7/1/2021
NSCLC,10/8/2017,-1,CONCURRENT,"Carboplatin,Paclitaxel",G359C2E:9E3B7,FALSE,10/8/2017
NSCLC,1/22/2018,1,ADVANCED,Pembrolizumab,G1:79593262B6,FALSE,12/9/2022
NSCLC,8/18/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3GDB6369:DC4,FALSE,9/16/2021
NSCLC,5/23/2013,-1,ADJUVANT,Off Systemic Therapy,G24C:63G27686,FALSE,11/25/2013
NSCLC,10/26/2018,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G4656G51E4EG7,FALSE,10/19/2018
NSCLC,11/24/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G3E76E32E795:,TRUE,4/27/2020
NSCLC,3/9/2025,3,ADVANCED,Gemcitabine,G177G4:B9E394,FALSE,4/2/2025
NSCLC,8/19/2024,2,ADVANCED,"Carboplatin,Paclitaxel",G164G31958638,FALSE,10/10/2024
NSCLC,4/1/2025,1,ADVANCED,Pembrolizumab,G365D2:FDG53F,FALSE,4/22/2025
NSCLC,5/30/2019,2,ADVANCED,"Fluorouracil,Irinotecan,Leucovorin",G56ED712FC18F,FALSE,6/25/2019
NSCLC,5/17/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2EGB9C5FC63C,FALSE,8/19/2022
NSCLC,4/26/2014,-1,ADJUVANT,Off Systemic Therapy,G24365CF6:6G7,FALSE,8/31/2022
NSCLC,3/15/2024,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G1E69F659F391,FALSE,8/15/2024
NSCLC,11/8/2015,-1,ADJUVANT,Off Systemic Therapy,G35146C5E4B61,FALSE,3/25/2016
NSCLC,11/8/2014,-1,CONCURRENT,"Cisplatin,Paclitaxel",G163D9B593927,FALSE,1/27/2015
NSCLC,1/10/2020,-1,ADJUVANT,Clinical Study Drug,G4992B5EB431G,FALSE,12/27/2019
NSCLC,3/19/2017,4,ADVANCED,Gemcitabine,G11B743:8G337,FALSE,1/22/2017
NSCLC,7/26/2023,-1,ADJUVANT,Off Systemic Therapy,G2389G8E2B4EC,FALSE,9/30/2023
NSCLC,1/26/2021,1,ADVANCED,Durvalumab,G12998681218G,FALSE,11/25/2021
NSCLC,9/23/2023,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1:3B43D3B55G,FALSE,1/19/2024
NSCLC,6/1/2023,-1,CONCURRENT,"Cisplatin,Pemetrexed",G3951BC5GBE44,FALSE,9/6/2023
NSCLC,11/9/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G45DDGFC1G86F,FALSE,11/23/2015
NSCLC,6/5/2013,1,LOCOREGIONAL,Erlotinib,G23E45CE13341,FALSE,7/11/2013
NSCLC,11/18/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1:2GG784D6FD,FALSE,1/14/2025
NSCLC,1/26/2024,-1,ADJUVANT,Durvalumab,G213:1B:7D2CF,FALSE,3/17/2025
NSCLC,5/5/2018,-1,CONCURRENT,"Carboplatin,Docetaxel",G17816EGGD:2:,FALSE,9/8/2018
NSCLC,12/27/2020,-1,ADVANCED,Off Systemic Therapy,G15875498G:F4,FALSE,1/29/2021
NSCLC,7/4/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G53C61B2GG71F,FALSE,7/18/2015
NSCLC,9/8/2020,3,ADVANCED,"Docetaxel,Ramucirumab",G3:C9BECD3F55,FALSE,11/23/2020
NSCLC,11/12/2015,1,ADVANCED,Erlotinib,G455E1367:DG4,FALSE,7/17/2016
NSCLC,10/19/2022,1,LOCOREGIONAL,"Ipilimumab,Nivolumab",G1G5G15146B3D,TRUE,2/23/2023
NSCLC,4/22/2021,1,ADVANCED,"Cisplatin,Pemetrexed",G17:EF9E52451,FALSE,8/1/2021
NSCLC,4/29/2012,1,ADVANCED,Erlotinib,G55C5E563EFC3,FALSE,6/28/2014
NSCLC,9/20/2021,-1,ADJUVANT,Anastrozole,G1FE2:9777177,FALSE,11/19/2021
NSCLC,12/4/2022,1,ADVANCED,"Carboplatin,Paclitaxel",G1532797B869C,FALSE,3/8/2023
NSCLC,8/24/2021,2,ADVANCED,Erlotinib,G1BG11DG4E257,FALSE,7/27/2021
NSCLC,11/6/2023,4,ADVANCED,"Ipilimumab,Nivolumab",G54F545489E59,FALSE,6/20/2024
NSCLC,10/24/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G4B1F584CB682,FALSE,1/22/2015
NSCLC,5/26/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G15GFGE5:BDC9,FALSE,10/5/2018
NSCLC,10/12/2024,1,ADVANCED,"Pembrolizumab,Pemetrexed",G3B9DBG4F4G94,TRUE,12/25/2024
NSCLC,10/24/2019,-1,ADJUVANT,Off Systemic Therapy,G459D:92E2344,FALSE,12/27/2020
NSCLC,7/23/2012,-1,ADJUVANT,Tamoxifen,G1B:584419G11,FALSE,6/8/2012
NSCLC,11/11/2024,-1,ADJUVANT,Relugolix,G214C6EC1517:,FALSE,1/18/2025
NSCLC,9/27/2022,-1,ADJUVANT,Azacitidine,G13F761779185,FALSE,3/25/2023
NSCLC,4/7/2019,-1,ADJUVANT,"Carboplatin,Gemcitabine",G1G913:D125BD,FALSE,4/20/2019
NSCLC,11/28/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G25F9:26DFGE7,FALSE,3/12/2025
NSCLC,8/15/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1DCEG91EG51E,FALSE,9/21/2024
NSCLC,7/28/2023,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G36G688G4EBD6,FALSE,9/4/2023
NSCLC,7/23/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3698C8B:5EE7,FALSE,9/22/2021
NSCLC,2/5/2018,2,ADVANCED,"Bevacizumab,Pembrolizumab,Pemetrexed",G23G13:GCG631,FALSE,1/21/2018
NSCLC,7/17/2018,1,ADVANCED,Osimertinib,G1169816459CC,FALSE,3/30/2025
NSCLC,10/7/2016,2,ADVANCED,Pembrolizumab,G35DE4B3:BCB8,FALSE,5/12/2019
NSCLC,7/24/2016,1,ADVANCED,Nivolumab,G1CD225858D1:,FALSE,1/7/2017
NSCLC,12/4/2018,1,ADVANCED,Bevacizumab,G11:1G4CE9G7B,TRUE,5/16/2019
NSCLC,6/27/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G439D41E1E1FB,FALSE,10/15/2021
NSCLC,10/4/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G1G194ECBE647,FALSE,1/17/2020
NSCLC,9/1/2022,1,ADVANCED,Pembrolizumab,G19237511G1:D,FALSE,10/25/2022
NSCLC,10/26/2022,2,ADVANCED,"Pemetrexed,Sotorasib",G2C38B34G8794,FALSE,3/12/2023
NSCLC,1/21/2020,2,ADVANCED,"Docetaxel,Gemcitabine",G1FFE6DDFB4DE,FALSE,4/7/2023
NSCLC,3/22/2024,-1,ADJUVANT,Pembrolizumab,G199G4682G18:,FALSE,4/24/2025
NSCLC,7/29/2020,1,ADVANCED,"Atezolizumab,Carboplatin,Paclitaxel Protein-Bound",G23:F54B4:E7F,FALSE,10/12/2020
NSCLC,6/17/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G358C8DCE9BD5,FALSE,8/30/2019
NSCLC,10/30/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G2G251E378FE8,TRUE,4/19/2020
NSCLC,12/2/2024,1,ADVANCED,Pembrolizumab,G3867F7D51E3D,TRUE,2/22/2025
NSCLC,10/12/2022,2,ADVANCED,"Carboplatin,Gemcitabine",G557E997E81G5,FALSE,4/22/2023
NSCLC,9/6/2023,-1,NEOADJUVANT,"Carboplatin,Nivolumab,Pemetrexed",G213:1B:7D2CF,FALSE,11/20/2023
NSCLC,8/31/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G257D9:2573CF,FALSE,11/26/2024
NSCLC,5/27/2020,3,ADVANCED,"Docetaxel,Gemcitabine",G3D:24E398DDF,FALSE,7/5/2021
NSCLC,3/24/2022,1,ADVANCED,"Cisplatin,Pembrolizumab,Pemetrexed",G1:DCBB2BG56F,FALSE,4/25/2022
NSCLC,7/27/2016,2,ADVANCED,Nivolumab,G2471D2GFG2E4,FALSE,8/19/2017
NSCLC,8/12/2013,0,,Line Zero,G3C99CBDB5D54,FALSE,12/16/2014
NSCLC,4/19/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G156F22D:3335,FALSE,4/1/2024
NSCLC,1/31/2020,-1,ADJUVANT,Hydroxyurea,G1:F129FBCE3F,FALSE,5/24/2020
NSCLC,1/11/2013,-1,NEOADJUVANT,"Carboplatin,Etoposide,Ifosfamide,Mesna,Rituximab",G48842BBE3634,FALSE,1/24/2013
NSCLC,8/20/2013,-1,NEOADJUVANT,Off Systemic Therapy,G19DB44:G31G8,FALSE,3/21/2020
NSCLC,2/13/2016,2,ADVANCED,Nivolumab,G1GDCB:FF9G:1,FALSE,4/9/2016
NSCLC,1/1/2013,-1,ADJUVANT,"Cyclophosphamide,Doxorubicin,Rituximab,Vincristine",G5995:57EB51E,FALSE,4/14/2013
NSCLC,3/13/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G222C:17:12DD,FALSE,5/18/2019
NSCLC,3/29/2018,1,ADVANCED,"Carboplatin,Docetaxel",G36BE14CG117:,FALSE,4/5/2018
NSCLC,2/25/2013,-1,CONCURRENT,"Carboplatin,Paclitaxel",G31:9DD57G8:5,FALSE,4/25/2013
NSCLC,9/19/2017,1,ADVANCED,"Cisplatin,Etoposide",G18G1G58:1447,FALSE,2/21/2019
NSCLC,5/15/2021,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,5/7/2022
NSCLC,6/23/2018,1,ADVANCED,"Carboplatin,Pemetrexed",G2G47CG7D:EEG,FALSE,6/13/2018
NSCLC,3/10/2021,-1,ADJUVANT,"Carboplatin,Gemcitabine",G4EF93:EF39:7,FALSE,4/20/2021
NSCLC,3/13/2022,1,ADVANCED,Pembrolizumab,G38F772G48B9C,TRUE,4/17/2025
NSCLC,8/30/2024,-1,ADJUVANT,Durvalumab,G1441B4DG:6FF,FALSE,4/12/2025
NSCLC,6/25/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G121:2D8:4E94,FALSE,9/9/2019
NSCLC,2/24/2015,-1,ADJUVANT,Letrozole,G17FC44B51E:3,FALSE,3/10/2015
NSCLC,12/2/2020,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,3/12/2021
NSCLC,7/23/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1G4D4C5D65E7,FALSE,12/7/2024
NSCLC,4/17/2018,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G34927D694398,FALSE,3/30/2018
NSCLC,7/28/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G14EB8:1:D44G,FALSE,9/23/2019
NSCLC,3/21/2018,1,ADVANCED,Nivolumab,G58FCD4G:G6DF,FALSE,9/1/2018
NSCLC,6/22/2021,1,ADVANCED,"Carboplatin,Pemetrexed",G57B5F4B556EG,FALSE,8/3/2021
NSCLC,12/18/2020,1,LOCOREGIONAL,"Carboplatin,Osimertinib,Pemetrexed",G32GG4C6C:87G,FALSE,3/30/2021
NSCLC,7/14/2019,1,LOCOREGIONAL,"Carboplatin,Pembrolizumab,Pemetrexed",G1D3:96CE9334,FALSE,9/20/2019
NSCLC,3/1/2022,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G4CCEFF5GB86F,FALSE,9/16/2022
NSCLC,9/28/2014,1,ADVANCED,Erlotinib,G263B3:534B15,FALSE,11/15/2016
NSCLC,6/5/2022,-1,ADJUVANT,Off Systemic Therapy,G41DE1E3BE99:,FALSE,12/24/2022
NSCLC,7/1/2016,2,ADVANCED,"Carboplatin,Gemcitabine,Necitumumab",G455E1367:DG4,FALSE,12/31/2016
NSCLC,6/7/2023,1,LOCOREGIONAL,Pembrolizumab,G16DE246787:5,TRUE,5/12/2025
NSCLC,10/8/2022,1,ADVANCED,"Pembrolizumab,Pemetrexed",G4E4734258BE1,TRUE,4/11/2025
NSCLC,11/6/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G35EFEEBCDBDC,FALSE,3/18/2016
NSCLC,8/2/2017,-1,ADJUVANT,Letrozole,G29D9FB:D1D6B,FALSE,8/20/2017
NSCLC,9/5/2016,-1,ADJUVANT,Off Systemic Therapy,G29D9FB:D1D6B,FALSE,7/26/2017
NSCLC,6/10/2018,1,ADVANCED,Pembrolizumab,G39F5FGEFFD67,FALSE,9/19/2018
NSCLC,3/7/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G3GB2G2DBGBG3,FALSE,7/15/2014
NSCLC,1/2/2024,-1,ADJUVANT,Anastrozole,G3316B72:E:48,FALSE,12/5/2023
NSCLC,5/18/2015,-1,ADJUVANT,Ibrutinib,G24:9:84DG17:,FALSE,12/4/2015
NSCLC,7/11/2023,-1,ADJUVANT,Off Systemic Therapy,G17169D3:3667,FALSE,3/27/2025
NSCLC,5/11/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G14::E36GD8C6,FALSE,5/8/2019
NSCLC,1/14/2013,1,ADVANCED,"Carboplatin,Pemetrexed",G125C8D8E:C:C,FALSE,4/7/2013
NSCLC,7/9/2014,2,ADVANCED,Gemcitabine,G1117E45EE891,FALSE,7/12/2014
NSCLC,10/26/2017,-1,ADJUVANT,Off Systemic Therapy,G1FE1DBD491BE,FALSE,1/22/2025
NSCLC,8/26/2017,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G1BG:7FD7572:,FALSE,10/11/2017
NSCLC,11/30/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G137D67:GFD9F,FALSE,4/17/2016
NSCLC,11/9/2021,-1,NEOADJUVANT,Off Systemic Therapy,G22FG21G231E9,FALSE,2/9/2022
NSCLC,9/11/2011,1,ADVANCED,"Cetuximab,Cisplatin,Vinorelbine",G153F976GBG:E,FALSE,1/26/2012
NSCLC,10/3/2019,2,ADVANCED,Gemcitabine,G1BB2C23:5573,FALSE,2/28/2020
NSCLC,5/10/2016,2,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G226G4F43C6FE,FALSE,10/3/2016
NSCLC,1/4/2017,-1,CONCURRENT,"Carboplatin,Paclitaxel",G11:82999D55C,FALSE,3/4/2017
NSCLC,4/27/2021,1,ADVANCED,Alectinib,G1F9CDC2FCB:5,FALSE,3/10/2022
NSCLC,2/11/2025,-1,ADJUVANT,Durvalumab,G2B4648:BGD83,FALSE,4/4/2025
NSCLC,6/9/2023,1,ADVANCED,Pembrolizumab,G164G31958638,TRUE,8/6/2024
NSCLC,3/5/2014,3,ADVANCED,Afatinib,G133G3GCBGE3D,FALSE,5/20/2014
NSCLC,8/15/2016,2,ADVANCED,Nivolumab,G4F354B:F341F,FALSE,7/7/2017
NSCLC,9/17/2021,1,ADVANCED,Capmatinib,G15:19EG3849:,FALSE,10/17/2021
NSCLC,5/9/2016,3,ADVANCED,Nivolumab,G167G71733G69,FALSE,11/9/2016
NSCLC,6/22/2021,2,ADVANCED,"Alectinib,Lorlatinib",G2CG3EF9E5:2B,FALSE,7/12/2021
NSCLC,7/8/2014,5,ADVANCED,"Everolimus,Exemestane",G19937F58E541,FALSE,9/23/2014
NSCLC,1/31/2023,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G14955945B53:,FALSE,3/16/2023
NSCLC,6/13/2024,4,ADVANCED,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G2FF5BBF:G7GF,FALSE,4/11/2025
NSCLC,2/5/2019,4,ADVANCED,Gemcitabine,G3B26D:2G114C,FALSE,4/3/2019
NSCLC,7/23/2024,-1,ADJUVANT,"Cisplatin,Gemcitabine",G535G:C261F1E,FALSE,9/18/2024
NSCLC,2/1/2017,-1,ADJUVANT,Clinical Study Drug,G1F482136BDE5,FALSE,5/30/2017
NSCLC,2/20/2021,1,ADVANCED,Pembrolizumab,G2D75DGG3E33:,FALSE,9/11/2021
NSCLC,4/2/2021,2,ADVANCED,Pembrolizumab,G3D:2:59GC48E,FALSE,1/20/2022
NSCLC,8/20/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G34BG69F45EE4,FALSE,9/20/2018
NSCLC,1/23/2020,-1,CONCURRENT,"Carboplatin,Paclitaxel",G25273E3EC7E1,FALSE,3/16/2020
NSCLC,5/21/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G5266FE:EBE18,FALSE,5/27/2015
NSCLC,5/23/2014,-1,ADJUVANT,Off Systemic Therapy,G1F:9CFGFGFC1,FALSE,1/3/2017
NSCLC,5/3/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G19511695D78G,FALSE,4/24/2025
NSCLC,9/26/2018,1,ADVANCED,Pembrolizumab,G23F23C5G7BFD,FALSE,11/29/2018
NSCLC,12/7/2014,-1,ADJUVANT,Off Systemic Therapy,G4891G553:D48,FALSE,6/8/2015
NSCLC,6/7/2019,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,1/14/2020
NSCLC,3/30/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G48:1B8F9G:B5,FALSE,4/23/2014
NSCLC,8/20/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G21744:G47B22,FALSE,9/26/2014
NSCLC,5/30/2020,1,ADVANCED,"Carboplatin,Paclitaxel",G392GC5134FFG,FALSE,6/21/2020
NSCLC,11/25/2019,1,ADVANCED,Pembrolizumab,G2CCC3642E:67,FALSE,3/19/2020
NSCLC,3/1/2019,1,ADVANCED,Durvalumab,G3DGG1C5C452:,FALSE,4/18/2019
NSCLC,5/22/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G13ED3F1277G4,FALSE,9/9/2017
NSCLC,11/3/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3B:47F525CE2,FALSE,1/10/2020
NSCLC,2/7/2014,-1,CONCURRENT,"Carboplatin,Docetaxel",G14FD45889171,FALSE,3/27/2014
NSCLC,3/27/2024,4,ADVANCED,"Carboplatin,Leuprolide,Pembrolizumab,Pemetrexed",G24F:E99C2926,FALSE,5/2/2024
NSCLC,6/17/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G39G:1GDD6BB5,FALSE,9/8/2016
NSCLC,10/4/2016,-1,ADJUVANT,Off Systemic Therapy,G4ED3922EEE48,FALSE,3/12/2019
NSCLC,4/15/2024,-1,ADJUVANT,Off Systemic Therapy,G1:F21E8E2D45,FALSE,2/1/2025
NSCLC,10/29/2018,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,2/20/2019
NSCLC,12/7/2022,-1,ADJUVANT,Durvalumab,G16D13269DE9G,FALSE,1/15/2024
NSCLC,2/12/2017,-1,ADJUVANT,Off Systemic Therapy,G3GB8B495B6:3,FALSE,10/31/2018
NSCLC,12/17/2018,-1,CONCURRENT,Off Systemic Therapy,G36:G2D34DE93,FALSE,3/5/2020
NSCLC,1/5/2021,1,ADVANCED,"Carboplatin,Ipilimumab,Nivolumab,Pemetrexed",G215817D1B289,FALSE,2/13/2021
NSCLC,4/13/2019,1,ADVANCED,Osimertinib,G31C:9::5EG5D,FALSE,11/11/2022
NSCLC,4/19/2023,2,ADVANCED,Sotorasib,G4253CG56F6FC,FALSE,5/21/2023
NSCLC,8/20/2023,1,ADVANCED,Pembrolizumab,G15F23G97C522,FALSE,7/31/2023
NSCLC,4/23/2013,-1,ADJUVANT,Off Systemic Therapy,G12F2F77BF3BF,FALSE,9/12/2016
NSCLC,3/31/2014,-1,ADJUVANT,Ado-Trastuzumab Emtansine,G16GE86G42194,FALSE,10/20/2014
NSCLC,7/24/2018,-1,ADJUVANT,Durvalumab,G14361:3FBBE:,FALSE,7/23/2019
NSCLC,4/18/2025,-1,ADJUVANT,"Carboplatin,Pemetrexed",G135B:GEC35G4,FALSE,5/4/2025
NSCLC,7/25/2024,1,ADVANCED,Durvalumab,G1FG3GD3:9D:3,FALSE,4/12/2025
NSCLC,9/16/2022,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1445DG1:E6:D,FALSE,1/3/2023
NSCLC,7/8/2014,-1,ADJUVANT,Exemestane,G358EF4457D52,FALSE,8/3/2014
NSCLC,3/3/2025,2,ADVANCED,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G4::3E61CFBB9,FALSE,5/23/2025
NSCLC,2/10/2020,-1,ADJUVANT,Pembrolizumab,G136E3F9:956D,FALSE,3/14/2020
NSCLC,6/1/2019,1,ADVANCED,Osimertinib,G175D3C95:34G,FALSE,6/23/2019
NSCLC,3/18/2014,-1,ADJUVANT,"Cisplatin,Pemetrexed",G23BB82DB453D,FALSE,6/13/2014
NSCLC,9/6/2024,-1,ADJUVANT,Off Systemic Therapy,G1F482136BDE5,FALSE,5/8/2025
NSCLC,7/18/2024,-1,CONCURRENT,"Carboplatin,Pemetrexed",G17235672EDGF,FALSE,8/27/2024
NSCLC,4/17/2017,2,ADVANCED,"Dasatinib,Nilotinib,Nivolumab",G14E7662::61C,FALSE,7/31/2022
NSCLC,8/12/2013,-1,ADJUVANT,Off Systemic Therapy,G474E:6F:6:B1,FALSE,4/28/2017
NSCLC,7/28/2011,1,ADVANCED,Anastrozole,G49E8CFG53::D,FALSE,2/2/2013
NSCLC,4/28/2023,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1FFE6DDFB4DE,FALSE,6/16/2023
NSCLC,1/25/2024,-1,ADJUVANT,Off Systemic Therapy,G4CF4FFFDGB63,FALSE,2/26/2025
NSCLC,10/18/2019,-1,ADJUVANT,Durvalumab,G27B37646G3C2,FALSE,9/25/2020
NSCLC,9/26/2023,-1,ADJUVANT,"Carboplatin,Pemetrexed",G11F2659368B9,FALSE,2/7/2024
NSCLC,5/31/2017,-1,NEOADJUVANT,Off Systemic Therapy,G19D32D1B89D8,FALSE,9/3/2017
NSCLC,1/25/2023,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1:9FCE6E6G6C,FALSE,4/9/2023
NSCLC,8/28/2016,1,ADVANCED,Nivolumab,G35DE4B3:BCB8,FALSE,11/23/2016
NSCLC,4/3/2012,-1,ADJUVANT,Off Systemic Therapy,G21B7762691EE,FALSE,10/2/2017
NSCLC,10/12/2013,2,ADVANCED,Vinorelbine,G393CEF118B21,FALSE,1/21/2014
NSCLC,8/20/2014,-1,ADJUVANT,Pemetrexed,G14FD45889171,FALSE,11/9/2014
NSCLC,4/30/2017,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1F9CDC2FCB:5,FALSE,8/7/2017
NSCLC,7/13/2020,1,ADVANCED,Pemetrexed,G1CC41:D:7C48,TRUE,8/17/2020
NSCLC,10/28/2015,3,ADVANCED,Nivolumab,G43D:C17:25FG,FALSE,12/14/2015
NSCLC,9/17/2021,2,ADVANCED,"Bevacizumab-Awwb,Carboplatin,Osimertinib,Pemetrexed",G1594:E29D2D9,FALSE,2/3/2022
NSCLC,8/16/2016,1,LOCOREGIONAL,"Bevacizumab,Carboplatin,Pemetrexed",G1:63D151:BB3,FALSE,10/18/2016
NSCLC,5/4/2013,5,ADVANCED,Paclitaxel Protein-Bound,G1468E9F5C9CG,FALSE,6/30/2013
NSCLC,3/16/2023,-1,ADJUVANT,"Cisplatin,Pemetrexed",G1G:2:8D7GC6F,FALSE,7/27/2023
NSCLC,2/5/2019,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G38E7C386CF5C,FALSE,5/13/2019
NSCLC,11/12/2021,1,ADVANCED,Pembrolizumab,G54F545489E59,FALSE,7/18/2022
NSCLC,2/27/2023,-1,ADJUVANT,Off Systemic Therapy,G32B1E29263BG,FALSE,3/25/2025
NSCLC,1/5/2014,2,ADVANCED,Paclitaxel Protein-Bound,G24C:63G27686,FALSE,3/28/2014
NSCLC,1/30/2025,2,ADVANCED,"Amivantamab-Vmjw,Carboplatin,Osimertinib,Pemetrexed",G54B7:9:4B62G,FALSE,4/23/2025
NSCLC,8/14/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G51F25:3GF134,FALSE,11/13/2015
NSCLC,12/30/2018,1,LOCOREGIONAL,Durvalumab,G548B2:G6G6D:,TRUE,1/26/2020
NSCLC,6/18/2022,1,ADVANCED,Pembrolizumab,G1DD638:C:184,FALSE,3/21/2025
NSCLC,12/4/2022,-1,ADJUVANT,Off Systemic Therapy,G2848BE3831EF,FALSE,10/6/2023
NSCLC,9/1/2022,3,ADVANCED,"Anastrozole,Durvalumab",G1885B3G8447B,FALSE,2/25/2025
NSCLC,5/1/2014,4,ADVANCED,Doxorubicin Pegylated Liposomal,G19937F58E541,FALSE,7/17/2014
NSCLC,7/14/2014,-1,ADJUVANT,"Cisplatin,Vinorelbine",G4891G553:D48,FALSE,11/28/2014
NSCLC,7/17/2021,1,ADVANCED,"Cisplatin,Pemetrexed",G1:64BD9C5919,FALSE,9/26/2021
NSCLC,10/12/2020,1,ADVANCED,Nivolumab,G3642135:5B4C,FALSE,5/18/2021
NSCLC,11/28/2024,1,ADVANCED,Pembrolizumab,G38579B136B1B,FALSE,4/14/2025
NSCLC,1/29/2021,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G16227785C51C,FALSE,10/28/2021
NSCLC,2/15/2025,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4DD6CBGD124F,FALSE,4/18/2025
NSCLC,8/3/2024,-1,ADJUVANT,Durvalumab,G2518G1D763FB,FALSE,8/25/2024
NSCLC,9/8/2017,-1,ADJUVANT,Off Systemic Therapy,G19D32D1B89D8,FALSE,1/21/2019
NSCLC,9/28/2016,-1,ADJUVANT,Off Systemic Therapy,G119F2D14F4C3,FALSE,7/3/2021
NSCLC,8/10/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G5:CE:F92EE8D,FALSE,6/15/2015
NSCLC,10/12/2015,3,ADVANCED,Nivolumab,G14FD45889171,FALSE,11/20/2015
NSCLC,4/25/2022,1,ADVANCED,"Carboplatin,Paclitaxel",G128:92:3BD3D,FALSE,7/30/2022
NSCLC,12/20/2015,2,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G45DDGFC1G86F,FALSE,4/6/2016
NSCLC,4/12/2024,1,LOCOREGIONAL,Gemcitabine,G51CG28FB981G,FALSE,11/26/2024
NSCLC,3/14/2019,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,8/25/2019
NSCLC,4/30/2019,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G1BB2C23:5573,FALSE,10/5/2019
NSCLC,4/21/2019,2,ADVANCED,"Carboplatin,Pemetrexed",G3B:GGE2C4G47,FALSE,4/24/2025
NSCLC,3/13/2021,3,ADVANCED,Pembrolizumab,G4936::B67G17,FALSE,3/4/2022
NSCLC,12/8/2024,1,ADVANCED,"Carboplatin,Osimertinib,Pemetrexed",G114:2E679C42,FALSE,4/21/2025
NSCLC,3/8/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G4229EB584D67,FALSE,4/2/2015
NSCLC,3/7/2023,-1,NEOADJUVANT,Off Systemic Therapy,G2DC29B:962F1,FALSE,7/11/2023
NSCLC,7/15/2024,-1,NEOADJUVANT,"Cisplatin,Gemcitabine,Pembrolizumab",G2E42F615FFFC,FALSE,10/29/2024
NSCLC,11/15/2015,4,ADVANCED,Afatinib,G3::1:B4F:3D4,FALSE,3/3/2016
NSCLC,4/5/2024,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G14E999899EFC,FALSE,1/14/2025
NSCLC,2/17/2019,-1,ADJUVANT,"Cisplatin,Docetaxel",G3D59288727DB,FALSE,4/28/2019
NSCLC,6/30/2020,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,4/14/2021
NSCLC,11/1/2023,-1,ADJUVANT,Off Systemic Therapy,G119DBG986C45,FALSE,3/1/2025
NSCLC,1/6/2013,1,ADVANCED,Paclitaxel Protein-Bound,G2B3::97221CC,FALSE,5/8/2013
NSCLC,8/29/2024,-1,ADJUVANT,Bicalutamide,G1E3BGE6C42B6,FALSE,10/14/2024
NSCLC,12/26/2024,2,ADVANCED,"Ipilimumab,Nivolumab",G3951BC5GBE44,FALSE,5/1/2025
NSCLC,2/24/2013,2,ADVANCED,Erlotinib,G3CE666498C:9,FALSE,5/22/2013
NSCLC,5/15/2017,2,ADVANCED,Osimertinib,G4C7:4GCD96C:,FALSE,5/16/2017
NSCLC,4/22/2014,2,ADVANCED,"Carboplatin,Pemetrexed",G48:1B8F9G:B5,FALSE,10/16/2014
NSCLC,1/3/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G18EBC2339CGG,FALSE,1/28/2015
NSCLC,9/24/2023,5,ADVANCED,"Carboplatin,Etoposide",G557E997E81G5,FALSE,11/27/2023
NSCLC,12/20/2021,3,ADVANCED,Pembrolizumab,G3D:2:59GC48E,FALSE,5/16/2022
NSCLC,4/25/2024,1,ADVANCED,"Cisplatin,Nivolumab,Pemetrexed",G3FG621769317,FALSE,6/17/2024
NSCLC,10/3/2020,1,ADVANCED,Osimertinib,G1594:E29D2D9,FALSE,9/4/2021
NSCLC,2/19/2015,1,ADVANCED,Clinical Study Drug,G1:D34FC71922,FALSE,5/24/2015
NSCLC,7/28/2021,1,ADVANCED,Osimertinib,G4:6E57617757,FALSE,3/24/2025
NSCLC,1/17/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G1GDG1C835C77,FALSE,6/8/2012
NSCLC,3/29/2017,2,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G332GBGFG7416,FALSE,11/13/2020
NSCLC,6/5/2023,1,ADVANCED,"Carboplatin,Paclitaxel",G13FC564CF8GF,FALSE,8/16/2023
NSCLC,7/6/2015,-1,ADJUVANT,Exemestane,G358EF4457D52,FALSE,5/10/2015
NSCLC,6/16/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G21881333DGG2,FALSE,9/17/2020
NSCLC,7/13/2023,1,ADVANCED,Pembrolizumab,G3G51E516C136,FALSE,1/21/2024
NSCLC,9/28/2019,-1,ADJUVANT,Durvalumab,G346FFEC8FE4C,FALSE,8/21/2020
NSCLC,7/9/2012,1,ADVANCED,"Cisplatin,Pemetrexed",G14GFF41D::2B,FALSE,9/18/2012
NSCLC,2/4/2015,-1,ADJUVANT,Off Systemic Therapy,G17FC44B51E:3,FALSE,3/13/2016
NSCLC,7/15/2018,2,ADVANCED,Osimertinib,G2D2EC6C91F3C,FALSE,9/20/2018
NSCLC,11/3/2023,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G177G4:B9E394,FALSE,1/21/2024
NSCLC,11/22/2024,-1,ADJUVANT,Off Systemic Therapy,G55D67392F8:9,FALSE,5/6/2025
NSCLC,11/3/2017,2,ADVANCED,Nivolumab,G2FF2946:4C6F,FALSE,4/19/2018
NSCLC,3/11/2017,-1,ADJUVANT,Off Systemic Therapy,G264B2D11BG13,FALSE,10/26/2017
NSCLC,8/27/2018,0,,Line Zero,G4936::B67G17,FALSE,3/9/2019
NSCLC,5/17/2022,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,5/20/2022
NSCLC,7/4/2017,-1,ADJUVANT,Hydroxyurea,G3487E:C:CDC6,FALSE,7/12/2017
NSCLC,5/15/2019,1,ADVANCED,Durvalumab,G4D2G1D2:G:5D,TRUE,10/5/2019
NSCLC,1/11/2012,-1,ADJUVANT,"Carboplatin,Docetaxel",G3BCC2GG732G:,FALSE,3/18/2012
NSCLC,4/3/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G11:E1E83E6:D,FALSE,5/1/2019
NSCLC,3/9/2016,1,ADVANCED,Erlotinib,G1B:EDB855:88,FALSE,4/15/2016
NSCLC,6/17/2017,-1,ADJUVANT,Off Systemic Therapy,G1B8G131F6FC6,FALSE,3/12/2018
NSCLC,3/14/2022,2,ADVANCED,Docetaxel,G19E:EBC916F5,FALSE,3/23/2022
NSCLC,11/30/2013,1,ADVANCED,"Cisplatin,Etoposide",G22:2G6GDG986,FALSE,1/1/2017
NSCLC,8/7/2022,2,ADVANCED,Durvalumab,G1885B3G8447B,FALSE,9/21/2022
NSCLC,1/4/2025,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G3FE8FEDF1F11,FALSE,3/27/2025
NSCLC,10/20/2021,1,ADVANCED,Osimertinib,G241FF877G59G,FALSE,1/3/2022
NSCLC,9/22/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G24GEG2:6C23D,FALSE,1/28/2022
NSCLC,2/12/2024,-1,ADJUVANT,Off Systemic Therapy,G53EDE5926292,FALSE,4/27/2025
NSCLC,9/21/2020,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G4::3E61CFBB9,FALSE,10/15/2020
NSCLC,11/4/2016,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1C49C5CC7:F7,FALSE,1/26/2017
NSCLC,2/20/2023,4,ADVANCED,Lorlatinib,G3BBG95F1669C,FALSE,4/15/2023
NSCLC,1/20/2023,-1,NEOADJUVANT,Leuprolide,G53D3D6874EB3,FALSE,3/23/2023
NSCLC,7/18/2024,1,ADVANCED,"Gemcitabine,Paclitaxel Protein-Bound",G2G47BC6:2484,FALSE,8/6/2024
NSCLC,8/29/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G269235FC:5C7,FALSE,12/15/2014
NSCLC,6/5/2024,-1,NEOADJUVANT,Off Systemic Therapy,G1DCDG73E53FF,FALSE,10/30/2024
NSCLC,9/6/2019,2,ADVANCED,"Carboplatin,Paclitaxel",G1CC5BCCG41B4,FALSE,10/30/2019
NSCLC,2/6/2014,1,ADVANCED,Erlotinib,G12E3G252G92G,FALSE,3/21/2015
NSCLC,3/24/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G224E93E7E9C6,FALSE,4/9/2025
NSCLC,12/29/2011,1,ADVANCED,"Carboplatin,Paclitaxel",G1C9B158617B6,FALSE,4/8/2014
NSCLC,3/15/2022,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,8/21/2024
NSCLC,5/21/2021,-1,ADJUVANT,Off Systemic Therapy,G319D776C24D5,FALSE,1/7/2025
NSCLC,12/19/2018,-1,CONCURRENT,"Carboplatin,Paclitaxel",G36:G2D34DE93,FALSE,12/7/2018
NSCLC,12/14/2019,1,ADVANCED,Durvalumab,G1B3558DGF36B,TRUE,6/25/2021
NSCLC,9/2/2023,-1,ADJUVANT,Off Systemic Therapy,G432E:9E:21DC,FALSE,4/16/2025
NSCLC,5/8/2023,3,ADVANCED,"Pembrolizumab,Sotorasib",G4253CG56F6FC,FALSE,5/6/2025
NSCLC,10/27/2013,-1,ADJUVANT,Anastrozole,G58E8F29:9:45,FALSE,10/30/2013
NSCLC,9/29/2019,1,ADVANCED,"Carboplatin,Paclitaxel",G2FF5BBF:G7GF,FALSE,5/26/2020
NSCLC,8/23/2017,-1,ADJUVANT,Off Systemic Therapy,G29D9FB:D1D6B,FALSE,8/30/2018
NSCLC,2/19/2024,2,ADVANCED,"Amivantamab-Vmjw,Carboplatin,Pemetrexed",G177G4:B9E394,FALSE,1/31/2025
NSCLC,12/8/2023,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G24F:E99C2926,FALSE,2/13/2024
NSCLC,10/30/2019,2,ADVANCED,Pemetrexed,G257459B7FF:E,FALSE,11/25/2019
NSCLC,2/3/2021,1,ADVANCED,Pembrolizumab,G16C41789C1C5,FALSE,6/11/2021
NSCLC,8/18/2017,1,ADVANCED,Pemetrexed,G26G426GG3C8F,TRUE,1/25/2020
NSCLC,1/10/2025,3,ADVANCED,Sotorasib,G1ED5EF238G3C,FALSE,4/28/2025
NSCLC,10/16/2020,2,ADVANCED,"Pembrolizumab,Pemetrexed",G1CC41:D:7C48,FALSE,2/3/2021
NSCLC,12/7/2018,-1,ADJUVANT,Off Systemic Therapy,G37C2D6679F35,FALSE,1/19/2019
NSCLC,3/10/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,TRUE,7/1/2021
NSCLC,1/26/2016,2,ADVANCED,Exemestane,G272F2D3BB8C2,FALSE,3/29/2016
NSCLC,11/23/2024,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G4989E69:D856,FALSE,11/11/2024
NSCLC,1/7/2020,1,ADVANCED,"Atezolizumab,Carboplatin,Paclitaxel",G4796E694GBED,FALSE,2/4/2020
NSCLC,3/23/2025,-1,ADJUVANT,"Bevacizumab-Bvzr,Capecitabine",G5724:G6:4ED5,FALSE,4/4/2025
NSCLC,1/15/2025,2,ADVANCED,"Carboplatin,Docetaxel",G4C88CEG2:289,FALSE,2/2/2025
NSCLC,12/6/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G4989E69:D856,FALSE,4/24/2025
NSCLC,11/24/2018,-1,ADJUVANT,Durvalumab,G3642135:5B4C,FALSE,2/14/2019
NSCLC,4/17/2020,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G3G2:1CGCB76E,FALSE,7/21/2020
NSCLC,4/3/2025,3,ADVANCED,Pemetrexed,G47DB481E783:,FALSE,4/4/2025
NSCLC,2/12/2024,-1,ADJUVANT,Pembrolizumab,G3:G1:CC15DG9,FALSE,3/6/2024
NSCLC,7/19/2014,2,ADVANCED,Leuprolide,G4G1G16FE1GF8,FALSE,10/16/2014
NSCLC,2/27/2022,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G33G487624E32,FALSE,5/13/2022
NSCLC,5/11/2023,-1,ADJUVANT,Off Systemic Therapy,G53C52948773G,FALSE,11/11/2023
NSCLC,6/24/2022,2,ADVANCED,Docetaxel,G54F545489E59,FALSE,3/14/2023
NSCLC,10/10/2024,1,ADVANCED,"Cisplatin,Durvalumab,Etoposide",G332:25G93F26,FALSE,3/30/2025
NSCLC,3/22/2023,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G22GF5E64E49D,FALSE,7/26/2023
NSCLC,1/24/2016,1,ADVANCED,Clinical Study Drug,G14E7662::61C,FALSE,5/14/2017
NSCLC,5/11/2019,-1,ADJUVANT,Off Systemic Therapy,G2G4EF:188C:1,FALSE,12/17/2020
NSCLC,10/29/2021,2,ADVANCED,"Bevacizumab-Awwb,Fluorouracil,Irinotecan,Leucovorin",G1G75:D51G1E5,FALSE,2/23/2022
NSCLC,2/16/2024,1,ADVANCED,Pembrolizumab,G3CG5712E:B54,TRUE,6/12/2024
NSCLC,10/11/2016,1,LOCOREGIONAL,Imatinib,G251214GDF65B,FALSE,1/9/2017
NSCLC,6/19/2019,-1,ADJUVANT,Off Systemic Therapy,G4992B5EB431G,FALSE,11/25/2019
NSCLC,6/8/2016,2,ADVANCED,Nivolumab,G137D67:GFD9F,FALSE,7/31/2016
NSCLC,8/18/2024,-1,ADJUVANT,Durvalumab,G17235672EDGF,FALSE,3/18/2025
NSCLC,7/20/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G2FF2946:4C6F,FALSE,11/26/2017
NSCLC,8/19/2014,2,ADVANCED,Bevacizumab,G254712FF2998,FALSE,8/30/2015
NSCLC,1/15/2025,1,ADVANCED,"Pembrolizumab,Pemetrexed",G5344:8G5698G,TRUE,5/12/2025
NSCLC,9/11/2024,1,ADVANCED,Pembrolizumab,G1G:94B69FD31,FALSE,4/13/2025
NSCLC,5/1/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G3B1F6B561ED5,TRUE,1/10/2020
NSCLC,10/31/2014,2,ADVANCED,Gemcitabine,G445B:B:15B5F,FALSE,12/9/2014
NSCLC,1/25/2024,-1,ADJUVANT,Off Systemic Therapy,G31G19E54FC:B,FALSE,3/5/2025
NSCLC,9/3/2021,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1E16D::267DF,FALSE,10/14/2021
NSCLC,9/12/2015,-1,ADJUVANT,Nivolumab,G57:2GEC9DD36,FALSE,1/2/2016
NSCLC,4/6/2016,-1,CONCURRENT,"Carboplatin,Paclitaxel",G166G5:E8CEDF,FALSE,10/4/2016
NSCLC,1/25/2025,5,ADVANCED,"Leuprolide,Pembrolizumab",G17G71B51EFE2,FALSE,3/28/2025
NSCLC,10/16/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G29D9FB:D1D6B,FALSE,2/11/2021
NSCLC,7/16/2020,1,ADVANCED,Durvalumab,G392GC5134FFG,TRUE,9/15/2020
NSCLC,3/15/2015,1,ADVANCED,Crizotinib,G234FGBCGD51F,FALSE,10/9/2015
NSCLC,10/5/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1GEF44EBD419,FALSE,2/27/2024
NSCLC,3/27/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G27D282B7225B,FALSE,6/22/2021
NSCLC,4/19/2023,-1,ADJUVANT,Atezolizumab,G1D14:53C99:F,FALSE,5/6/2024
NSCLC,6/15/2024,-1,CONCURRENT,"Carboplatin,Pemetrexed",G46:6C69:D9:C,FALSE,7/22/2024
NSCLC,4/15/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1195EGCD:B45,FALSE,5/5/2024
NSCLC,10/5/2021,-1,ADJUVANT,Off Systemic Therapy,G434GE998725C,FALSE,6/7/2023
NSCLC,12/12/2023,-1,ADJUVANT,"Carboplatin,Pemetrexed",G242GD729:FB:,FALSE,2/4/2024
NSCLC,4/19/2015,2,ADVANCED,"Docetaxel,Pemetrexed,Ramucirumab",G12D5DB79FEED,FALSE,4/6/2015
NSCLC,12/29/2017,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G3D1FC341FBF7,FALSE,3/25/2018
NSCLC,1/12/2018,1,ADVANCED,"Carboplatin,Pemetrexed",G2G1CF3FED3DG,FALSE,2/15/2018
NSCLC,4/20/2022,1,ADVANCED,"Bevacizumab-Awwb,Carboplatin,Pemetrexed",G129:BF885666,FALSE,7/17/2022
NSCLC,10/24/2012,-1,ADJUVANT,Off Systemic Therapy,G1B:584419G11,FALSE,4/22/2025
NSCLC,12/10/2017,1,ADVANCED,"Cisplatin,Pemetrexed",G14F3GC2D5E43,FALSE,10/21/2018
NSCLC,12/29/2023,-1,ADJUVANT,Osimertinib,G11F2659368B9,FALSE,3/17/2025
NSCLC,7/27/2024,5,ADVANCED,"Dabrafenib,Osimertinib,Trametinib",G31C:9::5EG5D,FALSE,2/14/2025
NSCLC,11/11/2024,3,ADVANCED,"Carboplatin,Paclitaxel",G2262335C:D62,FALSE,2/3/2025
NSCLC,6/20/2020,1,ADVANCED,Pembrolizumab,G3G2:1CGCB76E,TRUE,3/27/2021
NSCLC,8/29/2024,-1,ADJUVANT,Off Systemic Therapy,G52:6C556E791,FALSE,5/7/2025
NSCLC,5/22/2020,1,ADVANCED,"Carboplatin,Pemetrexed",G27C8FF:88CEC,FALSE,4/17/2020
NSCLC,8/10/2015,2,ADVANCED,Docetaxel,G2D5B71G65F2G,FALSE,3/20/2016
NSCLC,5/18/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G2G1D1B:745EG,TRUE,11/9/2020
NSCLC,3/2/2016,1,ADVANCED,"Bevacizumab,Pemetrexed",G35EFEEBCDBDC,TRUE,12/27/2016
NSCLC,4/22/2015,2,ADVANCED,"Carboplatin,Pemetrexed",G3GE686D11C25,FALSE,1/17/2016
NSCLC,10/9/2019,-1,ADJUVANT,"Carboplatin,Paclitaxel",G37973D8B1C9F,FALSE,12/18/2019
NSCLC,8/13/2024,1,ADVANCED,Osimertinib,G1E71G:B6G198,FALSE,3/26/2025
NSCLC,5/23/2017,3,ADVANCED,Vinorelbine,G1D:B49GGG719,FALSE,8/25/2018
NSCLC,6/15/2017,1,ADVANCED,Clinical Study Drug,G3GB6D5C:448G,FALSE,4/15/2018
NSCLC,11/12/2015,3,ADVANCED,"Gemcitabine,Temozolomide",G4DE3DE99E:13,FALSE,1/24/2016
NSCLC,10/31/2016,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1658GGG424E:,FALSE,1/14/2017
NSCLC,10/21/2024,2,ADVANCED,Docetaxel,G4G53233CD43C,FALSE,2/1/2025
NSCLC,1/18/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G2GBG8DEC7576,TRUE,2/7/2025
NSCLC,1/22/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G125G4C71EEB6,FALSE,2/3/2018
NSCLC,7/25/2019,1,ADVANCED,Osimertinib,G324DD277533C,FALSE,2/21/2020
NSCLC,10/3/2020,6,ADVANCED,Docetaxel,G3EC5EB18C676,FALSE,3/17/2021
NSCLC,4/12/2017,-1,ADJUVANT,Off Systemic Therapy,G1F482136BDE5,FALSE,2/28/2024
NSCLC,5/6/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G25F6:5:2:C36,TRUE,8/10/2019
NSCLC,11/8/2012,-1,ADJUVANT,"Cisplatin,Pemetrexed",G5545136B977G,FALSE,1/19/2013
NSCLC,6/26/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G12786B9C7G6D,FALSE,8/4/2018
NSCLC,4/1/2015,2,ADVANCED,Gemcitabine,G43D:C17:25FG,FALSE,9/9/2015
NSCLC,3/21/2023,-1,ADJUVANT,Off Systemic Therapy,G3124B666:88D,FALSE,9/16/2023
NSCLC,7/20/2022,-1,ADJUVANT,Durvalumab,G33G487624E32,FALSE,6/27/2023
NSCLC,7/30/2023,-1,ADJUVANT,Off Systemic Therapy,G437:CB1EF9DB,FALSE,9/24/2023
NSCLC,8/27/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G244773::F9D1,FALSE,1/3/2018
NSCLC,7/11/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1D894G21GC1E,FALSE,9/23/2024
NSCLC,9/9/2014,2,ADVANCED,Afatinib,G26534:GEG3:6,FALSE,12/12/2015
NSCLC,1/19/2023,1,ADVANCED,Zanubrutinib,G2D7F77586F3B,FALSE,10/4/2023
NSCLC,10/6/2018,-1,ADJUVANT,Off Systemic Therapy,G29D9FB:D1D6B,FALSE,8/1/2019
NSCLC,3/29/2023,4,ADVANCED,"Carboplatin,Gemcitabine",G1GC97BGC25B3,FALSE,10/12/2023
NSCLC,2/5/2019,-1,NEOADJUVANT,Leuprolide,G1D41F368EE:G,FALSE,3/8/2019
NSCLC,11/15/2019,3,ADVANCED,"Carboplatin,Gemcitabine",G24632:D18158,FALSE,2/10/2020
NSCLC,11/17/2012,1,ADVANCED,"Carboplatin,Gemcitabine",G19937F58E541,FALSE,10/27/2013
NSCLC,3/11/2021,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1CB3B346155D,FALSE,5/30/2021
NSCLC,9/10/2016,1,ADVANCED,"Carboplatin,Pemetrexed",G5:9BFG41:736,FALSE,9/3/2016
NSCLC,11/1/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,FALSE,2/16/2025
NSCLC,9/19/2023,-1,ADJUVANT,Atezolizumab,G2G22BF9DCG81,FALSE,5/19/2025
NSCLC,11/16/2023,-1,NEOADJUVANT,"Carboplatin,Nivolumab,Pemetrexed",G46:6C69:D9:C,FALSE,12/25/2023
NSCLC,4/9/2023,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G44DDC8341D18,FALSE,6/12/2023
NSCLC,3/27/2020,-1,ADJUVANT,Off Systemic Therapy,G4EF93:EF39:7,FALSE,3/6/2021
NSCLC,6/12/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G254712FF2998,FALSE,7/24/2014
NSCLC,4/2/2020,-1,ADJUVANT,"Cisplatin,Pemetrexed",G31G19E54FC:B,FALSE,7/5/2020
NSCLC,1/15/2021,1,ADVANCED,Erlotinib,G2C521EB94C:2,FALSE,5/10/2023
NSCLC,3/19/2015,2,ADVANCED,Erlotinib,G15B:95:E93C7,FALSE,4/3/2015
NSCLC,11/18/2013,2,ADVANCED,"Bevacizumab,Carboplatin,Gemcitabine,Pemetrexed",G4:72GGEFB4B:,FALSE,10/19/2014
NSCLC,8/30/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1G7:9D7EC1EC,FALSE,11/25/2018
NSCLC,2/12/2020,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2G45EC515283,FALSE,7/18/2020
NSCLC,6/19/2024,-1,ADJUVANT,Off Systemic Therapy,G2G6E1E144F8E,FALSE,3/10/2025
NSCLC,9/21/2018,2,ADVANCED,Nivolumab,G3E567F5B3:95,FALSE,10/31/2018
NSCLC,2/2/2016,-1,ADJUVANT,Off Systemic Therapy,G3DB42DD29B5G,FALSE,5/15/2021
NSCLC,9/19/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2339E2EC4B:E,FALSE,12/19/2024
NSCLC,2/13/2015,2,ADVANCED,"Carboplatin,Pemetrexed",G261CF698E543,FALSE,9/8/2015
NSCLC,10/3/2024,-1,CONCURRENT,"Anastrozole,Carboplatin,Paclitaxel",G2B4648:BGD83,FALSE,2/12/2025
NSCLC,3/9/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3G3424ECF92G,FALSE,3/13/2025
NSCLC,11/26/2022,-1,ADJUVANT,Hydroxyurea,G41DE1E3BE99:,FALSE,1/6/2023
NSCLC,6/16/2013,-1,CONCURRENT,"Carboplatin,Paclitaxel",G474E:6F:6:B1,FALSE,10/3/2013
NSCLC,6/22/2021,1,LOCOREGIONAL,"Gemcitabine,Paclitaxel Protein-Bound",G22D92C11D81G,FALSE,8/24/2021
NSCLC,7/11/2016,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G5273D::F8155,FALSE,11/11/2016
NSCLC,3/3/2012,-1,CONCURRENT,"Amifostine,Vinorelbine",G58E8F29:9:45,FALSE,3/9/2012
NSCLC,5/8/2018,1,ADVANCED,"Carboplatin,Gemcitabine",G499EB:16:7F3,FALSE,8/30/2018
NSCLC,9/20/2022,3,ADVANCED,"Alectinib,Bevacizumab-Awwb,Carboplatin,Pemetrexed",G217694659D6F,FALSE,2/19/2023
NSCLC,10/30/2015,3,ADVANCED,Nivolumab,G3::1:B4F:3D4,FALSE,1/1/2016
NSCLC,4/9/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC41:D:7C48,FALSE,7/27/2020
NSCLC,3/12/2020,3,ADVANCED,"Docetaxel,Ramucirumab",G1BB2C23:5573,FALSE,11/15/2020
NSCLC,5/12/2014,3,ADVANCED,Docetaxel,G1C32G396:F7G,FALSE,7/29/2014
NSCLC,3/26/2017,-1,ADJUVANT,Off Systemic Therapy,G1:641727397B,FALSE,2/29/2024
NSCLC,10/9/2011,2,ADVANCED,Pemetrexed,G1468E9F5C9CG,FALSE,12/22/2011
NSCLC,12/27/2018,3,ADVANCED,"Docetaxel,Ramucirumab",G4GE2BD8C57D9,FALSE,1/29/2019
NSCLC,7/30/2022,-1,ADJUVANT,Anastrozole,G1:9FCE6E6G6C,FALSE,7/28/2022
NSCLC,8/11/2014,2,ADVANCED,"Carboplatin,Pemetrexed",G18C1EG39143B,FALSE,8/29/2014
NSCLC,1/28/2022,1,ADVANCED,Capmatinib,G12E5EG31:6:5,FALSE,10/18/2022
NSCLC,7/28/2024,-1,NEOADJUVANT,"Cisplatin,Nivolumab,Pemetrexed",G2::G3B8CFF4C,FALSE,6/9/2024
NSCLC,3/5/2012,0,,Line Zero,G55C5E563EFC3,FALSE,5/21/2012
NSCLC,10/1/2023,-1,ADJUVANT,Pembrolizumab,G437:CB1EF9DB,FALSE,10/3/2023
NSCLC,5/23/2024,1,ADVANCED,"Atezolizumab,Carboplatin,Etoposide",G48::2:98C2EE,FALSE,7/22/2024
NSCLC,7/27/2015,-1,ADJUVANT,Off Systemic Therapy,G42734BB63:32,FALSE,6/10/2016
NSCLC,5/31/2021,-1,ADJUVANT,Alectinib,G1GECG2D6BB54,FALSE,2/22/2025
NSCLC,7/26/2017,2,ADVANCED,Nivolumab,G13ED3F1277G4,FALSE,8/11/2017
NSCLC,6/17/2017,1,ADVANCED,Pembrolizumab,G355524112BFE,FALSE,6/5/2017
NSCLC,5/22/2017,-1,ADJUVANT,"Cisplatin,Pemetrexed",G225D72BD2FD7,FALSE,6/16/2017
NSCLC,9/12/2024,1,ADVANCED,"Ipilimumab,Nivolumab",G47DB481E783:,TRUE,1/25/2025
NSCLC,6/6/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G14D44F4B44F2,FALSE,11/1/2012
NSCLC,12/11/2020,1,ADVANCED,"Ipilimumab,Nivolumab",G1:EE91B54:7C,FALSE,6/3/2021
NSCLC,4/7/2024,1,ADVANCED,"Ipilimumab,Nivolumab",G3G18F3E9E3C8,TRUE,7/31/2024
NSCLC,8/9/2017,1,ADVANCED,Nivolumab,G39C1C9BC249D,FALSE,7/15/2017
NSCLC,12/24/2021,-1,ADJUVANT,Off Systemic Therapy,G128:92:3BD3D,FALSE,5/27/2022
NSCLC,4/22/2021,-1,NEOADJUVANT,Off Systemic Therapy,G48FCG1D:D6C5,FALSE,1/25/2022
NSCLC,4/12/2011,1,ADVANCED,Bevacizumab,G247F67418GGD,FALSE,4/28/2012
NSCLC,4/26/2012,-1,CONCURRENT,Off Systemic Therapy,G58E8F29:9:45,FALSE,8/18/2012
NSCLC,4/5/2022,-1,ADJUVANT,Off Systemic Therapy,G4::3E61CFBB9,FALSE,11/10/2024
NSCLC,8/27/2018,2,ADVANCED,Rituximab,G27471:8B6217,FALSE,12/30/2018
NSCLC,7/28/2023,-1,ADJUVANT,Atezolizumab,G419EE8F1F59D,FALSE,7/20/2024
NSCLC,2/27/2015,2,ADVANCED,"Afatinib,Bevacizumab",G4C53C5GC48E:,FALSE,1/2/2016
NSCLC,1/26/2021,3,ADVANCED,Pemetrexed,G1CC41:D:7C48,FALSE,4/4/2021
NSCLC,11/15/2012,-1,CONCURRENT,Vinorelbine,G13F669ED2119,FALSE,6/7/2013
NSCLC,2/8/2025,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G24E8BG3DE8FB,FALSE,4/19/2025
NSCLC,3/4/2014,1,ADVANCED,Vinorelbine,G1C32G396:F7G,FALSE,2/19/2014
NSCLC,5/18/2021,6,ADVANCED,Vinorelbine,G3:C9BECD3F55,FALSE,1/19/2022
NSCLC,7/6/2019,-1,ADJUVANT,Off Systemic Therapy,G1:9FCE6E6G6C,FALSE,8/7/2020
NSCLC,9/27/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G1DB5D1BG667E,FALSE,12/15/2015
NSCLC,3/9/2019,1,ADVANCED,"Pembrolizumab,Pemetrexed",G2777F3E771D8,TRUE,8/27/2019
NSCLC,12/1/2020,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4D62843::5E1,FALSE,2/20/2021
NSCLC,11/4/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel Protein-Bound",G1C256DCCEDGD,FALSE,1/10/2015
NSCLC,2/17/2025,3,ADVANCED,Gemcitabine,G4G53233CD43C,FALSE,4/6/2025
NSCLC,10/8/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G3:35C52691D:,TRUE,4/13/2025
NSCLC,10/27/2018,3,ADVANCED,Afatinib,G1968F::311C2,FALSE,2/11/2019
NSCLC,12/29/2015,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G2D:3E7:FB16:,FALSE,3/29/2016
NSCLC,6/10/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G3EC5EB18C676,FALSE,5/15/2017
NSCLC,7/4/2012,1,ADVANCED,"Carboplatin,Gemcitabine",G3ED9686E8628,FALSE,6/30/2013
NSCLC,7/19/2015,2,ADVANCED,Erlotinib,G1G:DDC4EED88,FALSE,7/22/2017
NSCLC,5/23/2020,2,ADVANCED,Osimertinib,G4826CB54C27:,FALSE,10/27/2021
NSCLC,6/29/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G21B4CD9B81B7,FALSE,6/9/2012
NSCLC,7/9/2019,2,ADVANCED,"Docetaxel,Ramucirumab",G161:GEG632G8,FALSE,12/7/2019
NSCLC,6/14/2014,1,ADVANCED,"Bevacizumab,Pemetrexed",G1978F5FFE:43,FALSE,7/25/2014
NSCLC,6/1/2019,2,ADVANCED,"Paclitaxel Protein-Bound,Pembrolizumab",G5829EBB749DF,FALSE,5/31/2019
NSCLC,5/2/2016,4,ADVANCED,"Capecitabine,Fulvestrant",G272F2D3BB8C2,FALSE,11/21/2017
NSCLC,2/17/2012,2,ADVANCED,"Carboplatin,Gemcitabine",G2177D1::DG1E,FALSE,5/30/2012
NSCLC,3/31/2019,1,ADVANCED,Durvalumab,G58E33F7EG254,TRUE,10/17/2019
NSCLC,10/9/2019,4,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G14F3GC2D5E43,FALSE,2/26/2020
NSCLC,5/5/2021,1,ADVANCED,Alectinib,G217694659D6F,FALSE,7/16/2022
NSCLC,10/3/2022,-1,CONCURRENT,Off Systemic Therapy,G26B488B88188,FALSE,1/13/2024
NSCLC,1/21/2020,3,ADVANCED,"Docetaxel,Ramucirumab",G58E33F7EG254,FALSE,2/6/2020
NSCLC,11/25/2019,-1,ADJUVANT,Leuprolide,G1D41F368EE:G,FALSE,3/30/2020
NSCLC,8/9/2018,4,ADVANCED,Nivolumab,G1D:B49GGG719,FALSE,1/27/2019
NSCLC,2/28/2017,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,6/27/2017
NSCLC,3/10/2017,3,ADVANCED,Pembrolizumab,G35EFEEBCDBDC,FALSE,6/10/2018
NSCLC,2/27/2015,1,ADVANCED,"Bevacizumab,Pemetrexed",G11B743:8G337,TRUE,6/18/2016
NSCLC,3/26/2013,1,ADVANCED,Erlotinib,G18C1EG39143B,FALSE,9/27/2014
NSCLC,1/13/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1B11FE17FE99,FALSE,4/5/2023
NSCLC,5/15/2017,1,ADVANCED,Pembrolizumab,G57G45B:D1F17,FALSE,10/19/2017
NSCLC,6/2/2023,2,ADVANCED,Osimertinib,G2C521EB94C:2,FALSE,5/3/2025
NSCLC,3/18/2022,-1,ADJUVANT,Durvalumab,G2GD72:FBC5FG,FALSE,4/13/2024
NSCLC,1/23/2024,1,ADVANCED,"Carboplatin,Paclitaxel",G3B76E8182:B:,FALSE,5/18/2024
NSCLC,1/31/2021,-1,ADJUVANT,Off Systemic Therapy,G432E:9E:21DC,FALSE,7/11/2022
NSCLC,2/22/2017,1,ADVANCED,"Carboplatin,Pemetrexed",G5669E21B9D52,FALSE,3/7/2017
NSCLC,1/10/2018,1,ADVANCED,Pembrolizumab,G3B:GGE2C4G47,FALSE,3/6/2019
NSCLC,6/9/2020,-1,ADJUVANT,Azacitidine,G1:F129FBCE3F,FALSE,9/24/2020
NSCLC,6/20/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G4F3:G92:612D,FALSE,5/3/2018
NSCLC,5/11/2016,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G415ED9:41F64,FALSE,8/25/2017
NSCLC,11/28/2022,1,ADVANCED,Tepotinib,G278ED563CF9F,FALSE,6/21/2023
NSCLC,10/13/2016,3,ADVANCED,Pembrolizumab,G1:D34FC71922,FALSE,12/15/2016
NSCLC,7/20/2022,2,ADVANCED,"Alectinib,Lorlatinib",G217694659D6F,FALSE,10/1/2022
NSCLC,5/11/2017,1,ADVANCED,Erlotinib,G3DG:CFF4F7:G,FALSE,8/22/2017
NSCLC,2/17/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G11D1:8:62429,FALSE,7/15/2015
NSCLC,7/17/2015,-1,CONCURRENT,"Carboplatin,Paclitaxel",G2364B7D68FE2,FALSE,11/24/2015
NSCLC,12/17/2015,3,ADVANCED,"Nivolumab,Vemurafenib",G4C53C5GC48E:,FALSE,6/19/2016
NSCLC,7/15/2017,1,ADVANCED,Bevacizumab,G19GDC129D136,FALSE,7/18/2018
NSCLC,10/25/2024,3,ADVANCED,Docetaxel,G164G31958638,FALSE,11/4/2024
NSCLC,7/2/2015,-1,CONCURRENT,Off Systemic Therapy,G2799FBE7D4B8,FALSE,4/17/2025
NSCLC,10/8/2023,-1,ADJUVANT,"Carboplatin,Pemetrexed",G2:737C75FGBF,FALSE,2/1/2024
NSCLC,6/1/2023,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1ECEG1B31B5C,TRUE,9/11/2023
NSCLC,7/4/2022,-1,ADJUVANT,Off Systemic Therapy,G376E97C95:G:,FALSE,8/12/2023
NSCLC,8/14/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G28G5D2B769B5,FALSE,11/7/2014
NSCLC,3/27/2024,2,ADVANCED,Pembrolizumab,G1E2B6::D8477,FALSE,4/21/2025
NSCLC,12/12/2023,-1,ADJUVANT,Off Systemic Therapy,G56B734583C17,FALSE,3/12/2025
NSCLC,8/29/2011,-1,ADJUVANT,"Cisplatin,Paclitaxel",G56B4BCB27428,FALSE,1/4/2012
NSCLC,3/24/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G1DD111EC2E4G,FALSE,5/22/2021
NSCLC,5/4/2024,1,ADVANCED,Osimertinib,G33E55:63F87C,FALSE,4/19/2025
NSCLC,3/6/2013,-1,ADJUVANT,Off Systemic Therapy,G31:9DD57G8:5,FALSE,12/11/2013
NSCLC,3/23/2019,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,FALSE,3/25/2020
NSCLC,3/30/2015,-1,ADJUVANT,Off Systemic Therapy,G2F23BB58DF:9,FALSE,12/17/2015
NSCLC,5/19/2014,-1,ADJUVANT,Cisplatin,G1F:9CFGFGFC1,FALSE,6/3/2014
NSCLC,10/1/2023,-1,ADJUVANT,"Cisplatin,Pemetrexed",G12184C2C1CC4,FALSE,12/16/2023
NSCLC,11/12/2022,3,ADVANCED,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin",G16C41789C1C5,FALSE,5/14/2023
NSCLC,7/8/2017,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,11/14/2017
NSCLC,8/22/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G35:D379:C56C,FALSE,12/1/2021
NSCLC,2/12/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G4497G86984C8,FALSE,4/11/2015
NSCLC,9/13/2022,-1,ADJUVANT,"Cisplatin,Pemetrexed",G5344:8G5698G,FALSE,11/17/2022
NSCLC,2/5/2013,1,ADVANCED,Gemcitabine,G1665E:E6:E1:,FALSE,12/28/2013
NSCLC,3/24/2024,1,ADVANCED,Pembrolizumab,G1:46DC16B5B8,TRUE,7/11/2024
NSCLC,4/1/2020,-1,ADJUVANT,Off Systemic Therapy,G1CG8EF93777D,FALSE,8/14/2020
NSCLC,2/6/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G14DC7EEE99BF,FALSE,10/7/2015
NSCLC,7/5/2015,1,ADVANCED,"Carboplatin,Pemetrexed",G243C3G2697F5,FALSE,6/26/2015
NSCLC,12/31/2012,1,ADVANCED,"Carboplatin,Docetaxel",G32:::74B314F,FALSE,2/1/2013
NSCLC,3/8/2025,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4CFGEG188695,FALSE,3/6/2025
NSCLC,3/31/2024,1,ADVANCED,"Cisplatin,Gemcitabine,Pembrolizumab",G28F814933C3F,FALSE,8/28/2024
NSCLC,4/18/2015,-1,ADJUVANT,Off Systemic Therapy,G266C31886:66,FALSE,9/3/2024
NSCLC,12/9/2014,1,ADVANCED,"Gemcitabine,Vinorelbine",G14FD45889171,FALSE,2/11/2015
NSCLC,1/7/2016,1,ADVANCED,Pemetrexed,G28E1765:691E,FALSE,4/29/2022
NSCLC,10/30/2018,-1,ADJUVANT,Off Systemic Therapy,G2CC42E:::G72,FALSE,1/15/2019
NSCLC,6/3/2014,1,ADVANCED,"Carboplatin,Pemetrexed",G2D5B71G65F2G,FALSE,7/27/2015
NSCLC,5/17/2019,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G4C915B9CFD61,FALSE,9/19/2019
NSCLC,6/21/2015,-1,ADJUVANT,Off Systemic Therapy,G358EF4457D52,FALSE,6/4/2016
NSCLC,7/31/2019,1,ADVANCED,"Cisplatin,Etoposide",G1B3558DGF36B,FALSE,12/25/2019
NSCLC,10/13/2024,-1,ADJUVANT,Off Systemic Therapy,G2E42F615FFFC,FALSE,11/26/2024
NSCLC,4/5/2022,1,ADVANCED,Durvalumab,G287777772FGE,TRUE,11/28/2022
NSCLC,2/13/2012,-1,ADJUVANT,Off Systemic Therapy,G3BCC2GG732G:,FALSE,9/27/2014
NSCLC,6/18/2011,1,ADVANCED,Clinical Study Drug,G118F63B281FD,FALSE,6/18/2011
NSCLC,12/10/2022,-1,NEOADJUVANT,"Carboplatin,Nivolumab,Paclitaxel",G2DC29B:962F1,FALSE,1/29/2023
NSCLC,11/12/2021,-1,ADVANCED,Off Systemic Therapy,G54F545489E59,FALSE,11/11/2021
NSCLC,2/25/2020,1,ADVANCED,Osimertinib,G5B3B6C1D1B9E,FALSE,4/13/2025
NSCLC,2/24/2024,-1,ADJUVANT,"Carboplatin,Paclitaxel,Pembrolizumab",G1F167DBC45:8,FALSE,3/1/2024
NSCLC,6/13/2015,2,ADVANCED,Nivolumab,G1G:548DD7228,FALSE,8/15/2017
NSCLC,2/11/2022,1,ADVANCED,Sotorasib,G3CFD616B13G9,FALSE,6/8/2022
NSCLC,8/25/2021,-1,ADJUVANT,"Bendamustine,Rituximab-Pvvr",G1B6GF976DEG:,FALSE,1/21/2023
NSCLC,9/21/2020,-1,ADJUVANT,"Letrozole,Osimertinib",G31G19E54FC:B,FALSE,10/6/2023
NSCLC,2/23/2024,1,ADVANCED,Pembrolizumab,G353EE82411C:,FALSE,4/15/2024
NSCLC,12/12/2019,2,ADVANCED,"Docetaxel,Gemcitabine,Pazopanib",G51:G:C712CC6,FALSE,7/16/2020
NSCLC,4/10/2012,2,ADVANCED,"Docetaxel,Gemcitabine",G344BC2:6BGE1,FALSE,1/14/2013
NSCLC,11/4/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G1D42285:8G7C,FALSE,1/16/2016
NSCLC,1/28/2024,-1,ADJUVANT,Durvalumab,G445F26762F72,FALSE,4/24/2024
NSCLC,8/10/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1G5G8G1EE2EG,FALSE,7/23/2019
NSCLC,3/17/2018,3,ADVANCED,Gemcitabine,G2FF2946:4C6F,FALSE,7/1/2018
NSCLC,4/24/2015,1,ADVANCED,"Carboplatin,Gemcitabine,Nivolumab",G5762B778F:95,FALSE,3/27/2016
NSCLC,5/7/2020,-1,ADJUVANT,"Cisplatin,Pemetrexed",G2F1E5F6F6:E1,FALSE,8/17/2020
NSCLC,11/16/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1F9BCG13:EFD,FALSE,4/7/2022
NSCLC,2/10/2015,2,ADVANCED,Pemetrexed,G1E772CFC2E2E,FALSE,2/7/2015
NSCLC,7/17/2020,3,ADVANCED,Nivolumab,G22D6BD662E16,FALSE,5/26/2024
NSCLC,11/21/2022,3,ADVANCED,"Bevacizumab-Bvzr,Carboplatin,Osimertinib,Pemetrexed",G4725296E3CE4,FALSE,2/15/2023
NSCLC,4/14/2014,1,ADVANCED,Erlotinib,G1188466C5727,FALSE,12/25/2014
NSCLC,7/4/2024,1,ADVANCED,Pembrolizumab,G28F814933C3F,TRUE,12/29/2024
NSCLC,7/20/2013,1,ADVANCED,"Carboplatin,Gemcitabine",G4:72GGEFB4B:,FALSE,11/16/2013
NSCLC,10/3/2021,4,ADVANCED,"Atezolizumab,Paclitaxel Protein-Bound",G2G1D1B:745EG,FALSE,11/17/2021
NSCLC,3/16/2019,1,ADVANCED,Anastrozole,G1F26CECEF:89,FALSE,4/29/2019
NSCLC,9/17/2011,1,ADVANCED,"Carboplatin,Paclitaxel",G161FDD242EB9,FALSE,11/30/2011
NSCLC,3/4/2013,-1,ADJUVANT,Off Systemic Therapy,G3DG:2D1DGE8B,FALSE,9/16/2014
NSCLC,5/6/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1CC5BCCG41B4,FALSE,8/16/2019
NSCLC,11/28/2023,1,ADVANCED,"Docetaxel,Ramucirumab",G53C52948773G,FALSE,3/19/2024
NSCLC,3/26/2023,3,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2D168F99BCD4,FALSE,10/22/2023
NSCLC,2/21/2018,2,ADVANCED,Nivolumab,G4464DBGC:5B4,FALSE,4/5/2025
NSCLC,12/9/2024,-1,ADJUVANT,Durvalumab,G1GEF44EBD419,FALSE,3/21/2025
NSCLC,9/9/2021,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1653:4:85F6:,FALSE,12/23/2021
NSCLC,4/1/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2457626BC269,FALSE,4/27/2025
NSCLC,8/9/2011,1,ADVANCED,Clinical Study Drug,G4GE2958C:E1C,FALSE,5/4/2012
NSCLC,3/8/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G56CF8BF38D:7,FALSE,9/23/2013
NSCLC,12/10/2018,1,ADVANCED,Paclitaxel Protein-Bound,G5829EBB749DF,FALSE,4/30/2019
NSCLC,2/19/2018,2,ADVANCED,Pembrolizumab,G22F:D77B6329,FALSE,3/1/2018
NSCLC,4/26/2022,3,ADVANCED,"Ipilimumab,Nivolumab",G17177B5C7D7F,FALSE,12/5/2022
NSCLC,12/17/2021,3,ADVANCED,Durvalumab,G1:64BD9C5919,FALSE,2/16/2024
NSCLC,3/22/2024,-1,ADJUVANT,Pembrolizumab,G242GD729:FB:,FALSE,4/28/2024
NSCLC,9/9/2021,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G25483:FF8C25,FALSE,12/31/2021
NSCLC,3/5/2025,3,ADVANCED,Sotorasib,G1G:1C482FFGC,FALSE,4/14/2025
NSCLC,10/21/2023,-1,CONCURRENT,"Carboplatin,Paclitaxel,Pembrolizumab",G224DD757657B,FALSE,1/25/2024
NSCLC,10/24/2015,1,ADVANCED,Clinical Study Drug,G132B61FB651B,FALSE,11/29/2015
NSCLC,5/28/2023,6,ADVANCED,Niraparib,G38D11EG5F826,FALSE,8/15/2024
NSCLC,7/10/2018,1,LOCOREGIONAL,"Cisplatin,Pemetrexed",G548B2:G6G6D:,FALSE,11/24/2018
NSCLC,9/30/2016,-1,ADJUVANT,Fulvestrant,G286G2E848134,FALSE,10/22/2016
NSCLC,8/18/2024,2,ADVANCED,Cemiplimab,G2262335C:D62,FALSE,11/22/2024
NSCLC,12/6/2012,1,ADVANCED,Bevacizumab,G1E589EBD8F93,TRUE,3/26/2013
NSCLC,8/18/2014,-1,ADJUVANT,"Carboplatin,Paclitaxel",G325B2E578F89,FALSE,1/30/2015
NSCLC,3/20/2025,2,ADVANCED,"Docetaxel,Ramucirumab",G2F327FD5:2:3,FALSE,3/20/2025
NSCLC,4/29/2022,1,ADVANCED,Cisplatin,G116:6C4GD4D2,FALSE,12/12/2024
NSCLC,11/20/2023,2,ADVANCED,"Carboplatin,Pemetrexed",G252328CFG4E1,FALSE,1/27/2024
NSCLC,12/8/2021,0,,Line Zero,G28:58D343FCF,FALSE,7/30/2022
NSCLC,12/7/2024,2,LOCOREGIONAL,Gemcitabine,G51CG28FB981G,FALSE,4/16/2025
NSCLC,11/7/2019,-1,ADJUVANT,Rituximab,G5545136B977G,FALSE,10/17/2019
NSCLC,12/4/2016,-1,ADJUVANT,"Cisplatin,Gemcitabine",G1:641727397B,FALSE,4/5/2017
NSCLC,6/23/2022,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G4C4FFC35G979,FALSE,10/6/2022
NSCLC,4/12/2019,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G21:2B8189648,FALSE,4/23/2019
NSCLC,10/26/2021,-1,ADJUVANT,Anastrozole,G1:9FCE6E6G6C,FALSE,11/12/2021
NSCLC,3/23/2013,-1,CONCURRENT,Pemetrexed,G289C6438E26:,FALSE,3/21/2013
NSCLC,8/13/2017,-1,ADJUVANT,"Cisplatin,Etoposide",G2CF99E8E8CF7,FALSE,9/16/2017
NSCLC,10/16/2022,-1,NEOADJUVANT,"Cyclophosphamide,Docetaxel",G1GFD92F489E7,FALSE,1/9/2023
NSCLC,7/2/2023,-1,ADJUVANT,Osimertinib,G1:9FCE6E6G6C,FALSE,4/17/2025
NSCLC,3/11/2012,-1,ADJUVANT,Off Systemic Therapy,G56B4BCB27428,FALSE,5/8/2014
NSCLC,1/16/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G153G5833D6D1,FALSE,4/1/2019
NSCLC,6/19/2021,-1,NEOADJUVANT,Pembrolizumab,G38C61:99G266,FALSE,6/6/2021
NSCLC,12/11/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G4B63:1C9D452,FALSE,9/3/2016
NSCLC,6/9/2023,1,ADVANCED,Pembrolizumab,G1554C84G3CD2,FALSE,10/26/2023
NSCLC,10/23/2017,1,ADVANCED,"Carboplatin,Gemcitabine",G18B63F1G3977,FALSE,1/16/2018
NSCLC,1/16/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G2G173G:4FD7E,FALSE,1/20/2014
NSCLC,10/23/2023,-1,ADJUVANT,Off Systemic Therapy,G31G19E54FC:B,FALSE,12/24/2023
NSCLC,5/20/2019,-1,ADJUVANT,Off Systemic Therapy,G1G913:D125BD,FALSE,5/26/2020
NSCLC,3/25/2020,1,ADVANCED,"Carboplatin,Pemetrexed",G4826CB54C27:,FALSE,4/23/2020
NSCLC,10/23/2018,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G462G467E1BF1,FALSE,10/30/2018
NSCLC,8/18/2015,-1,ADJUVANT,"Carboplatin,Paclitaxel",G134249173C:9,FALSE,10/22/2015
NSCLC,11/21/2016,2,ADVANCED,Erlotinib,G5273D::F8155,FALSE,11/15/2016
NSCLC,8/2/2019,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound,Pembrolizumab",G1C22CGB1F5C2,FALSE,12/23/2019
NSCLC,2/20/2023,-1,ADJUVANT,Anastrozole,G1GFD92F489E7,FALSE,2/20/2023
NSCLC,10/24/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G38F8684B8FG8,FALSE,11/2/2015
NSCLC,7/4/2014,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G2EBF3CF86FF9,FALSE,10/25/2014
NSCLC,4/10/2024,-1,ADJUVANT,"Abiraterone,Leuprolide,Pembrolizumab",G2G419135CEEC,FALSE,5/1/2025
NSCLC,8/13/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G1CG8EF93777D,FALSE,10/30/2019
NSCLC,4/9/2016,3,ADVANCED,Fulvestrant,G272F2D3BB8C2,FALSE,6/1/2016
NSCLC,3/7/2025,1,ADVANCED,"Carboplatin,Pemetrexed",G242GD729:FB:,FALSE,5/7/2025
NSCLC,7/17/2013,5,ADVANCED,"Carboplatin,Gemcitabine",G18E7528ED97:,FALSE,9/15/2013
NSCLC,10/26/2014,1,ADVANCED,"Cisplatin,Clinical Study Drug,Docetaxel",G1E772CFC2E2E,FALSE,2/12/2015
NSCLC,1/2/2017,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G15C9CDFE7236,FALSE,4/1/2017
NSCLC,8/4/2021,1,ADVANCED,Durvalumab,G11F85:F1CG29,FALSE,12/28/2021
NSCLC,9/23/2023,2,ADVANCED,Osimertinib,G1::2C155D:6E,FALSE,4/28/2025
NSCLC,8/5/2022,1,ADVANCED,Durvalumab,G128:92:3BD3D,TRUE,2/13/2023
NSCLC,10/8/2021,-1,NEOADJUVANT,Capecitabine,G23ED3EB7B1B2,FALSE,11/9/2021
NSCLC,7/21/2021,2,ADVANCED,Amivantamab-Vmjw,G57B5F4B556EG,FALSE,3/11/2022
NSCLC,6/30/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G1GE52D9E9C7B,FALSE,11/21/2015
NSCLC,8/7/2017,-1,ADJUVANT,"Carboplatin,Paclitaxel",G1FE1DBD491BE,FALSE,9/28/2017
NSCLC,3/7/2016,1,ADVANCED,Bevacizumab,G193F989CDC3D,TRUE,3/12/2016
NSCLC,1/7/2016,1,ADVANCED,"Carboplatin,Paclitaxel",G24E:FB36:C8B,FALSE,3/14/2025
NSCLC,4/16/2021,-1,ADJUVANT,Off Systemic Therapy,G1FE2:9777177,FALSE,11/5/2021
NSCLC,9/28/2024,2,ADVANCED,"Cemiplimab,Pemetrexed",G1D75:47CG6C7,FALSE,12/19/2024
NSCLC,3/13/2023,4,ADVANCED,Fam-Trastuzumab Deruxtecan-Nxki,G4725296E3CE4,FALSE,3/29/2023
NSCLC,5/7/2016,-1,ADJUVANT,Off Systemic Therapy,G5817G:99GE51,FALSE,11/15/2016
NSCLC,9/15/2021,1,ADVANCED,Pemetrexed,G2C38B34G8794,TRUE,10/24/2022
NSCLC,4/26/2018,-1,ADJUVANT,Off Systemic Therapy,G3142D1E86841,FALSE,10/21/2018
NSCLC,9/8/2022,2,ADVANCED,Pembrolizumab,G19:83254DDF6,FALSE,3/6/2023
NSCLC,1/28/2021,5,ADVANCED,Pembrolizumab,G3:C9BECD3F55,FALSE,5/21/2021
NSCLC,6/13/2023,1,LOCOREGIONAL,"Carboplatin,Pembrolizumab,Pemetrexed",G2F55125:5174,FALSE,6/8/2024
NSCLC,5/20/2023,1,ADVANCED,Pembrolizumab,G1EE49EC392G6,FALSE,6/11/2024
NSCLC,2/24/2023,1,ADVANCED,"Carboplatin,Cemiplimab,Pemetrexed",G563BBB4G:855,FALSE,5/20/2023
NSCLC,12/5/2014,2,ADVANCED,Gemcitabine,G1D84CDE8:C5E,FALSE,4/4/2015
NSCLC,5/25/2021,4,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G11:F93GC6851,FALSE,5/21/2021
NSCLC,2/12/2014,-1,CONCURRENT,Off Systemic Therapy,G1185:32426FB,FALSE,2/14/2015
NSCLC,6/25/2019,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G26EC77G8EG55,FALSE,9/16/2019
NSCLC,5/25/2014,1,ADVANCED,"Carboplatin,Paclitaxel",G45GCCC8711F:,FALSE,1/14/2022
NSCLC,9/3/2020,1,ADVANCED,Pembrolizumab,G21881333DGG2,TRUE,4/24/2021
NSCLC,9/20/2021,-1,NEOADJUVANT,"Carboplatin,Paclitaxel",G35:D379:C56C,FALSE,9/7/2021
NSCLC,2/28/2016,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G226G4F43C6FE,FALSE,5/15/2016
NSCLC,11/4/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G1::2C155D:6E,TRUE,11/10/2023
NSCLC,11/10/2019,1,ADVANCED,Osimertinib,G4BFGE1G7646C,FALSE,3/11/2020
NSCLC,7/20/2021,2,ADVANCED,Clinical Study Drug,G1G7:9D7EC1EC,FALSE,9/7/2021
NSCLC,3/10/2018,1,ADVANCED,Durvalumab,G1G78CEE:7E:3,TRUE,7/20/2018
NSCLC,6/13/2019,-1,ADJUVANT,Bicalutamide,G4992B5EB431G,FALSE,5/24/2019
NSCLC,5/17/2020,-1,CONCURRENT,"Carboplatin,Paclitaxel",G11F85:F1CG29,FALSE,10/21/2020
NSCLC,1/26/2015,1,ADVANCED,Letrozole,G16GE86G42194,FALSE,12/19/2015
NSCLC,5/9/2021,-1,CONCURRENT,"Carboplatin,Paclitaxel",G376E97C95:G:,FALSE,8/12/2021
NSCLC,7/1/2018,-1,ADJUVANT,Off Systemic Therapy,G3487E:C:CDC6,FALSE,11/17/2018
NSCLC,5/17/2018,-1,ADJUVANT,"Carboplatin,Paclitaxel",G59G454E1B6B3,FALSE,7/24/2018
NSCLC,4/22/2020,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G252C2C21CF9:,FALSE,7/26/2020
NSCLC,12/16/2019,1,ADVANCED,"Carboplatin,Paclitaxel,Pembrolizumab",G27:4356GC7E5,FALSE,6/2/2020
NSCLC,9/8/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G19E:848FD3G5,FALSE,2/17/2021
NSCLC,5/30/2013,-1,ADJUVANT,Off Systemic Therapy,G13F669ED2119,FALSE,2/2/2014
NSCLC,12/26/2013,2,ADVANCED,Pemetrexed,G2FF1862EC655,FALSE,1/24/2014
NSCLC,11/7/2016,-1,ADJUVANT,"Fulvestrant,Palbociclib",G286G2E848134,FALSE,2/3/2019
NSCLC,6/1/2020,2,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1B59D86EEB5E,FALSE,12/29/2022
NSCLC,12/31/2016,1,ADVANCED,"Cisplatin,Etoposide,Paclitaxel",G4GE2BD8C57D9,FALSE,9/27/2017
NSCLC,6/26/2012,3,ADVANCED,Erlotinib,G2177D1::DG1E,FALSE,7/3/2012
NSCLC,3/5/2013,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G131EFCB91:B2,FALSE,9/13/2013
NSCLC,4/5/2023,1,ADVANCED,Durvalumab,G1532797B869C,TRUE,7/17/2023
NSCLC,7/1/2016,1,ADVANCED,"Bevacizumab,Pemetrexed",G1D:B49GGG719,TRUE,11/14/2016
NSCLC,7/23/2015,2,ADVANCED,Crizotinib,G53C61B2GG71F,FALSE,4/14/2016
NSCLC,4/3/2023,3,LOCOREGIONAL,Paclitaxel Protein-Bound,G548B2:G6G6D:,FALSE,12/18/2024
NSCLC,3/22/2020,1,ADVANCED,"Carboplatin,Pemetrexed",G517B45372B5D,FALSE,6/10/2020
NSCLC,12/27/2024,-1,ADJUVANT,"Bevacizumab-Bvzr,Fluorouracil,Leucovorin,Oxaliplatin",G5724:G6:4ED5,FALSE,3/7/2025
NSCLC,7/3/2019,1,ADVANCED,Clinical Study Drug,G262FC43B61CF,FALSE,8/14/2019
NSCLC,7/9/2012,2,ADVANCED,Pemetrexed,G1EEBCF2E91G2,FALSE,7/24/2013
NSCLC,11/2/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G39GB9B7D:9:C,FALSE,12/28/2015
NSCLC,1/25/2019,-1,ADJUVANT,Durvalumab,G2CC42E:::G72,FALSE,7/12/2019
NSCLC,2/28/2023,-1,ADJUVANT,"Carboplatin,Pemetrexed",G1D14:53C99:F,FALSE,4/22/2023
NSCLC,8/4/2016,1,ADVANCED,Nivolumab,G11:F93GC6851,FALSE,6/19/2020
NSCLC,11/8/2021,1,ADVANCED,"Carboplatin,Paclitaxel",G337BE1E83:B7,FALSE,2/13/2022
NSCLC,12/18/2021,1,ADVANCED,Pembrolizumab,G2GF55749G7G9,FALSE,12/25/2021
NSCLC,11/2/2024,1,ADVANCED,"Ipilimumab,Nivolumab",G11E67B3F9DC7,TRUE,3/31/2025
NSCLC,2/10/2014,2,ADVANCED,"Bevacizumab,Gemcitabine",G3FFB5516FEDF,FALSE,6/30/2014
NSCLC,2/10/2020,2,ADVANCED,"Docetaxel,Ramucirumab",G2CCC3642E:67,FALSE,3/1/2020
NSCLC,1/12/2014,-1,ADJUVANT,"Carboplatin,Docetaxel",G59G63545722G,FALSE,3/29/2014
NSCLC,4/25/2025,2,ADVANCED,Durvalumab,G1FG3GD3:9D:3,FALSE,4/29/2025
NSCLC,10/8/2024,3,ADVANCED,Durvalumab,G3FG621769317,FALSE,4/1/2025
NSCLC,2/8/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G24632:D18158,FALSE,5/11/2019
NSCLC,12/16/2019,-1,CONCURRENT,"Carboplatin,Paclitaxel",G4EF93:EF39:7,FALSE,4/2/2020
NSCLC,12/8/2019,2,ADVANCED,Methotrexate,G298FGDFDG8E7,FALSE,1/18/2020
NSCLC,5/6/2020,2,ADVANCED,Pembrolizumab,G517B45372B5D,FALSE,12/26/2020
NSCLC,1/24/2020,-1,ADJUVANT,"Cisplatin,Pemetrexed",G3E464G5769E:,FALSE,5/7/2020
NSCLC,6/25/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G269E92F97C56,FALSE,2/10/2016
NSCLC,2/7/2020,1,ADVANCED,Pemetrexed,G27:46:6B7F9E,TRUE,4/9/2025
NSCLC,7/15/2021,-1,ADJUVANT,Off Systemic Therapy,G1B11153DEF52,FALSE,11/6/2024
NSCLC,4/21/2024,1,ADVANCED,Cemiplimab,G4484725BB423,TRUE,1/20/2025
NSCLC,4/22/2012,1,ADVANCED,"Carboplatin,Paclitaxel",G1F4G973F319F,FALSE,3/20/2013
NSCLC,3/14/2020,-1,ADJUVANT,Durvalumab,G4EF93:EF39:7,FALSE,4/7/2020
NSCLC,7/17/2024,2,ADVANCED,"Carboplatin,Osimertinib,Pemetrexed",G18DFE96F9:2G,FALSE,4/6/2025
NSCLC,11/1/2020,3,ADVANCED,Gemcitabine,G121:2D8:4E94,FALSE,6/15/2021
NSCLC,3/23/2016,2,ADVANCED,"Carboplatin,Nivolumab,Paclitaxel",G5762B778F:95,FALSE,6/28/2016
NSCLC,6/12/2018,1,ADVANCED,Nivolumab,G4C2EB36BG3:G,FALSE,4/10/2019
NSCLC,12/25/2014,3,ADVANCED,Docetaxel,G1:78734BCEDB,FALSE,3/1/2015
NSCLC,12/18/2018,1,ADVANCED,Afatinib,G5:7G3C6E4C81,FALSE,12/28/2018
NSCLC,8/31/2024,1,ADVANCED,"Carboplatin,Pemetrexed",G3951BC5GBE44,FALSE,12/7/2024
NSCLC,12/3/2019,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G1934B71378C6,FALSE,3/19/2020
NSCLC,3/8/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G128F49G19C6D,FALSE,5/30/2015
NSCLC,2/3/2024,-1,NEOADJUVANT,Off Systemic Therapy,G46:6C69:D9:C,FALSE,5/28/2024
NSCLC,3/18/2020,-1,ADJUVANT,"Enzalutamide,Leuprolide",G1D41F368EE:G,FALSE,4/13/2025
NSCLC,4/16/2015,-1,CONCURRENT,Off Systemic Therapy,G2:B72E3:5CD9,FALSE,2/4/2017
NSCLC,5/23/2021,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G3:35C52691D:,FALSE,9/29/2021
NSCLC,9/27/2023,2,ADVANCED,Nivolumab,G1CF4D5D1:BF3,FALSE,10/11/2023
NSCLC,4/1/2024,2,ADVANCED,Gemcitabine,G53C52948773G,FALSE,4/15/2024
NSCLC,5/23/2013,-1,ADJUVANT,Off Systemic Therapy,G5995:57EB51E,FALSE,5/24/2018
NSCLC,5/3/2015,2,ADVANCED,"Carboplatin,Pemetrexed",G1:D34FC71922,FALSE,10/26/2016
NSCLC,11/29/2024,1,ADVANCED,Pembrolizumab,G2BEFF41G59F1,FALSE,11/16/2024
NSCLC,2/10/2022,-1,ADJUVANT,Off Systemic Therapy,G22FG21G231E9,FALSE,6/17/2022
NSCLC,2/2/2024,1,ADVANCED,Osimertinib,G54B7:9:4B62G,FALSE,1/11/2025
NSCLC,9/15/2015,1,ADVANCED,"Carboplatin,Etoposide",G325B2E578F89,FALSE,3/10/2016
NSCLC,4/26/2023,-1,ADJUVANT,Pembrolizumab,G2G22BF9DCG81,FALSE,6/29/2023
NSCLC,12/24/2021,7,ADVANCED,"Ipilimumab,Nivolumab",G3:C9BECD3F55,FALSE,3/29/2022
NSCLC,8/13/2019,2,ADVANCED,Pembrolizumab,G3EG8DGC9B:1E,FALSE,6/15/2020
NSCLC,5/14/2018,1,ADVANCED,Pembrolizumab,G4GD:D13B31BB,FALSE,12/30/2018
NSCLC,1/6/2014,-1,ADJUVANT,Off Systemic Therapy,G358963178E45,FALSE,6/30/2014
NSCLC,9/27/2016,-1,CONCURRENT,"Carboplatin,Paclitaxel Protein-Bound",G264B2D11BG13,FALSE,1/26/2017
NSCLC,9/16/2020,1,ADVANCED,Pembrolizumab,G1F8F989D:8C8,FALSE,11/28/2022
NSCLC,3/17/2012,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G433B43E81BG1,FALSE,9/17/2012
NSCLC,10/16/2013,-1,ADJUVANT,"Cisplatin,Vinorelbine",G11D1:8:62429,FALSE,12/26/2013
NSCLC,9/2/2021,1,ADVANCED,"Erlotinib,Ramucirumab",G4725296E3CE4,FALSE,10/18/2021
NSCLC,4/4/2015,-1,ADJUVANT,"Carboplatin,Paclitaxel",G266C31886:66,FALSE,4/17/2015
NSCLC,1/1/2021,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G48FCG1D:D6C5,FALSE,4/27/2021
NSCLC,11/21/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G2GBG899C7446,FALSE,1/11/2025
NSCLC,3/17/2013,-1,ADJUVANT,Off Systemic Therapy,G1G:1C482FFGC,FALSE,11/24/2014
NSCLC,3/13/2022,-1,ADJUVANT,Off Systemic Therapy,G485C85BECGC4,FALSE,11/25/2024
NSCLC,11/6/2024,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G5344:8G5698G,FALSE,2/17/2025
NSCLC,3/7/2025,4,ADVANCED,"Docetaxel,Ramucirumab",G2262335C:D62,FALSE,3/24/2025
NSCLC,4/5/2015,-1,ADJUVANT,"Cisplatin,Gemcitabine",G24:75F1:6CB3,FALSE,5/18/2015
NSCLC,6/16/2020,2,ADVANCED,Osimertinib,G115873FC55G5,FALSE,1/17/2021
NSCLC,10/12/2024,1,LOCOREGIONAL,Exemestane,G1561187B7F::,FALSE,2/20/2025
NSCLC,1/18/2015,-1,CONCURRENT,"Carboplatin,Paclitaxel Protein-Bound",G57:2GEC9DD36,FALSE,10/19/2015
NSCLC,2/17/2016,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G1E586G415EF7,FALSE,2/20/2016
NSCLC,3/10/2023,1,ADVANCED,"Atezolizumab,Bevacizumab-Awwb",G2FB35E4B8C3C,TRUE,3/25/2024
NSCLC,8/23/2017,2,ADVANCED,Nivolumab,G33E77:6CF7F3,FALSE,12/12/2017
NSCLC,7/6/2020,3,ADVANCED,"Clinical Study Drug,Doxorubicin",G51:G:C712CC6,FALSE,3/6/2021
NSCLC,3/5/2025,1,ADVANCED,"Pembrolizumab,Pemetrexed",G4F6F:2B3D7CG,TRUE,4/15/2025
NSCLC,4/25/2022,4,ADVANCED,"Ipilimumab,Nivolumab",G1594:E29D2D9,FALSE,6/2/2022
NSCLC,12/12/2012,2,ADVANCED,Erlotinib,G3B942496:87:,FALSE,12/23/2012
NSCLC,9/27/2024,-1,ADJUVANT,Durvalumab,G3B8B956G8339,FALSE,4/13/2025
NSCLC,11/27/2023,-1,ADJUVANT,Durvalumab,G55D67392F8:9,FALSE,12/22/2024
NSCLC,6/1/2020,1,ADVANCED,Pembrolizumab,G1GC7BGB8G544,TRUE,8/15/2020
NSCLC,1/6/2021,-1,ADJUVANT,Off Systemic Therapy,G574795::16B2,FALSE,3/23/2025
NSCLC,11/19/2014,1,ADVANCED,"Bevacizumab,Carboplatin,Pemetrexed",G46:87GF7FGC9,FALSE,4/20/2015
NSCLC,9/22/2023,3,ADVANCED,"Amivantamab-Vmjw,Osimertinib",G2FF5BBF:G7GF,FALSE,5/5/2024
NSCLC,1/29/2018,1,ADVANCED,"Carboplatin,Paclitaxel",G135BB2F5GCDF,FALSE,6/2/2018
NSCLC,9/13/2017,1,ADVANCED,Erlotinib,G115873FC55G5,FALSE,5/18/2020
NSCLC,9/30/2011,2,ADVANCED,Pemetrexed,G18E7528ED97:,FALSE,2/29/2012
NSCLC,12/11/2021,5,ADVANCED,Gemcitabine,G2G1D1B:745EG,FALSE,2/5/2022
NSCLC,5/22/2024,-1,CONCURRENT,"Carboplatin,Paclitaxel",G147D:E6:68B1,FALSE,7/29/2024
NSCLC,7/7/2021,1,ADVANCED,"Pembrolizumab,Pemetrexed",G27D282B7225B,TRUE,12/28/2021
NSCLC,3/24/2015,1,ADVANCED,Pemetrexed,G45C13CFDDB84,TRUE,12/14/2015
NSCLC,4/7/2016,2,ADVANCED,Nivolumab,G2F23BB58DF:9,FALSE,7/15/2019
NSCLC,12/1/2011,-1,ADJUVANT,Pemetrexed,G56B4BCB27428,FALSE,3/13/2012
NSCLC,3/13/2017,-1,ADJUVANT,Off Systemic Therapy,G11:82999D55C,FALSE,5/22/2018
NSCLC,6/1/2024,1,ADVANCED,"Carboplatin,Cemiplimab,Pemetrexed",G28F9:5:3CC38,FALSE,8/11/2024
NSCLC,5/31/2014,1,ADVANCED,Pemetrexed,G253D7G:9C8CE,TRUE,6/12/2014
NSCLC,2/2/2023,3,ADVANCED,"Docetaxel,Nivolumab",G2C38B34G8794,FALSE,9/22/2024
NSCLC,4/27/2024,1,ADVANCED,Durvalumab,G1BGE419C:CE7,TRUE,4/23/2025
NSCLC,9/8/2018,-1,ADJUVANT,Durvalumab,G459D:92E2344,FALSE,11/15/2019
NSCLC,11/13/2014,-1,ADJUVANT,Off Systemic Therapy,G19E:848FD3G5,FALSE,10/1/2019
NSCLC,9/3/2018,-1,ADJUVANT,"Carboplatin,Paclitaxel",G3642135:5B4C,FALSE,12/16/2018
NSCLC,4/13/2023,-1,ADJUVANT,"Atezolizumab,Bevacizumab-Bvzr",G2389G8E2B4EC,FALSE,7/31/2023
NSCLC,1/20/2025,1,ADVANCED,"Gemcitabine,Paclitaxel Protein-Bound",G559EGF3BF82E,FALSE,2/26/2025
NSCLC,7/27/2013,-1,NEOADJUVANT,"Carboplatin,Pemetrexed",G227FDC93E654,FALSE,11/1/2013
NSCLC,2/8/2021,-1,ADJUVANT,Anastrozole,G432E:9E:21DC,FALSE,1/1/2021
NSCLC,12/21/2017,1,ADVANCED,"Pembrolizumab,Pemetrexed",G27B:6426G6DG,TRUE,4/28/2020
NSCLC,8/16/2021,1,ADVANCED,Pembrolizumab,G226625298DGC,FALSE,9/15/2021
NSCLC,9/28/2013,5,ADVANCED,Pemetrexed,G166B735:96D2,FALSE,11/12/2013
NSCLC,12/2/2018,1,ADVANCED,"Carboplatin,Paclitaxel",G58E33F7EG254,FALSE,3/5/2019
NSCLC,11/16/2015,2,ADVANCED,Nivolumab,G4B1F584CB682,FALSE,1/19/2016
NSCLC,2/28/2024,1,ADVANCED,Alectinib,G1:641727397B,FALSE,4/19/2025
NSCLC,2/26/2015,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G448FDE96D2D6,FALSE,2/17/2015
NSCLC,11/7/2024,-1,ADJUVANT,Off Systemic Therapy,G35DGE621BE1E,FALSE,4/26/2025
NSCLC,5/31/2012,-1,NEOADJUVANT,Clinical Study Drug,G3B698C119:F8,FALSE,7/27/2012
NSCLC,6/13/2015,1,ADVANCED,"Carboplatin,Paclitaxel",G11545861:F9G,FALSE,3/13/2016
NSCLC,9/1/2020,1,ADVANCED,Nivolumab,G1CG8EF93777D,FALSE,2/24/2022
NSCLC,4/24/2023,-1,ADJUVANT,Off Systemic Therapy,G4C4:64E35941,FALSE,2/1/2025
NSCLC,6/12/2022,-1,ADJUVANT,Osimertinib,G22FG21G231E9,FALSE,6/18/2023
NSCLC,5/11/2022,1,ADVANCED,Durvalumab,G225D5E995642,TRUE,6/25/2022
NSCLC,9/30/2017,1,ADVANCED,"Carboplatin,Pembrolizumab,Pemetrexed",G27B:6426G6DG,FALSE,12/30/2017
NSCLC,9/5/2021,1,LOCOREGIONAL,"Carboplatin,Paclitaxel",G1G4BC1:B::63,FALSE,11/19/2021
NSCLC,4/6/2022,3,ADVANCED,"Amivantamab-Vmjw,Osimertinib",G57B5F4B556EG,FALSE,3/2/2022
NSCLC,8/22/2020,1,ADVANCED,Pembrolizumab,G252C2C21CF9:,TRUE,7/24/2022
NSCLC,7/26/2012,1,ADVANCED,"Cetuximab,Irinotecan",G1D61871659DG,FALSE,8/10/2012
NSCLC,10/8/2013,1,ADVANCED,"Carboplatin,Paclitaxel",G4D6CD2B8C5FD,FALSE,10/27/2013
NSCLC,3/7/2013,-1,CONCURRENT,Off Systemic Therapy,G48842BBE3634,FALSE,6/26/2013
NSCLC,5/17/2015,1,ADVANCED,"Bevacizumab,Carboplatin,Paclitaxel",G25E1C41F29EC,FALSE,9/22/2015
NSCLC,4/4/2019,-1,ADJUVANT,"Carboplatin,Pembrolizumab,Pemetrexed",G2G4EF:188C:1,FALSE,4/26/2019
NSCLC,3/6/2019,1,ADVANCED,Crizotinib,G183BG5B65678,FALSE,2/10/2020
NSCLC,5/19/2011,1,ADVANCED,"Carboplatin,Paclitaxel",G54368FF4E2E3,FALSE,5/25/2011
NSCLC,1/15/2016,1,ADVANCED,"Bevacizumab,Pemetrexed",G38D11EG5F826,TRUE,3/16/2020
NSCLC,3/13/2012,3,ADVANCED,Paclitaxel Protein-Bound,G18E7528ED97:,FALSE,9/5/2012
NSCLC,4/9/2014,1,ADVANCED,"Carboplatin,Paclitaxel Protein-Bound",G26534:GEG3:6,FALSE,8/9/2014
